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ABSTRACT 
The Gram-positive pathogens Corynebacterium diphtheriae and Streptococcus pyogenes 
both require iron for survival.  These bacteria have developed sophisticated heme uptake and 
transport protein machinery responsible for the import of iron into the cell, in the form of heme 
from the human host. The heme utilization pathway (hmu) of C. diphtheriae utilizes multiple 
proteins to bind and transport heme into the cell.  One of these proteins, HmuT, delivers heme to 
the ABC transporter HmuUV. The axial ligation of the heme in HmuT was probed by 
examination of wild-type HmuT and a series of conserved heme pocket residue mutants, H136A, 
Y235A, R237A, Y272A, M292A, Y349A, and Y349F. Characterization by UV-visible 
absorption, resonance Raman, and magnetic circular dichroism spectroscopies indicated that 
H136 and Y235 are the axial ligands in HmuT. Electrospray ionization mass spectrometry was 
also utilized to assess the roles of conserved residues in contribution to heme binding.  
The S. pyogenes streptococcal iron acquisition (sia)/heme transport system (hts) utilizes 
multiple proteins to bring host heme to the intracellular space.  Both the substrate binding protein 
SiaA and the hemoprotein surface receptor Shr were investigated.  The kinetic effects on SiaA 
heme release were probed through chemical unfolding of axial ligand mutants M79A and 
H229A, as well mutants thought to contribute to heme binding, K61A and C58A, and a control 
mutant, C47A. The unfolding pathways showed two processes for protein denaturation. This is 
consistent with heme loss from protein forms differing by the orientation of the heme in the 
binding pocket. The ease of protein unfolding is related to the strength of interaction of the 
residues with the heme. 
Shr contains two NEAT (near-iron transporter) domains (Shr-N1 and Shr-N2) which can 
both bind heme. Biophysical studies of both Shr-N1 and Shr-N2 indicated a new class of NEAT 
domains which utilize methionine as an axial ligand, rather than a tyrosine. Thermal and 
chemical unfolding showed ferrous Shr-N1 and Shr-N2 to be most resistant to denaturation. Shr-
N2 was prone to autoreduction. Together, sequence alignment, homology modeling, and spectral 
signatures are all consistent with two methionines as the heme ligands of this novel type of 
NEAT heme-binding domain. 
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1 INTRODUCTION  
1.1 Iron and Heme in Bacteria 
Iron is an essential nutrient for the majority of living organisms to survive (1, 2).  This 
element is found in the ferric and ferrous oxidation states when at standard physiological 
conditions.  The broad redox potential of iron allows for iron-bound proteins to play a diverse 
role in biological processes such as energy transducing pathways, gene regulation, and dioxygen 
transport (3).  Ferrous iron is soluble at physiological pH, unlike ferric iron, and can undergo 
Fenton chemistry which converts ferrous iron and hydrogen peroxide to ferric iron and reactive 
oxygen species (1, 4, 5).  Excess free iron in the cell results in a buildup of reactive species 
which attacks various cellular components and lead to oxidative damage to the cell (3, 6).  
Nature has overcome this problem by placing iron in a protoporphyrin IX ring, thus creating the 
macromolecule heme (3, 7).    Commonly, human host heme is bound to proteins such as 
myoglobin (Mb), hemoglobin (Hb), haptoglobin (Hp), and hemopexin (1, 2, 6).  As a result, 
bacteria have developed various strategies to either synthesize heme or take up the host heme 
into the bacterial cytoplasm to be used as a nutritional source.  It has also been shown that some 
bacterial species utilize both strategies (8).  Pathogenic bacteria which rely on heme uptake have 
developed sophisticated machinery to obtain the heme using proteins in their cellular membranes 
(4, 5, 9).   
1.2 ABC Tranporters 
ABC transporters make up a class of integral membrane proteins that utilize energy 
provided by ATP to pump various compounds across cellular membranes (10-12).  These 
proteins are found in a wide variety of organisms and participate in import and export 
mechanisms required for survival of the cell.  ABC transporters are found in both prokaryotic 
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and eukaryotic cells (12).  In prokaryotes, the transporter is generally located at the plasma 
membrane with ATP hydrolysis on the cytoplasmic side.  Eukaryotes also have ABC transporters 
in organellar membranes.   
A general ABC transporter is made of two transmembrane (TM) modules and two ATP-
binding cassettes [otherwise known as nucleotide binding domains (NBDs)].  Import type ABC 
transporters are commonly found in prokaryotic systems and are responsible for bringing 
nutrients, sugars, and amino acids into the cell (13).  Importers contain a substrate binding 
protein which brings the substrate to the ABC transporter (11, 13).  The importer TM modules 
and ATP-binding cassette domains are generally encoded on different genes (11).  Exporters are 
commonly found in eukaryotic systems, and in some prokaryotic systems, and are responsible 
for pumping out drugs and toxins from the intracellular space (13).  Unlike importers, exporter 
functional domains are encoded on a single gene (10, 13, 14).   
Currently, four classes of ABC transporters have been identified based on TMD fold 
(12).  Three of the four classes are importers which are found only in prokaryotes: Type I, Type 
II, and energy coupling factor (ECF) transporters (also referred to as Type III transporters).  The 
fourth class is the exporter fold which is identified in all characterized exporters to date and is 
found in both prokaryotes and eukaryotes.  Type I and II importers rely on SBDs to bring the 
substrate to the TMDs.  In some instances, the SBD is fused to the TMD.  Although differences 
exist in regards to overall fold of these importers, bacterial heme uptake pathways rely on ABC 
importers to deliver heme to the cell (2, 3, 9).   
1.3 Gram-negative Heme Uptake Pathways 
Heme uptake systems exist in both Gram-negative and Gram-positive bacteria and many 
reviews have been written on the subject (2, 3, 5, 15-17).  Due to structural differences between 
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the two types of bacteria, these pathogens have developed different strategies to bring heme to 
the intracellular space using protein shuttles including ABC importers. The most widely studied 
group of pathogenic heme uptake pathways are that of Gram-negative bacteria (5).  These 
pathogens must transport heme through the outer membrane (OM) to the periplasmic space and 
then through the periplasmic membrane to reach the intracellular space (2, 3).   Two types of 
heme uptake systems have been identified for Gram-negative bacteria: hemophore secretion and 
direct binding of host heme to OM receptors (15).  
1.3.1 Hemophore-mediated heme uptake  
Two types of hemophore systems have been identified in Gram-negative bacteria: has 
(heme acquisition system) and hxu (heme/hemopexin utilization) (2, 17, 18).  Multiple bacterial 
species have shown to utilize the has system including Yersinia pestis, Serratia marcescens, 
Yersinia enterolitica, Pseudomonas aeruginosa, and Pseudomonas fluorescens.  The has operon 
encodes for multiple proteins and includes the hemophore HasA, which is secreted from the cell, 
scavenges heme from Hb, and delivers it to the OM receptor HasR.  HasA from S. marcescens 
and P. aeruginosa bind heme utilizing a histidine/tyrosine binding motif (H32/Y75) while Y. 
pestis HasA uses a single tyrosine (Y75) to bind the heme in a pentacoordinate fashion. In all 
species of characterized HasA, studies have shown an additional conserved histidine (H83) 
which hydrogen-bonds to the axial tyrosine.  Once heme is brought to the OM receptor, the heme 
is transferred to the periplasmic space where it binds to periplasmic heme binding proteins.  
HxuA from Haemophilus influenzae is another hemophore which is able to scavenge 
heme by forming a complex with hemopexin (18).  HxuA, along with the heme receptor HxuC, 
induce heme release from hemopexin, allowing HxuC to bind the host heme.  This hemophore is 
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an exception to other known hemophores in that HxuA is not able to bind heme although it has 
been shown it is essential for heme uptake and transfer.  
Mycobacterium turberculosis (Mtb) has also been identified as bacteria which utilizes a 
hemophore system although Mtb is not classified as either Gram-negative or positive since it 
does not have the same membrane chemical aspects seen in either type of bacteria (19).  Mtb 
uses the hemophore Rv0203 to scavenge heme from Hb (2, 18).  This protein differs from other 
hemophores in fold, yet is thought to utilize a similar His/Tyr binding motif as seen in HasA.  
Rv0203 delivers heme to the heme receptors MmpL11 and MmpL3 which then pass the heme to 
MhuD for degradation (2).  
1.3.2 Heme transfer across outer membrane 
Once heme has reached the OM, either by a hemophore or received by an OM heme 
receptor directly, the heme must be transported across the membrane (2, 3, 15, 17, 18).  Energy 
to complete this transfer is coupled with bacterial proton motive force in conjunction with an 
inner membrane complex, TonB/ExbB/ExbD, also known as the TonB box (2, 18).  The majority 
of known OM heme receptors are members of the TonB-depedent outer transporter (TBDT) 
family and utilize the energy from the TonB box to bring heme across the membrane into the 
periplasmic space (15).  These transmembrane proteins are comprised of a closed β-barrel 
structure and made of 22 antiparallel β-sheets (3).  Most commonly these receptors recognize 
and bind host Hb and hemoglobin-haptoglobin (Hb-Hp) (2, 3).   
Although over 30 OM heme receptors have been reported, the only crystal structure 
determined is of apo-ShuA from Shigella dysenteriae which has been shown to recognize host 
methemoglobin and binds heme using two histidines, H86 and H428 (2, 3).  Other bis-histidine 
OM receptors, based on sequence similarity and homology, include P. aeruginosa PhuR, 
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Porphyromonas gingivalis HmuR, S. marcescens HasR, and Y. enterocolitica HemR (2, 15).  
Once the heme is passed through the OM receptor, the heme is transferred to periplasmic binding 
proteins (PBPs) which work alongside ABC importers to bring heme into the cell.  The exact 
mechanism of the transfer from the OM the periplasmic membrane is still unknown (3).  
1.3.3 Heme transfer across inner periplasmic membrane 
Gram-negative PBPs receive heme from OM receptors and deliver the heme to ABC 
transport systems within the periplasmic membrane to bring heme into the cell (2).  Only a few 
Gram-negative PBPs have been studied including S. dysenteriae ShuT, P. aeruginosa PhuT, and 
Y. pestis HmuT (YpHmuT).    
1.3.3.1 S. dysenteriae ShuT and P. aeruginosa PhuT 
ShuT and PhuT are protein homologs with about ~35% sequence identity (2). PhuT/ShuT 
both utilize a conserved tyrosine residue to coordinate one heme molecule (20).  The proteins 
share a similar fold although there are differences in the heme pocket environment (2).  In the 
PhuT heme binding site, a R73 is in position to H-bond to the axial tyrosine while this residue is 
replaced by a lysine pointing away from the axial tyrosine in ShuT.  The heme propionates in 
ShuT are pointed inside the protein while PhuT heme propionates are oriented outside of the 
heme pocket.  The mechanism of ShuT/PhuT heme binding and release is yet to be determined. 
Both ShuT and PhuT deliver heme to the inner membrane ABC transporter.  Only the S. 
dysenteriae shuttle ShuUV has been studied (2).  Due to the nature of ABC transporter proteins, 
(membrane-bound) these studies were carried out in liposomes.  The study was performed using 
ShuT, ShuUV, and ShuS (cytoplasmic-binding protein), and ATP.  The cytoplasmic-binding 
proteins in Gram-negative bacteria are thought to degrade heme once through the periplasmic 
membrane, although this has not been completely determined.  Complete transfer of heme 
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through the shuttle required all of the listed proteins and ATP, indicating heme transfer from 
ShuUV to ShuS, and ATP binding and hydrolysis, are coupled.  Additionally, E74 and E207 
were required for appropriate binding of holoShuT with ShuU.   
1.3.3.2 Y. pestis HmuT 
YpHmuT binds heme using a His/Tyr axial ligand pair (21). This protein delivers heme to 
the HmuUV ABC transport system to be brought into the cellular space. HmuT contains two 
lobes, similar in structure, which are connected by a single backbone α-helix, a common feature 
among periplasmic heme binding proteins. A crystal structure of holo-YpHmuT showed the 
heme pocket to be larger than both ShuT and PhuT with two stacked hemes bound in the pocket 
(2).  The propionate groups of the hemes were arranged in such a way that the propionates from 
one heme molecule were pointing outside of the protein, while the propionates from the other 
heme were pointing inward.  Isothermal titration calorimetry experiments showed the protein to 
bind the heme in a 2:1 molar ratio confirming the structural finding.  Similar to PhuT, YpHmuT 
also has an arginine in enough proximity to H-bond to the axial tyrosine although the hydrogen-
bonding has not been directly observed.   
YpHmuT delivers heme to the HmuUV ABC transporter (2, 21, 22).  The crystal structure 
of HmuUV has been determined (22).  The structure reveals a conserved H142 in HmuU and a 
conserved Y93 in HmuV.  It has been proposed the heme could be bound by either both of these 
residues, or only one, during heme transfer (2).  Similar to ShuT, YpHmuT contains two 
conserved glutamic acid residues which are thought to participate in docking of YpHmuT to 
HmuUV (22).   
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1.4 Gram-Positive Heme Uptake Pathways 
Contrary to Gram-negative bacteria, Gram-positive cells have a thick peptidoglycan layer 
composed of proteins, teichoic acids, and carbohydrates (18).  Heme can either bind to surface 
receptor proteins to be shuttled through the membrane to an ABC transporter, or be scavenged by 
hemophores and then shuttled through the membrane (2, 3, 18).  The most commonly studied 
Gram-positive heme uptake and transfer systems are Staphylococcus aureus, Bacillus anthracis, 
Streptococcus pyogenes, and Corynebacterium diphtheriae. The focus of this dissertation will be 
on heme uptake in S. pyogenes and C. diphtheriae.   
1.4.1 S. aureus Isd System and NEAT domains 
S. aureus utilizes the iron-responsive surface determinant (Isd) system heme uptake 
pathways and is the most extensively studied Gram-positive shuttle. The Isd system is composed 
of nine proteins, most of which have been structurally determined or characterized (2, 23).  
Four of the nine Isd proteins function as cell wall anchored surface receptors and are 
classified as NEAT-containing proteins: IsdA, IsdB, IsdC, and IsdH.  NEAT (near iron 
transporter) domains are a group of conserved residues, about 125 amino acids long, which are 
rich in beta-strands, contain a 310 α-helix and bind heme (2, 24).  NEAT proteins have been 
shown to utilize the YXXXY heme binding motif in which the first tyrosine in the sequence is 
the heme axial ligand and the second tyrosine H-bonds to the first.  The number of NEAT 
domains in a protein can vary and not all NEAT domains with this motif have been shown to 
bind heme. Additionally, these proteins also utilize a SXXXXY/F motif which assists in the 
stabilization of the bound heme.  The serine extends from the beginning of the 310 α-helix and 
hydrogen bonds to one of the heme propionates while the tyrosine or phenylalanine at the end of 
the motif stacks over the heme.  
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Numerous kinetic heme transfer studies have shown the Isd uptake pathway to proceed 
via transfer between various partners (2, 25, 26).  IsdB and IsdH are the most exposed to the 
extracellular surroundings and can both remove heme from Hb or Hb-Hp, respectively, and can 
transfer to either IsdA or IsdC.  IsdC then transfers heme to the substrate binding protein IsdE.  
The ABC transporter IsdDF brings the heme into the cellular space.  Once passed through the 
transport system and into the cytoplasm, IsdG and IsdI degrade the heme and release the iron for 
use by the organism (8). 
1.4.1.1 IsdB  
IsdB is exposed to the S. aureus extracellular surroundings and transports host heme to 
IsdA (23, 27, 28). IsdB contains two NEAT domains, IsdB-N1 and IsdB-N2, numbered from N-
terminus to C-terminus.  It has been shown IsdB-N1 can bind to Hb, but is not able to bind heme.  
In contrast, IsdB-N2 can bind heme, but not Hb (28).  IsdB-N2 has the canonical YXXXY heme 
binding motif as seen in other NEAT proteins.  The IsdB-N2 domain alone is capable of 
transporting heme to IsdA, but transfers at a faster rate when the full construct IsdB construct is 
present.   
The crystal structure of heme-bound IsdB-N2 showed an eight-stranded β-sandwich fold 
similar to that in IsdA and IsdC (28).  Distinct from other Isd NEAT domains, there is an α-helix 
at the C-terminus following the eighth β-strand. Y440 coordinates the heme iron in the fifth 
position and hydrogen bonds with the phenol group of Y444.  IsdB-N2 is an exception to the 
simple tyrosine ligation of other Isd NEAT proteins.  The crystal structure shows it utilizes a 
five-coordinate Tyr/Met ligation system while spectroscopic studies indicate the protein exists as 
a mixture of five-coordinate and six-coordinate heme.  Mutation of residues directly contributing 
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to heme binding, particularly Y440A, Y444A, S361A, and M362L, showed that binding of heme 
was disrupted.  
1.4.1.2 IsdH 
S. aureus IsdH, also referred to as HarA, is responsible for the uptake of heme from Hb, 
Hp, and Hb-Hp complexes (29, 30). IsdH contains three NEAT domains, each with different 
binding functions.  IsdH-N1 and IsdH-N2 bind Hb, Hp, and Hb-Hp complexes, but not heme, 
while IsdH-N3 binds either single or multiple hemes (23, 29-31).  
The crystal structure of holo IsdH-N3 displays similar structural fold as seen in all other 
NEAT proteins including eight β-strands (30). A single tyrosine residue, Y642, coordinates the 
ferric heme in a five-coordinate fashion with Y646 hydrogen-bonding to the axial Y642. The 
heme propionate groups form hydrogen bonds with S563 and Y646 in the heme pocket. The 
double mutant Y642A/Y646A resulted in diminished ability of heme-binding.  
1.4.1.3 IsdA 
IsdA retrieves heme from extracellular proteins IsdB and IsdH and delivers heme to IsdC 
(23).  IsdA contains one NEAT domain which is capable of binding heme. The crystal structure 
of holo-IsdA NEAT shows the domain is similar in fold to other NEAT proteins, consisting of 
eight β-strands (27).  The heme iron has a five-coordinate ligation with Y166 as the axial ligand 
hydrogen-bonded to Y170 (27, 32). Reduction of IsdA results in a heme ligand switch with H83 
serving as the axial ligand rather than Y166 (27, 32-34).  Reoxidation yielded the original ferric 
heme with tyrosine as the proximal ligand.  
Spectroscopic studies of point mutations further demonstrated the participation of 
specific amino acids in the binding of heme in ferric IsdA (27).  Y166A and Y170A both result 
in almost total loss of heme binding. Other tyrosine residues within the NEAT domain were also 
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mutated and showed no alteration of heme acquisition.  H83A showed no effect on the ability of 
IsdA to bind heme.  
1.4.1.4 IsdC and IsdE 
IsdC is responsible for transporting heme to IsdE and contains one NEAT domain (23).  
The crystal structure of Holo-IsdC shows the protein to be similar in fold to other NEAT proteins 
(35).  IsdC utilizes a five-coordinate ferric heme ligation system with Y132 as the axial ligand 
(34, 35).  As with other NEAT proteins, Y136 is hydrogen bonded to the axial Y132 giving a 
YXXXY motif. 
IsdE is the substrate binding protein which delivers heme to the ABC transporter, IsdDF 
(23).  Apo-IsdE can only accept heme from holo-IsdC (33, 36).  Structurally, IsdE has similar 
fold to other substrate binding proteins with two lobes connected by an α-helix forming a bi-
lobed topology (37).  Unlike the previously discussed Isd proteins, IsdE utilizes a His/Met 
(H229/M78) ligation system to bind the heme.  
Alanine mutations of H229 and M78 yielded a significant loss in the capability of IsdE to 
bind heme (37, 38).  The double mutant (M78A/H229A) showed a complete loss of IsdE heme 
binding ability. Reduction and addition of carbon monoxide to IsdE resulted in a low-spin 
ferrous coordination with His and CO serving as the axial ligands.  
1.4.2 Bacillus anthracis hemophore mediated heme uptake 
Three different heme uptake systems have been identified in B. anthracis: Isd, Hal, and 
BslK (2, 18, 39-42).  All of the pathways utilize NEAT domains to bind and transfer heme 
although not all of the domains are capable of transfer.  
Unlike the S. aureus Isd system, the B. anthracis system utilizes two hemophores to 
extract heme from host Hb which then bring heme to the surface-anchored IsdC protein.  The 
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two hemophores IsdX1 and IsdX2 contain one and five NEAT domains, respectively.   Similar to 
the S. aureus Isd system, many of the IsdX NEAT domains utilize the YXXXY heme binding 
motif: IsdX1 and NEAT domains 1, 3, 4 and 5 of IsdX2.  IsdX2-N2 has a histidine which 
replaces the second tyrosine in the motif creating an YXXXH motif.   Both IsdX1 and IsdX2-N5 
have been structurally determined (43, 44).  Crystal structures show both proteins exhibit the 
canonical β-sandwich fold and the heme is bound by a tyrosine residue.  A 310 helix utilizing the 
conserved SXXXXY motif stabilizes the heme in the pocket.  
The B. anthracis S-layer protein K (BslK) is a surface localized NEAT protein which 
transfers heme to IsdC (42).  B. anthracis contains an outer structure called the S-layer which is a 
crystalline protein layer surrounding the cell and BslK is proposed via homology to be associated 
with the S-layer.  Heme transfer studies show BslK rapidly transfers heme to apo-IsdC.  The 
crystal structure of this protein is still undetermined.  
The heme-acquisition leucine-rich repeat protein, Hal, is another B. anthracis NEAT 
heme transport system (41).  Sequence alignment with other NEAT proteins shows Hal has the 
SXXXXY binding motif, but is lacking the complete YXXXY motif which is replaced with 
YXXXF.  Homology modeling indicated the first tyrosine in the YXXXF motif is in position to 
bind the heme.  Directly opposite of the heme is another tyrosine which could be in position to 
bind the heme. More studies need to be performed in order to elucidate the contributions of each 
pathway. 
1.4.3 Heme uptake by S. pyogenes 
The Group A Streptococcus (GAS) from S. pyogenes utilizes the Shr/Shp/HtsABC locus 
for heme uptake (2, 45-47).  The streptococcal hemeoprotein receptor (Shr) and Shp are surface 
exposed proteins which are anchored to the cell wall.  The heme transport Streptococcus ABC 
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importer (HtsA)/streptococcal iron acquisition (SiaA) ABC system delivers heme to the 
intracellular space.  Chapter 5 of this dissertation gives a detailed overview of SiaA heme 
binding. 
Shr contains two NEAT domains (Shr-N1 and Shr-N2), both of which are able to bind 
heme.  The crystal structures of these domains remain unknown.  Shr is able to receive heme 
from methemoglobin (48).  The kinetics of heme transfer between the proteins in this pathway 
has been studied in detail (49-52).  Additional kinetic studies of heme transfer between the 
NEAT domains of Shr to apo-Shp (the next protein in the pathway) showed transfer from Shr-N1 
to apo-Shp to be rapid while transfer was much slower for Shr-N2 (53).  Chapters 7 and 8 of this 
dissertation go into detail in regards to heme binding of these proteins. 
The crystal structure of Shp has been determined and showed the protein utilized a 
bismethionine heme axial ligation (M66/M153) (54).  Although similar in fold to other NEAT 
proteins, Shp shares very little sequence similarity with NEAT domains lacking the SXXXXY 
and YXXXY motifs and is therefore not considered a NEAT protein.  Shp heme affinity studies 
indicated loss of the Fe–M153 bond results in a large reduction of holoShp stability (49).  Shp 
delivers heme to HtsA/SiaA which is a His/Met coordinate protein.   
1.4.4 C. diphtheriae heme uptake 
C. diphtheriae is the a causative agent of diphtheria, a well-known upper respiratory tract 
disease that carries a high mortality rate in humans (55).  The high virulence factor of this 
pathogen is due to its ability to secrete diphtheria toxin (DT).  DT is encoded by the tox gene and 
is negatively regulated by a DT repressor protein (DtxR) and by iron.  DtxR is known to regulate 
at least 50 genes in C. diphtheriae (56, 57).  Although this toxin has attracted much attention, it 
is also known that the ability of the pathogen to take up heme from its external environment is 
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critical in determining virulence factors and ultimately survival of the pathogenic organism 
within the host.  
C. diphtheriae has been shown to utilize a siderophore-specific uptake system encoded 
by ciuABCDE genes and genes which encode for an ABC-type hemin transporter system called 
HmuTUV (56-60).  These three genes, hmuT, hmuU, and hmuV are individually DtxR- and iron-
regulated transcriptional regions.  A fourth gene, htaA is on the same operon as the hmuTUV 
genes.  Removal of either hmuTUV, htaA, or the entire hmu gene cluster resulted in a decreased 
ability of the pathogen to utilize hemin and Hb as sources of iron (59, 60). This finding indicated 
HtaA and the ABC-transport system in C. diphtheriae are used for the uptake of hemin into the 
cell. HtaB and htaC are additional genes within the hmu gene cluster and are transcribed 
independently (59, 61).  C. diphtheriae has alternate hemin uptake pathways indicated by the 
ability of the pathogen to still utilize both hemoglobin and hemin as sources of iron even upon 
the deletion of the hmu gene cluster. 
It is currently proposed that heme from the extracellular surroundings initially binds to 
HtaA and is either passed to HtaB, or directly to HmuT which is the substrate binding protein to 
the HmuUV ABC transport system (59, 62).  HmuU is the ABC permease and HmuV is the 
ATPase (56).  Once imported, HmuO, a heme oxygenase, releases the iron from the porphyrin. 
HmuO is encoded by hmuO and it is not a part of the hemin transport gene cluster, yet it is 
regulated by DtxR and iron (59, 60, 63).   
1.4.4.1 HtaA and HtaB 
HtaA, a surface-anchored hemin binding protein, contains a hydrophobic C-terminal 
region along with an N-terminal leader peptide which is thought to assist in the anchoring to the 
cellular surface (59, 60). The htaA gene, which encodes for HtaA, is part of a six gene cluster 
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that makes up the hmu cluster of C. diphtheriae (60).  This protein contains two conserved 
regions (CR) of about 150 amino acids each in length, both of which can bind heme (59, 60).  
HtaB is also a heme binding protein, anchored to the cell and exposed at the surface in the same 
manner as HtaA and contains one CR.  Mutation of htaB showed no affect in the ability of the 
cell to utilize hemin or Hb as a source of iron.  Heme is passed from either HtaA or HtaB to 
HmuT.  Heme binding of HmuT is discussed in detail in Chapters 2 – 4.   
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2     HEME BINDING BY CORYNEBACTERIUM DIPHTHERIAE HMUT: FUNCTION 
AND HEME ENVIRONMENT 
This chapter has been published verbatim in Draganova, E. B., Akbas, N., Adrian, S. A., Lukat-
Rodgers, G., Collins, D. P., Dawson, J. H., Allen, C. E., Schmitt, M. P., Rodgers, K. R., and 
Dixon, D. W. (2015), Biochemistry 54(43): 6598-60.  The expression, purification, and UV-
visible spectroscopy of the WT and mutants were performed at Georgia State University.   
2.1 Abstract 
The heme uptake pathway (hmu) of Corynebacterium diphtheriae utilizes multiple 
proteins to bind and transport heme into the cell.  One of these proteins, HmuT, delivers heme to 
the ABC transporter HmuUV.  In this study, the axial ligation of the heme in ferric HmuT is 
probed by examination of wild-type HmuT and a series of conserved heme pocket residue 
mutants, H136A, Y235A, and M292A.  Characterization by UV-visible absorption, resonance 
Raman, and magnetic circular dichroism spectroscopies indicate that H136 and Y235 are the 
axial ligands in ferric HmuT.  Consistent with this assignment of axial ligands, ferric WT and 
H136A HmuT are difficult to reduce while Y235A reduces readily in the presence of dithionite.  
Raman frequencies of the FeCO distortions in WT, H136A, and Y235A HmuT−CO complexes 
provide further evidence for the axial ligand assignments.  Additionally, these frequencies 
provide insight into the nonbonding environment of the heme pocket.  Ferrous Y235A and the 
Y235A−CO complex reveal that the imidazole of H136 exists in two forms, one neutral and one 
with imidazolate character, consistent with a hydrogen-bond acceptor on the H136 side of the 
heme.  The ferric fluoride complex of Y235A reveals the presence of at least one hydrogen-bond 
donor on the Y235 side of the heme.  Hemoglobin utilization assays showed that the axial Y235 
ligand is required for heme uptake in HmuT.   
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2.2 Introduction 
Iron is required for infection in essentially all bacterial pathogens (1).  In vertebrate 
infections, the most abundant source of iron is heme (iron protoporphyrin IX), which comes 
primarily from hemoglobin.  Bacteria have developed sophisticated approaches to transport heme 
into the cytoplasm.  These pathways have been the focus of recent reviews (2-6). 
To date, pathogenic bacterial heme uptake pathways that have been characterized in detail 
have involved ATP-binding cassette (ABC) transporters.  These transmembrane systems utilize 
the energy yield from ATP hydrolysis to pump various compounds across cellular membranes 
(7;8).  An ABC transporter comprises two transmembrane modules and two ATPase subunits.  
Import ABC transporters are commonly found in prokaryotic systems and have an associated 
substrate binding protein [in this instance a heme binding protein (HBP)] that brings the substrate 
to the ABC transporter (9).   
A number of HBP’s have been characterized.  Pseudomonas aeruginosa PhuT (10) and 
Shigella dysenteriae ShuT (10;11) both contain a conserved tyrosine that binds the heme in a 
pentacoordinate fashion.  Yersinia pestis HmuT (YpHmuT) utilizes a His/Tyr ligation and binds 
heme both as a monomer and as a π-stacked dimer (12;13).  Staphylococcus aureus IsdE (14) 
and Streptococcus pyogenes SiaA/HtsA (15;16) both form hexacoordinate heme complexes 
having His/Met axial ligation.   
The variety of heme binding motifs leads to an interest in further characterization of other 
HBP’s.  One such protein is found in the pathogen Corynebacterium diphtheriae, a Gram-
positive bacterium which is the causative agent of diphtheria, a well-known upper respiratory 
tract disease that carries a high mortality rate in humans (17).  Diphtheria is still common in 
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developing countries due to low vaccination rates (18).  C. diphtheriae requires iron for survival 
and for virulence (19-24).  
C. diphtheriae acquires heme via an ABC-type heme binding protein transporter system 
(20) (Figure 2.1).  A variety of heme sources can be used including hemoglobin (Hb), 
hemoglobin/haptoglobin, and myoglobin (Mb) (25).  The heme utilization (hmu) operon includes 
hmuT (the HBP/substrate binding protein), hmuU (the permease) and hmuV (the ATPase), which 
form an ABC transport system (26).  The htaA gene is located immediately upstream of the 
hmuTUV locus.  Upstream to the htaA gene, is the htaC gene and a promoter region.  
Downstream of the hmuV gene is a promoter region and the htaB gene.  The hmuTUV and htaA 
genes form a single operon, while htaB and htaC are transcribed independently (27).  HtaA and 
HtaB are proposed to be anchored to the cytoplasmic membrane through a C-terminal 
hydrophobic region.  Both proteins are exposed to the bacterial surface, suggesting that these 
heme binding proteins may function as heme receptors (26).  It has been shown that HtaA passes 
heme to HtaB (22).  The next protein in the pathway is the HBP HmuT (CdHmuT), which 
donates heme to the HmuUV transporter.  Once the heme is brought into the cell, the heme 
oxygenase HmuO catalyzes the O2–dependent degradation of the heme, which releases its iron 
for further use in cellular functions (28;29). 
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Figure 2.1 Model for heme uptake in C. diphtheriae. Arrows indicate the direction of hemin 
transfer.  It is proposed that hemin would transfer from Hb, a known hemin donor, to the surface 
exposed hemin binding protein, HtaA, and be transferred to HtaB (membrane-anchored protein) 
followed by HmuT (substrate binding protein).  The hemin would then be passed to the ABC 
transporter, comprised of HmuU (membrane-bound protease) and HmuV (the ATPase), to bring 
the hemin into the cytosolic space.   Alternatively, HtaA could transfer hemin directly to HmuT.    
 
Sequence alignment studies of CdHmuT with other Corynebacterium species reveal two 
conserved tyrosines: Tyr235 and Tyr349 as well as a conserved histidine (His136) and 
methionine (Met292) (Figure 2.11 S1).  Homology modeling shows that Tyr235 is probably an 
axial ligand and that either His136 or Met292 could also bind as a sixth ligand.  CdHmuT is 
unique among its homologs in that the proposed axial His and Tyr ligands are reversed with 
respect to their positions in the structurally characterized proteins ShuT, PhuT and YpHmuT 
(Figure 2.12 S2).  That is, the tyrosines in all proteins in heme uptake pathways known to date 
come from the N-terminal part of the sequence, but CdHmuT is predicted to have the tyrosine 
from the C-terminal part of the sequence.  As this prediction indicates a key role for tyrosine in 
heme transfer, it was important to establish the axial ligands in CdHmuT.  Herein we report the 
biophysical characterization of CdHmuT and a number of its mutants.  UV-visible absorption, 
resonance Raman (rR), and magnetic circular dichroism (MCD) studies combine to give a 
picture of this novel heme uptake protein. 
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2.3 Materials and Methods 
2.3.1  Bacterial strains and media 
E. coli strains DH5α and TOP10 (Invitrogen) were used for routine cloning and plasmid 
maintenance, while XL-1 Gold (Stratagene) was used in the mutagenesis experiments.  E. coli 
BL21(DE3) (Novagen) was used for protein expression.  Corynebacterium ulcerans strain CU77 
was previously described (Schmitt & Drazek, 2001) and carries a point mutation that results in 
premature termination of the hmuT gene (Schmitt, unpublished observation).  Chromosomal 
DNA from C. diphtheriae strain 1737 (Popovic et al., 1996) was used as the source DNA for 
PCR.  Luria-Bertani (LB) medium was used for culturing E. coli and Heart Infusion Broth 
containing 0.2% Tween 80 (HIBTW) was used for growth of C. ulcerans strains.  Bacterial 
stocks were maintained in 20% glycerol at -80o C.  Antibiotics were added to LB medium at 50 
g/ml for kanamycin and to HIBTW at 2 μg/ml for chloramphenicol.  HIBTW was made low 
iron by the addition of ethylenediamine di(o-hydroxyphenylacetic acid) (EDDA) at 12 g/ml.  
Modified PGT is a semi-defined low iron media that has been previously described (Tai et al., 
1990).  Antibiotics, EDDA, Tween 80, were obtained from Sigma Chemical Co. and hemoglobin 
(human) was purchased from MP BioMedical. 
2.3.2 Plasmid construction   
The HmuT expression construct was developed using the pET28a expression vector 
(Novagen).  A PCR-derived DNA fragment containing the C. diphtheriae hmuT coding region 
was initially cloned into the pCR-Blunt II-TOPO vector (Invitrogen).  The DNA fragment 
harboring the hmuT gene was subsequently ligated into the NcoI-EcoRI sites in pET28a and the 
expression plasmid was then transformed into BL21(DE3).  The cloned hmuT gene in the 
pET28a vector lacked the 20-amino acid N-terminal secretion signal and contained an N-
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terminal Strep-tag, which was used for protein purification.  The following primers were used in 
the PCR: hmuTF; 5’-CC ATGGCA AGC TGG AGC CAC CCG CAG TTC GAA AAG GGT GTC 
CAG GGC ACA TAT-3’; hmuTR; 5’-GAATTC CTA TAC CTG TGG GTC ATAC-3’: underlined 
sequences indicate restriction sites and the sequence in italics encodes the 8-amino acid Strep-
tag. 
2.3.3 Site-directed mutagenesis and hemoglobin-iron utilization assays 
Site-directed mutants were made using the QuikChange Lightning kit (Stratagene) 
according to the manufacturer’s instructions.  Briefly, 125 ng of each primer containing the 
targeted base change and 50 ng of plasmid template were used in the QuikChange reaction.  
Methylated template DNA was removed from the reaction by digestion with DpnI restriction 
endonuclease, and mutagenized DNA was recovered by transformation into XL1-Gold 
competent cells.  The presence of the base changes was confirmed by sequence analysis.  
Plasmids used for site-directed mutagenesis were pET28a containing the cloned Strep-tag-hmuT 
gene, and plasmid pCD842, which harbors the hmuT gene on the E. coli-Corynebacterium 
shuttle vector pCM2.6 (30).  The hemoglobin utilization assay has been described previously 
(29).  
2.3.4 Expression and purification of CdHmuT 
HmuT was expressed and purified from BL21(DE3) (pEThmuT) cells.  The N-terminal 
leader sequence was deleted and replaced with a Strep-tag.  The native construct started at 
residue 21 (Gly) and extended to the native stop codon.  The culture was prepared in LB medium 
containing 50 µg/mL kanamycin.  Inoculation was done with an overnight pre-culture and cells 
were grown at 37 °C.  When the OD600 of the culture reached 0.5 – 0.6, protein expression was 
induced by adding isopropyl β-D-1-thiogalactopyranoside (IPTG) to a final concentration of 1.0 
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mM.  The culture was incubated for 3 h at 27 °C.  Cells were harvested by centrifugation at 8000 
x g.  The cell pellet was resuspended in lysis solution (100 mM Tris-Cl, 150 mM NaCl, pH 8.0) 
containing a protease inhibitor cocktail (Roche Complete Mini, EDTA-free, following the 
manufacturer protocol).  The cells were broken using a cell disrupter or sonication.  The lysate 
was then centrifuged at 8000 x g, and the supernatant was syringe-filtered with a 0.45 m filter.   
All of the following purification steps were conducted at 4 °C using fast protein liquid 
chromatography and all buffer solutions were pH 8.0 unless specified otherwise.  The protein 
sample was loaded onto a Strep-Tactin Superflow column (5 mL, IBA BioTAGnology) 
equilibrated with buffer A (100 mM Tris-Cl, 150 mM NaCl, pH 8.0).  Unbound material was 
washed out with 5 column volumes of buffer A.  HmuT was eluted with 10 column volumes of 
buffer B containing 100 mM Tris-Cl, 150 mM NaCl, 2.5 mM desthiobiotin, pH 8.0 applied using 
a linear gradient.  The purities of the fractions were evaluated using SDS-PAGE.  Native-PAGE 
did not show dimers, indicating that the protein is monomeric in solution.  Minor differences in 
the optical spectra were observed as a function of the buffer type.  Heme loading of the WT and 
mutants were variable from batch to batch.  The following heme loading percentages were 
estimated to the nearest 10%: WT, 100%; M292A, 100%; H136A, 95%; and Y235A, 20%.  For 
the WT protein, spectral signatures associated with a heme dimer at the binding site were seen in 
a few instances of impure or damaged protein.   
2.3.5 Magnetic circular dichroism spectroscopy   
Magnetic circular dichroism (MCD) spectra were measured with a magnetic field 
strength of 1.41 T by using a JASCO J815 spectrophotometer.  This instrument was equipped 
with a JASCO MCD-1B electromagnet and interfaced with a Silicon Solutions PC through a 
JASCO IF-815-2 interface unit.  Data acquisition and manipulation using Cary or Jasco software 
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has been previously described (31).  To ensure homogeneity of ferric oxidation for the various 
mutants, ferricyanide was used to fully oxidize the heme center, followed by desalting 
chromatography.  The resulting spectra were compared to data from other heme-containing 
proteins with known binding site structures and optical spectra.  All spectral measurements for 
all proteins were carried out with a 0.2 cm quartz cuvette at 4 °C in 50 mM phosphate buffer 
(either pH 6.5 or 10).   
2.3.6 Resonance Raman spectroscopy  
Resonance Raman (rR) spectra were collected using the 441.6-nm emission line from a 
HeCd laser or either 406.7 nm or 413.1 nm emission from a Kr+ laser.  Spectra were recorded at 
ambient temperature using the 135° backscattering geometry with the laser beam focused to a 
line on a spinning 5 mm NMR tube.  Toluene, DMSO, and CH2Br2 were used as external 
standards for spectral calibration.  UV-visible absorption spectra were recorded before and after 
rR experiments to verify that the samples were not altered by exposure to the laser beam.  The 
final concentrations of all Fe(III) samples were between 25 and 80 μM protein in 100 mM buffer 
solution.  The buffers used were CHES, pH 10.0, Tris-Cl, pH 8.8 or 8.0, sodium phosphate 
buffer, pH 7.0 or 5.8, MES, pH 5.1, and sodium acetate buffer, pH 5.0.  The D2O and H218O 
samples of the Y235A mutant were made by diluting a concentrated sample of the protein into 
CHES buffer made with either D2O or H218O at pD 10 or pH 10, respectively.  Resonance Raman 
spectra were collected with laser powers between 9 and 12 mW at the sample. 
The ferric fluoride adduct of Y235A HmuT was prepared by titration with 0.8 M NaF 
solution in 0.1 M sodium phosphate buffer at pH 5.8.  The final protein and NaF concentrations 
were 80 μM and 330 mM, respectively.  The laser power was 9.7 mW for the 406.7 nm Kr+ 
excitation and 4.6 mW for the 441.6 nm HeCd excitation.   
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Ferrous HmuT(Y235A) samples (36 μM) were prepared anaerobically in 5 mm NMR 
tubes.  The protein samples were prepared in 0.1 M Tris-Cl pH 8.2 and equilibrated with water-
saturated, O2-scrubbed N2 that had been saturated with water.  After equilibration under the N2 
atmosphere, an 86-fold excess of aqueous sodium dithionite, buffered at the same pH, was added 
using a gas-tight 10 μL syringe.  Laser power for the ferrous samples ranged from 4 to 8 mW.  
Ferrous carbonyl adducts (36 to 75 μM) were prepared by reducing the proteins in 0.1 M Tris-Cl 
pH 8.8 with a 70- to 180-fold excess of buffered sodium dithionite, as described above, except 
that the reduction was carried out under an atmosphere of natural abundance CO or 13CO (99 
atom % 13C) instead of N2.  Laser power for the heme carbonyl samples was held between 2 and 
4.5 mW to minimize CO ligand photolysis. 
2.4 Results 
2.4.1 Heme ligation in ferric HmuT 
 An alignment of the HmuT amino acid sequences of various Corynebacterium species showed 
that two tyrosine residues (Y235 and Y349) as well as H136 and M292 were highly conserved in 
this group of bacteria (Figure 2.11 S1).  A homology model of HmuT (Figure 2.2) was created by 
I-TASSER (32) with YpHmuT (26% sequence identity) as one of the templates along with four 
HBP’s for which crystal structures have been solved: PhuT from P. aeruginosa (10), ShuT from 
S. dysenteriae (10), IsdE from S. aureus (14) and YpHmuT (12).    
30 
 
Figure 2.2 I-TASSER homology model of CdHmuT displayed using PyMOL (93). Shown are the 
locations of H136, Y235, R237, M292, and Y349. 
 
The model indicated that it was probable that CdHmuT would have a Tyr as one axial ligand, and 
a Met or His as the second.  Based on this homology model and sequence alignment, the H136A, 
Y235A, and M292A mutants were created to probe the heme axial ligation. 
2.4.2 Conserved residues and the biological function of HmuT   
To determine if H136, Y235, and M292 are important for the biological function of 
HmuT, the ability of the cloned hmuT genes to complement a Hb-iron utilization defect was 
assessed.  It was previously shown that the CU77 mutant strain of C. ulcerans HmuT (CuHmuT) 
was defective for HmuT activity (20).  The cloned hmuT gene from either Corynebacterium 
species could fully restore the wild-type phenotype to this strain.  Complementation studies with 
each of the H136A, Y235A, and M292A CdHmuT mutants revealed that only Y235A was unable 
to restore growth fully (Figure 2.3).  Thus, Y235 is essential for the heme-iron utilization 
function of HmuT.   
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Figure 2.3Hb-iron utilization assay. C. ulcerans CU77 (hmuT) carrying plasmids that encode 
the wild type (pCD842) and various mutants of the hmuT gene were assessed for their ability to 
use Hb as the sole iron source for growth in low-iron mPGT medium.  Cultures were grown for 
36 h at 37 oC in the presence of 25 µg/ml Hb supplemented with 10 µM EDDA, and then cell 
density was measured by absorbance at A600.  Results are the mean of three independent 
experiments ± standard deviation.  The growth difference between WT (pCD842) and Y235A is 
significant at p < 0.01.   
 
2.4.3 Spectroscopy of wild-type CdHmuT 
The UV-visible absorption spectrum of ferric wild-type (WT) CdHmuT showed a Soret 
peak at 407 nm and four peaks in the α,β region at 492, 546, 569, and 616 nm (Figure 2.4).  The 
charge transfer band at 616 nm is characteristic of a high-spin (HS) species, and the two α,β 
bands at 569 and 546 nm are consistent with the presence of a low-spin (LS) species.  Hence, 
these data suggest an equilibrium mixture of HS and LS WT CdHmuT.  This UV-visible 
absorption spectrum is strikingly similar to that observed for Serratia marcescens HasA 
(SmHasA) (406, 494, 537, 568 and 618 nm) which is known to have His/Tyr axial ligation and 
exists in a thermal spin equilibrium (33).   
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Figure 2.4 UV-visible absorption spectra of the Fe(III) forms of WT CdHmuT (solid line), 
H136A (dashed line), and Y235A (dotted line) normalized at the Soret.  The samples were taken 
in 50 mM Tris-Cl at pH 7.0. 
 
Ligation of the heme was further probed by the use of MCD.  Initial comparisons of the 
spectra of WT CdHmuT with models having His-only or His/Met axial ligation did not give 
entirely similar spectral profiles (data not shown).  The UV-visible absorption and MCD spectra 
were then compared with two five-coordinate Tyr-ligated proteins, bovine liver catalase (BLC) 
(34-36) and the H93Y mutant of Mb (37) (Figure 2.13 S3).  The differences in the spectra 
indicated that WT CdHmuT does not adopt a five-coordinate, tyrosine-ligated geometry. 
WT CdHmuT was then compared to a model for the His/Tyr ligand set:  leghemoglobin a 
with exogenous phenol (38).  This complex adopts a six-coordinate heme binding structure with 
a histidine axial ligand and a phenol in the trans position.  Figure 2.5 shows that both the UV-
visible absorption and MCD spectra were in agreement with those of the WT CdHmuT 
supporting the conclusion that CdHmuT is a His/Tyr protein. 
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Figure 2.5 The UV-visible absorption and MCD comparison spectra for Fe(III) WT CdHmuT at 
pH 6.5 with Fe(III) phenol-bound leghemoglobin a. The samples were taken in 50 mM phosphate 
buffer. Spectra were slightly dependent on buffer conditions.  The spectrum of phenol-bound 
leghemoglobin a was replotted from (38). 
 
Soret-excited rR spectra of WT CdHmuT were recorded over the pH range of 5.0 to 10.0 
(Figure 2.14 S4).  Two bands are observed in the 1470 – 1510 cm─1 region of the rR spectrum.  
The pair of ν3 bands observed at 1475 and 1504 cm─1 indicates that the protein contains a 
mixture of six-coordinate high-spin (6cHS) and six-coordinate low-spin (6cLS) hemes.  This is 
consistent with the UV-visible absorption spectra shown in Figure 4.  The rR spectra were 
independent of pH, indicating that the HS/LS equilibrium is not governed by any acid-base 
speciation of the heme or the protein over this pH range. 
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2.4.4 Spectroscopy of M292A CdHmuT   
The UV-visible absorption (Figure 2.15 S5) and rR (Figure 2.6) spectra for the WT and M292A 
proteins, as well as the dependence of the rR spectrum on pH (Figure 2.16 S6), were almost 
identical; the MCD spectra showed only slight differences in absorbance maxima (Figure 2.15 
S5).  The overall similarities in the spectra indicated that Met is not an axial ligand. 
 
Figure 2.6 Comparison of the Soret-excited rR spectra of WT CdHmuT, M292A, H136A, and 
Y235A. Protein concentrations were 80, 70, 25 and 36 μM, respectively.  All samples were 
prepared in 50 mM Tris-Cl at pH 7.0.  The spectra were recorded with 406.7-nm excitation.  A) 
Low frequency and B) high frequency spectra of WT CdHmuT (blue), M292A (black), H136A 
(green), and Y235A (red). 
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2.4.5 Spectroscopy of H136A CdHmuT  
In the optical spectrum, H136A CdHmuT gave a broad Soret band that was blue-shifted 
to 400 nm, compared to the WT, and three defined bands in the α,β region, including one at 620 
nm (Figure 2.4).  The H136A mutant was compared with three tyrosine models:  ShuT (11), BLC 
(34-36), and Mb-H93Y (37) (Figure 2.17 S7).  In the UV-visible absorption spectra, the Soret 
peaks for all four proteins were similar, with maxima located from 400 to 407 nm.  In the visible 
region, the characteristic high-spin peak located past 600 nm was evident for H136A HmuT, 
BLC, and ShuT and blue-shifted for H93Y Mb.  The peaks and troughs in the visible region of 
the MCD spectrum are evidence for tyrosinate ligation.  Together, the data indicate a ferric five-
coordinate tyrosinate-bound heme.   
The Soret-excited rR spectrum of H136A HmuT had ν3 bands at 1479 and 1487 cm─1, 
indicating the presence of 6cHS and five-coordinate high-spin (5cHS) hemes, respectively 
(Figure 2.6).  The presence of HS species reflects the weakened axial ligand field in the absence 
of His136 (39;40).  The bands at 721 and 693 cm─1 are assigned to γ5 (symmetric pyrrole ring 
fold, A2u in D4h) and γ15 (symmetric pyrrole ring fold, B2u in D4h), respectively, by analogy to Mb 
(41-43).  Intensification of the bands arising from these modes, which are normally Raman 
forbidden, reveals lowering of the porphyrin symmetry.  Pentacoordination of the heme iron 
center, as anticipated for H136A mutation and as indicated by the core-size marker band 
frequencies in Figure 6B, is expected to drive the heme iron out of the mean porphyrin plane 
toward the Y235 side chain.  This type of coordination typically increases the extent of porphyrin 
doming.   
The rR spectrum of H136A does not exhibit a pH dependence over the range of 5.0 to 
10.0 (Figure 2.18 S8) suggesting that neither the 5cHS or the 6cHS H136A species binds 
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hydroxide under alkaline conditions.  The inability to form a hydroxide complex has also been 
reported for SmHasA H32A, wherein tyrosinate is the lone amino acid ligand to the heme (44).  
In fact, there are very few examples of Fe(III) porphyrinates having two anionic axial RO− 
ligands, including OH−, because large overall positive charges are necessary to stabilize such 
axial ligand sets (45;46).  Thus, the rR spectra are consistent with an equilibrium mixture of 
5cHS Fe−Tyr− and 6cHS H2O−Fe−Tyr− axial ligation. 
2.4.6 Spectroscopy of Y235A CdHmuT   
Y235A CdHmuT had a Soret band that was red-shifted by 7 nm compared to the WT protein and 
a significant shoulder near 350 nm, which was absent from the WT and other mutants (Figure 
2.4).  The α,β region had bands at 575 and 540 nm and no charge transfer band, consistent with a 
predominantly LS heme.   
Figure 2.7 compares the UV-visible absorption and MCD spectra of this mutant in the 
ferric state at pH 10 with two His/OH- complexes, alkaline Hb at pH 10 (47) and horseradish 
peroxidase (HRP) at pH 12.5 (48).  The peaks and troughs in both the Soret and visible regions 
are located at comparable wavelengths and exhibit similar relative intensities.  These similarities 
indicate that Y235A adopts a His/OH− ligation set at high pH.  
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Figure 2.7 The UV-visible absorption and MCD spectra for Fe(III) Y235A CdHmuT at pH 10 
with Fe(III) alkaline Hb (pH 10) and Fe(III) HRP (pH 12.5).  The samples were prepared in 50 
mM phosphate buffer.  The spectra of alkaline Hb and HRP were replotted from (47) and (48), 
respectively. 
 
The heme speciation of Y235A was found to be sensitive to pH in the Raman spectra 
(Figure 2.8).  Y235A was shown to shift from a mixture of 6cHS (1473 cm─1) and 6cLS (1501 
cm─1) at pH 10.0 to all 6cHS (1477 cm─1) at pH 5.0 (Figure 2.8C).  Based on changes in the 
relative rR intensities as a function of pH, the pKa of the acidic form is near 6.   
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Figure 2.8 The pH dependence of ferric Y235A monitored by 406.7 nm-excited rR spectra (11 
mW power at sample). A)  Isotopologs of Y235A at pH 10 prepared in H2O, D2O, and H2
18O.  
Difference spectra of D2O-H2
18O and H2O-H2
18O  shown at the top of the figure were generated 
by subtraction of the respective parent spectra at the bottom of the figure.  B)  Low frequency 
and C)  high frequency spectra of ferric Y235A as a function of pH.  Samples were between 25 
and 60 μM. 
 
To determine whether the alkaline species comprising the HS/LS equilibrium are 
hydroxide complexes, the 2H and 18O isotopologs were generated in D2O and H218O, and their 
Soret-excited rR spectra recorded (Figure 2.8A).  Two isotope-sensitive bands were observed.  
The band at 521 cm─1 in H2O shifted to 504 and 489 cm─1 in D2O and H218O, respectively, and is 
assigned to the νFe─OH mode of LS Y235A−OH.  The second isotope-sensitive band appeared at 
433 cm─1 and shifted to 412 cm─1 in H218O and is tentatively assigned to the νFe─OH mode of HS 
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Y235A−OH component of the mixture.  The difference feature for the HS νFe─OH observed in the 
D2O − H218O difference spectrum has considerably less amplitude than that of the LS νFe─OH 
making the shift due to deuterium in the HS complex difficult to measure.  Y235A is similar to 
Mb, Hb, and various other heme protein hydroxides (49-53) that exist as HS/LS mixtures.  Since 
the alkaline form of Y235A HmuT is a hydroxide complex, it is likely that the 6cHS species that 
dominates below pH 6 is an aqua complex.   
2.4.7 Heme environment in CdHmuT   
Useful insight into the distal electrostatic landscape and the σ-donor strength of the trans 
ligand are derived from the position of ferrous heme carbonyl complexes on a νFe−CO/νC−O 
correlation plot (54-56).  WT and H136A could be reduced with dithionite only in the presence 
of CO (which binds to, and stabilizes, the ferrous form of the heme); this has been observed 
previously for hemes with very low reduction potentials (57).  The Soret-excited rR spectra are 
shown in Figure 2.19 S9.  Three 13C-sensitive bands were observed for the WT and H136A 
CdHmuT proteins while four were observed for the Y235A mutant.  The spectrum of WT reveals 
isotope-sensitive bands at 535, 585, and 1920 cm−1 which shift to 531, 558, and 1878 cm−1, 
respectively, in the HmuT−13CO spectrum.  They are assigned to the νFe−C, δFeCO, and νC−O 
modes, respectively.  For the H136A mutant, the isotope–sensitive bands shifted from 530, 574, 
and 1929 cm─1 to 525, 556, and 1884 cm─1, respectively.  Thus, its νFe-C frequency was 5 cm─1 
lower than those of WT, and its νC−O frequency was 9 cm─1 greater, consistent with a weakened 
π-backbonding characteristic of the trans-Tyr ligand in this mutant.  The largest differences were 
observed for the Y235A mutant with two νFe−C bands occurring at 491 and 509 cm─1, a δFeCO 
frequency of 574 cm─1, and νC-O band at 1943 cm─1 which shift to 488, 505, 559, and 1898 cm─1, 
respectively, with 13C (Figure 2.19 S9).   
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The inverse correlation between νFe−C and νC−O frequencies is plotted for CdHmuT and its 
heme pocket mutants along with a number of heme−CO proteins and model complexes for 
comparison in Figure 2.9.  The WT HmuT−CO point falls on the νFe−C/νC−O correlation plot in a 
position consistent with its proximal ligand being a weaker donor than His, suggesting that WT 
HmuT−CO contains a weak proximal Fe(II)−O bond, such as Fe(II)−Tyr or Fe(II)−OH2 (58).  
 
Figure 2.9 Backbonding correlation plot of νFe-CO versus νC-O for ferrous carbonyls of heme 
proteins showing the dependences of their positions on axial ligation and distal pocket 
properties.  WT (blue), H136A (green), Y235A (red) are shown as stars on the plot.  Catalase, 
hexagon; HasA(Y75A), ◊; HasA(WT), ○; HasA(H83A), ○; HasA(H32A), ○ (57;71).  The dashed 
line is the least squares line for six-coordinate Fe−CO adducts in which the proximal ligand is 
thiolate or imidazolate; the dotted line is the least squares line for Fe−CO adducts with 
proximal histidine (neutral imidazole) (53;57;59) (and references therein); and the solid line 
represents a compilation of “five-coordinate” model complexes (55) (and references therein) 
and heme proteins which the ligand trans to CO is coordinated through an oxygen atom (61). 
  
Distal H-bond donors to the bound CO ligand and positive charge enhance π-
backbonding.  Both of these interactions weaken the C−O bond while strengthening the Fe−C 
bond, placing points high and to the left on the imidazole correlation line (e.g., νFe−C 520 cm−1 
and νC−O 1935 cm−1) (59).  Off-axis Fe−C−O distortion and negative charge weaken backbonding 
which, absent other factors such as hydrogen bonding, is characterized by positions to the low 
41 
and to the right on the correlation line.  Thus, the positions of WT HmuT−CO and H136A−CO 
would be interpreted as due to a positive charge near and/or H-bond donation to the bound CO. 
The bottom set of spectra in Figure 2.19 S9 reveal that Y235A HmuT−CO has two 
conformers whose positions on the νFe−C/νC−O correlation plot (Figure 2.9) are distinct from each 
other and from WT and H136A HmuT−CO.  One conformer is located on the imidazole line, 
indicating neutral histidine axial ligation; its position relative to other proteins on the imidazole 
correlation line is consistent with a modest distal H-bonding interaction.  In contrast, the second 
conformer is slightly above the imidazolate line suggesting that the proximal histidine (His136) 
has some imidazolate character, perhaps due to its interaction with an H-bond acceptor in the 
proximal pocket.  
2.4.8 Ferric Y235A CdHmuT−fluoride   
Fluoride complexes of heme proteins are sensitive probes of the distal H-bonding 
environment (60;61).  The energy of the charge transfer band at 600 – 620 nm (CT1) together 
with the Fe−F stretching frequency constitutes a sensitive probe of H-bond strength between a 
distal H-bond donor and the bound F− ligand.  Low νFe─F frequencies correlate with red-shifted 
CT1 bands in complexes having strong hydrogen bonds.  The νFe─F mode of Y235A HmuT−F 
was identified by exciting into its CT2 band (450 – 460 nm) with 441.6-nm light (Figure 2.10).  
Relative enhancement of scattering by the νFe─F mode with 441.6-nm excitation is considerably 
greater than with Soret excitation; peak fitting of the 441.6-nm excited rR spectrum shown in 
Figure 2.10A revealed that the νFe─F band occurs at 392 cm─1.  The Y235A HmuT−F CT1 band 
was observed at 613 nm (16,313 cm─1) (Figure 2.10A inset).  Correlation of its νFe─F and the CT1 
energy places Y235A CdHmuT low on the correlation plot in Figure 2.10B which is consistent 
with strong hydrogen bonding between the bound F− ligand and the distal pocket. 
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Figure 2.10 Characterization of Y235A−F by correlation of the FeIII−F stretching frequency and 
CT1 energy.  A) Low frequency window of the rR spectra of Y235A−F using Raman excitation 
into the CT2 (441.6 nm) and Soret (406.7 nm) bands.  Protein was 80 μM in 100 mM sodium 
phosphate buffer in 330 mM sodium fluoride, pH 5.8.  Laser power at the sample was 4.6 mW 
with 441.6-nm excitation and 9.7 mW with 406.7-nm excitation.  Peak fitting analyses of both 
spectra are overlaid on the original spectra with the calculated FeIII−F stretching band shown in 
red; calculated 8 and propionate and vinyl bending bands are shown in black; the overall fit is 
shown in magenta.  Inset: Visible spectrum of Y235A−F rR sample.  B)  Correlation plot of Fe-F 
frequency and the CT1 energy.  Y235A is shown in red.  Other points are from Nicoletti and 
coworkers (61).  Open circles are for mutants of truncated Hb from Thermobifida fusca (Tf-
trHb) with varying number of hydrogen bonds between the distal pocket and the fluoride (60;61). 
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2.4.9 Ferrous Y235A CdHmuT 
Unlike WT and H136A CdHmuT, which are slow to reduce with aqueous buffered S2O42−, 
Y235A CdHmuT was readily converted to a 5cHS ferrous heme (ν4, 1354 cm─1; ν3, 1467 cm─1) 
upon reaction with S2O42− (spectra not shown).  The νFe─His frequency for 5cHS ferrous hemes 
has been shown to be significantly enhanced with 441.6 nm laser excitation (62) and two νFe─His 
modes for ferrous HmuT-Y235A are tentatively assigned to bands at 221 and 249 cm─1 based on 
comparison of their relative enhancements in the 441.6 and 413.1-nm excited spectra in Figure 
2.20 S10.  Observation of two νFe─His modes is consistent with two proximal pocket conformers 
in Y235A CdHmuT, which are distinguished by the extent of imidazolate character of the 
proximal His ligand.  These are likely the same conformers responsible for the two νFe−C 
frequencies (491 and 509 cm-1) in the corresponding carbonyl spectrum shown in Figure 2.21 
S11. 
2.5 Discussion 
2.5.1 His/Tyr ligand set identified for HmuT:heme complex 
2.5.1.1 Ferric species 
Sequence alignment, homology modeling, and UV-visible absorption, MCD, and rR 
spectroscopies all lead to the conclusion that WT CdHmuT contains a six-coordinate active site 
with a tyrosine bound to one axial position of the heme and a histidine bound to the other.   
H136A CdHmuT exhibited both UV-visible absorption and MCD spectral features of 
other five-coordinate tyrosine-ligated proteins such as BLC (36), Mycobacterium avium ssp. 
paratuberculosis (MAP) (36), Plexaura homomalla coral allene oxide synthase (cAOS) (35), S. 
dysenteriae ShuT (11),  and the S. aureus Isd system: IsdA-N1 (63-65), IsdB-N2 (66), IsdC-N1 
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(65;67), and IsdH-N3 (66;68).  The ~620 nm charge transfer band appears to be characteristic of 
a tyrosine bound to the heme.   
The Y235A mutant showed loss of the charge transfer band in the UV-visible absorption 
spectrum, consistent with removal of the axial tyrosine.  Both the UV-visible absorption and 
MCD spectra of Y235A were not comparable with other known 5c His-bound heme proteins, but 
rather with 6c His/OH− species, such as HRP (48) or alkaline hemoglobin (47).  It was concluded 
that the ferric iron was still ligated to H136, but with the axial position vacated by the mutated 
Y235 occupied by a hydroxide ligand.  This His/OH− motif was seen not only at pH 10, but also 
at pH 6.5.  pKa values of water trans to histidine in ferric heme proteins vary from > 10 down to 
at least 6.8 (see examples in Table 2.1).  The homology model indicates that the Arg237 side 
chain is found in the heme pocket on the side opposite the axial histidine.  Thus, the low pKa for 
Y235A may be attributable to the interaction of water with this cationic side chain, which could 
serve as the H-bond donor to the axial Tyr235 ligand.  Consistent with this proposal, in almost 
all tyrosine-heme proteins studied to date, the axial tyrosine is hydrogen-bonded to a second 
residue; common examples include Tyr, Arg and His (see examples in Table S2).   
For heme proteins having a bound water ligand, a decrease in the Fe−OH stretching 
frequency relative to Mb and Hb has been attributed to strong hydrogen bond donation to the 
hydroxide.  For example, in hemoglobin from M. tuberculosis (HbN) a 35 cm─1 decrease in the 
HS Fe−OH stretching frequency has been attributed to a strong interaction between the bound 
hydroxide and a distal tyrosine side chain (52).  Very strong hydrogen bonding in alkaline HRP 
similarly gives rise to the LS Fe─OH  frequency of 503 cm─1, 47 cm─1 lower than the LS Fe─OH  
Mb frequency of 550  cm
─1 (49).  For Y235A CdHmuT, the LS and HS Fe−OH stretching 
frequencies are 29 and 58 cm─1 lower, respectively, than those reported for Mb.  This strongly 
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suggests Tyr235 has a hydrogen bonding partner that upon removal of Tyr235 its normal H-bond 
partner serves as a H-bond donor to the hydroxide ligand.  The presence of a strong hydrogen 
bonding partner on the Tyr235 side of the heme is further supported by the position of the 
Y235A HmuT−F on the Fe─F frequency/CT1 energy empirical correlation plot (Figure 2.10B).  
On the correlation plot, it lies very close to the Thermobifida fusca (Tf-trHb) fluoride adduct 
which has two strong hydrogen bonds between the fluoride and the distal heme pocket (61). 
2.5.1.2 Ferrous Species 
The ferrous spectra of the wild-type and the H136A mutant could not be reduced under 
standard reductive conditions, e.g., sodium dithionite, unless in the presence of CO, which binds 
to the ferrous heme.  This contrasts with reduction of Y235A, which is readily effected.  These 
observations are consistent with His/Tyr heme ligation.  Related observations have been made 
for HasA (57), which has a very low reduction potential (−550 mV versus SHE) (69).  Upon 
mutation of its axial tyrosine, it is also readily reduced by dithionite (57).   
Proteins and engineered mutants that can bind CO with either a trans His or Tyr have a 
histidine in some instances and an oxygen ligand (tyrosine or water) in others (57).   For 
example, the His/Tyr protein HasA, gives an O−Fe−CO species upon reduction in the presence 
of CO (57).  Human heme oxygenase H25Y, with a tyrosine axial ligand in the ferric form, gives 
an H2O−Fe−CO species (70).  Catalase, with an axial tyrosine, is thought to form the 
Tyr−Fe−CO species (71).   
The νFe−CO band in the Soret-excited rR spectrum of catalase−CO has been reported to be 
more intense than the totally symmetric ν7 band (71).  This signature was correlated with the 
anionic character of the proximal Tyr whose coordination to heme iron is stabilized by H-
bonding to a His residue.  Although the νFe−CO bands for WT and H136A HmuT CO complexes 
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are not more intense than their ν7 bands, they are quite intense relative to the νFe−CO band of 
Y235A HmuT−CO.  This is taken as further evidence for a charge neutral Tyr−Fe(II)−CO 
species in H136A CdHmuT and WT CdHmuT. 
Y235A was reduced by aqueous S2O4
2− in the absence of CO.  Based on the two Fe−His 
stretching frequencies of 221 and 249 cm─1, ferrous Y235A CdHmuT has one conformer with 
Fe−His proximal bond of strength comparable to that of Mb and Hb (218 – 224 cm─1) (72;73) 
and a second conformer with significant imidazolate character in the proximal histidine similar 
to that observed for peroxidases (i.e., νFe−Im‾ occurs at 244 cm−1 for HRP) (74). 
2.5.2 Why tyrosine?   
Although not common in heme proteins (75), the His/Tyr ligand set has also been 
observed in S. marcescens HasA (76), P. aeruginosa HasA (77;78) and PhuR (79), E. coli CcmE 
(80;81), Paracoccus denitrificans MauG (82), and Y. pestis HmuT (12).  Of these, HasA, PhuR, 
CcmE and HmuT are all involved in heme transfer.  MauG, in contrast, appears to use the 
tyrosinate axial ligand to stabilize a high oxidation center in the mechanistic pathway of this 
protein (83).  The His/Tyr ligand set is also known in hemoglobin variants such as Hb M 
Saskatoon (84) and has been created by site-directed mutagenesis of sperm whale Mb 
(HisE7Tyr) (85).   
Tyrosine alone is also an axial ligand in a number of proteins in heme uptake pathways 
characterized to date, including S. dysenteriae ShuT (10), P. aeruginosa PhuT (10;11), Y. pestis 
HasA (86), N. meningitidis HmbR (87) and the heme uptake proteins from the S. aureus Isd 
system [IsdA (64), IsdB (88), IsdC (67), and IsdH (68)] as well as IsdX1 and IsdX2-N5 of 
Bacillus anthracis (89;90).  Sequence alignment of the Isd proteins revealed these tyrosine 
residues are conserved among species, and their role in heme binding is significant.  It is possible 
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that tyrosine favors ligand switching; it has been noted that S. aureus IsdA binds heme using 
Tyr166 in the oxidized state and His83 in the reduced state of the protein (14;63;65).  IsdB-N2, 
which has an axial tyrosine, also binds an axial methionine under some circumstances (88). 
Modulation of H-bond donation to the axial tyrosine may play a role in triggering heme 
release and transfer.  In some instances, the hydrogen bonding residue participates in an extended 
H-bonding network that also involves the heme propionates (91).  Disruption of the hydrogen 
bonding network in these cases could have cooperative effects on the structure of the protein, its 
affinity for ferric heme, and potentially on the kinetics and mechanism of ferric heme transfer 
(33;44;57).   
Tyrosine may also be employed as an axial ligand to ensure heme remains in its ferric 
form (57).  Tyrosinate-bound heme proteins are characterized by low reduction potentials, 
consistent with stabilization of the Fe(III) center by the negative charge of the tyrosinate.  For 
example, the midpoint reduction potential of SmHasA was reported to be −550 mV (69), nearly 
0.5 V more negative than the potential of −60 mV for the Fe(III)/Fe(II) couple (92).  The redox 
potential indicates that tyrosine binds more strongly with the Fe(III) of hemin than with the 
Fe(II) of heme.  Assuming that the His/Tyr axial ligation in HmuT imposes a similarly negative 
potential as in HasA, estimation of this difference in binding free energy is facilitated by a 
thermodynamic cycle (Figure 2.22 S12).  Based on this cycle, (ΔGIII−ΔGII) = nF(Eb°−Ef°) = 
−4.7×104 J·mol−1 where ΔGIII and ΔGII are the free energies of apoHmuT complexation with 
FeIIIPPIX to give HmuTIII and FeIIPPIX to yield HmuTII, respectively.  Eb° and Ef° are the 
reduction potentials of bound (HmuTIII) and free FeIIIPPIX, respectively.  Thus, formation of 
HmuTIII is favored by an estimated 47 kJ·mol−1 over HmuTII.  This would strongly favor binding 
of the ferric form of the protein, thereby favoring uptake of Fe(III) by any bacterium having a 
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Tyr−-based HBP that delivers FeIIIPPIX to the ABC permease.  This discrimination could help 
guard against the damaging effects of Fenton-type chemistry from buildup of free heme in the 
reducing environment of the cell. 
HmuT joins a growing number of extracellular and cell-surface HBP’s that use the H-
bond assisted axial Tyr ligand motif to bind and stabilize FeIIIPPIX.  These proteins share high 
affinities for ferric heme and ostensibly use the free energy of protein-protein complexation to 
destabilize their FeIIIPPIX-bound states, thereby facilitating transfer to the acceptor protein (5).   
2.6 Conclusions 
Multiple lines of spectroscopic evidence have revealed the heme axial ligand set in HmuT 
from C. diphtheriae to be His136/Tyr235 from the N- and C-terminal domains of the protein, 
respectively.  The same axial ligand set is found in YpHmuT, but with the His and Tyr ligands 
arising from the C- and N-terminal domains of the proteins, respectively.  This highlights the 
variety of binding motifs used by heme binding proteins in bacteria.  Solution speciation of the 
ferric form of CdHmuT is dominated by the 1:1 complex, which, like HasA, exists as a thermal 
spin state equilibrium between 6cHS and 6cLS complexes.  Ferric CdHmuT is slow to reduce 
with S2O42− in the presence of CO with His136 being replaced by CO upon reduction.  The 
position of the trans-Tyr carbonyl complex on the neutral O-bound ligand line of the π-
backbonding correlation plot suggests that, as in HasA−CO, the Tyr-based phenol ligand is a 
charge neutral heme carbonyl.  Thus, HmuT reinforces the emerging theme of extracellular and 
cell surface heme-binding proteins that use H-bond assisted axial Tyr ligands to stabilize hemin-
bound states that require a heme-accepting partner for release and transfer of the hemin substrate.  
Moreover, the axial Tyr ligand (Tyr235 in CdHmuT) is required for full hemin uptake function in 
C. diphtheriae. 
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2.9 Supplemental Information 
2.9.1 Supplemental Figures 
 
Figure 2.11 S1 Alignment of the amino acid sequence of HmuT from various Corynebacterium 
species. Species are designated as follows: Cd: C. diphtheriae 1737/NCTC13129; CU: C. 
ulcerans 712; Cjk: C. jeikeium k411-jk0316; Cglut: C. glutamicum ATCC 13032; Curea: C. 
urealyticum DSM 7109.  Conserved residues that were subjected to site-directed mutagenesis 
are indicated above the sequence alignment; asterisks indicate sequence identity and colons and 
periods show sequence similarity. 
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Figure 2.12 S2 Alignment of the amino acid sequence of CdHmuT with four HBPs with known 
crystal structures. Square boxes indicate the known axial ligands.  Orange: P. aeruginosa PhuT 
(1) and S. dysenteriae ShuT (1).  Green: S. aureus IsdE (2).  Blue: Y. pestis HmuT (3).  Red: C. 
diphtheriae HmuT.  For CdHmuT, M292 is also shown. 
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Figure 2.13 S3 Comparison of the UV-visible absorption and MCD spectra for Fe(III) WT 
CdHmuT at pH 6.5 with Fe(III) bovine liver catalase (BLC) and H93Y myoglobin.   
The samples were taken in 50 mM phosphate buffer.  Spectra were slightly dependent on buffer 
conditions.  The spectra of BLC and H93Y myoglobin were replotted from (4-6) and (7), 
respectively. 
 
 
Figure 2.14 S4 The rR spectrum of ferric WT CdHmuT as a function of pH. A) Low frequency 
window.  B) High frequency window.  Protein concentration was 40 μM; excitation frequency of 
413.1 nm was used with 9.4 mW laser power at the sample.  The pH values are as indicated with 
the buffers described in the experimental section. 
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Figure 2.15 S5 Top panel: UV-visible absorption spectrum of WT CdHmuT (black) and M292A 
CdHmuT (red). The samples were taken in 50 mM Tris-Cl, pH 7.0.  Bottom panel: Comparison 
of the MCD spectra for Fe(III) M292A CdHmuT at pH 6.5 with Fe(III) WT CdHmuT and Fe(III) 
phenol-leg Hb a.  The samples were taken in 50 mM phosphate buffer.  The spectrum of phenol-
leg Hb a was replotted from (8). 
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Figure 2.16 S6 The rR spectrum of ferric M292A as a function of pH. Protein concentration was 
36 μM; 406.7-nm excitation with 11 mW at the sample was used. The spectrum of ferric WT 
HmuT at pH 5.0 (red) is overlaid on the M292A pH 5.0 spectrum for comparison purposes. 
Coordination state and spin state markers ν3, ν2 and ν10 appear at the same frequencies in both 
spectra. The only noticeable difference between the WT and M292A spectra is the 1537 cm−1 
shoulder, which is assigned to ν11 (the B1g, Cβ-Cβ stretching mode) in the WT spectrum, and 
which is absent in the M292A spectrum. 
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Figure 2.17 S7 The UV-visible absorption and MCD comparison spectra for Fe(III) H136A 
CdHmuT at pH 6.5. Bottom panel: Comparison of the MCD spectra for Fe(III) H136A CdHmuT 
with Fe(III) WT CdHmuT, Fe(III) ShuT, Fe(III) H93Y Mb, and Fe(III) BLC.  All samples in the 
work were taken in 50 mM phosphate buffer.  Spectra of H93Y, ShuT, and BLC were replotted 
from (7),(9), and (4-6), respectively.   
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Figure 2.18 S8 The rR spectrum of ferric H136A as a function of pH.  Protein concentration was 
25 μM; 406.7-nm excitation with 11 mW at the sample was used. 
 
 
Figure 2.19 S9 Resonance Raman spectra of the ferrous carbonyls of WT CdHmuT, H136A, and 
Y235A recorded using 413.1-nm excitation. Natural abundance HmuT−CO (black), 
HmuT−13CO (red) and difference (blue) spectra are shown for each protein.  Spectra of WT and 
H136A were recorded at pH 8.8 and that of Y235A at pH 8.2.  The asterisks in the carbonyl 
stretching region of the Y235A spectrum mark plasma emission lines from the Kr+ laser. 
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Figure 2.20 S10 Comparison of the low frequency RR window of ferrous Y235A spectra obtained 
with 413.1-nm and 441.6-nm excitation. Laser powers at the sample were 4.0 mW and 4.6 mW, 
respectively.  The solutions were 38 μM in protein and 100 mM in Tris-Cl, pH 8.8. 
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Figure 2.21 S11 The Fe−C stretching region of the Y235A-CO rR spectrum.  The experimental 
data for the natural abundance CO (black) and 13CO (burgundy) complexes are shown with the 
peak fitting analysis of the 509/505 (magenta) and 491/488 cm−1 bands (red).  Band widths are 
24 and 18 cm−1, respectively.  The 466 cm−1 band is not 13C sensitive.  The simulated spectra are 
shown in blue; they are the sums of the fit peaks.  The difference spectrum, obtained by 
subtraction of 13CO spectrum from the natural abundance CO spectrum, is shown in green.  The 
simulated 12CO−13CO difference spectrum (blue) is the difference between the simulated spectra 
for the 12CO and 13CO complexes.  
 
 
Figure 2.22 S12 Thermodynamic cycle for heme binding and reduction. 
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2.9.2 Supplemental Tables 
Table 2.1 pKa values of water trans to histidine in selected ferric heme proteins.  The pKa of 
ferrous microperoxidase 8 is reported as 10.9 (10).  
Class Protein Fe(III) Reference 
CCOx Cytochrome c oxidase 9.0 (11) 
ClD GR-1 chlorite dismutase 8.2 (12) 
ClD Ideonella dechloratans chlorite dismutase 8.5 (13) 
ClD 
Dechloromonas aromatica chlorite 
dismutase 
8.7 (14) 
FixL Rhizobium meliloti FixL 9.3 (15) 
FixL Bradyrhizobium japonicum FixL 9.3 (15) 
FixL Rhizobium meliloti FixL 10 (15) 
Hb Leghemoglobin 8.3 (16) 
Hb Hemoglobin I (clam) 9.6 (17) 
H-NOX 
Thermoanaerobacter tengcongensis  H-
NOX 
6.8 (18) 
H-NOX 
Thermoanaerobacter tengcongensis  H-
NOX I5L 
7.9 (18) 
H-NOX 
Thermoanaerobacter tengcongensis  H-
NOX I5L/P115A 
>10 (18) 
H-NOX 
Thermoanaerobacter tengcongensis  H-
NOX P115A 
>10 (18) 
HO Heme oxygenase 7.6 (19;20) 
HO Mammalian HO-1 7.6 (20) 
HO Rat heme oxygenase-1 7.6 (20) 
HO Pseudomonas aeruginosa heme oxygenase 8.3  (21) 
HO Mammalian HO-2 8.5 (22) 
HO Bacterial heme oxygenase HmuO 9.0 (23) 
HO Neisseriae meningitidis  heme oxygenase 9.3 (24) 
HRP Horseradish peroxidase 10.9 
(25) 
(26) 
IsdI Staphylococcus aureus IsdI 7.1 (27) 
Mb 
Porcine myoglobin 
H64V/V68H/H93A/H97F 
7.17 (28) 
Mb Aplysia myoglobin 7.6 (25) 
Mb 
Porcine myoglobin 
H64V/V68H/H93G/H97F 
7.74 (28) 
Mb Dolabella auricularia myoglobin 7.8 (29) 
Mb Sperm whale myoglobin 8.95 (25) 
MP Microperoxidase 8 9.6 (10;30) 
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Table 2.2 Selected His/Tyr and Tyr heme-binding proteins with corresponding residues which 
are hydrogen-bonded to the axial tyrosine ligand.  The examples are ordered by hydrogen 
bonding motif. 
Protein 
Axial 
Ligation 
Hydroge
n 
Bonding 
Residue 
Motifa Soret  Q Bands Reference 
S. aureus IsdA Y166 Y170 YxxxY 406 502, 535, 628 (31) 
S. aureus IsdB-
N2 
Y440 Y444 YxxxY 406 504, 540, 630 (32) 
S. aureus IsdC Y132 Y136 YxxxY 403 502, 533, 627 (33) 
S. aureus IsdH-
N3 
Y642 Y646 YxxxY 401 504, 537, 630 (34) 
B. anthracis 
IsdX1 
Y136 Y140 YxxxY 400 505, 540, 630 (35) 
B. anthracis  
IsdX2-N5 
Y108 Y112 YxxxY 404 500, 630 (36) 
P. aeruginosa 
HasA 
H32/Y75 H83 YxxxxxxxH 407 495, 540, 577, 616 (37) 
S. marcesans 
HasA 
H32/Y75 H83 YxxxxxxxH 406 494, 537, 568, 618 (38) 
Y. pestis HasA Y75 H81 YxxxxxH 403 498, 535, 620 (39) 
Y. pestis HmuT Y70/H167 R72b YxR 404  (3) 
C. diphtheriae 
HmuT 
H136/Y235 R237c YxR 407 492, 546, 569, 616 This work 
C. diphtheriae 
HmuT H136A 
Y235 R237c YxR 400 504, 546, 620 This work 
C. diphtheriae 
HmuT Y235A 
H136 -- -- 412 540, 575 This work 
P. aeruginosa 
PhuT 
Y71 R73 YxR 400 500, 534, 624 (1) 
S. dysenteriae 
ShuT  
Y67 K69b YxK 400 500, 521, 617 (1) 
P. homomalla 
cAOS 
Y353 R349 RxxxY 406 500, 534, 620 (6) 
Bovine liver 
catalase 
Y357 R353 RxxxY 404.5 500, 535, 622 (6;40) 
M. avium ssp. 
paratuberculosi
s MAP 
Y294 R290 RxxxY 406 503, 621 (6) 
a Residues in bold represent the amino acid hydrogen bonded to the axial ligand. 
b Predicted that the residue could hydrogen bond the axial ligand, but is not directly observed in 
the crystal structure. 
c Predicted that the residue could hydrogen bond the axial ligand via homology modeling and 
spectroscopic studies. 
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3 CORYNEBACTERIUM DIPTHERIAE HMUT: A CLOSER LOOK AT CONSERVED 
RESIDUES 
This chapter is additional work on C. diphtheriae HmuT, spanning from our work in Chapter 2. 
The following chapter is intended for publication.  Site-directed mutagenesis of R237A, 
expression, purification, UV-visible absorption spectroscopy, thermal unfolding, and mass 
spectrometry were performed at Georgia State University.  
3.1 Abstract 
The heme binding protein HmuT is part of the Corynebacterium diphtheriae heme uptake 
pathway and is responsible for the delivery of heme to the HmuUV ABC transporter.  HmuT 
binds heme with a conserved His/Tyr heme binding motif.  Sequence alignment indicated other 
conserved residues which may be important for heme binding: R237, Y272, M292, and Y349.  
In this study, a combination of UV-visible and resonance Raman spectroscopies, along with 
collision-induced dissociation electrospray ionization mass spectrometry and thermal unfolding 
titrations, are utilized to probe the roles of each conserved residue in regards to heme binding.  
R237 acts as a hydrogen-bonding partner to the axial tyrosine ligand while Y272 may be 
participating as a hydrogen-bond partner to another residue in the pocket.  M292 appears to 
buttress the axial tyrosine in the pocket as shown by the detection of multiple Fe(II)-CO species 
by Raman spectroscopy.  Y349, although predicted to not be near the heme-binding pocket, 
results in a minimally heme-loaded protein and may alter the overall fold of HmuT in some 
fashion.  In addition, the plasticity of the overall HmuT protein was probed using heme 
reconstitution experiments and showed HmuT has the ability to bind heme in more than one 
form.      
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3.2 Introduction 
Iron is a necessary element for almost all living organisms, including pathogenic bacteria 
(1, 2).  Studies have shown the availability of iron to a pathogen is linked to not only survival, 
but also virulence (2, 3).  In the human host, the majority of iron is commonly found in the form 
of heme bound to proteins such as myoglobin and hemoglobin.  Although some bacteria are able 
to synthesize heme, others rely solely on uptake from host heme sources (1, 4).  As a result, 
pathogenic bacteria have developed sophisticated strategies to obtain required iron, in the form 
of heme, from the host.     
Studies of heme uptake pathways in both Gram-negative and Gram-positive bacteria have 
been the subject of many reviews (1-3, 5-8).  Commonly studied Gram-negative pathways 
involve Pseudomonas aeruginosa, Shigella dysenteriae, and Yersinia pestis (1, 3, 5, 9).  Gram-
positive pathways such as Staphylococcus aureus (10, 11), Bacillus anthracis (12), 
Streptococcus pyogenes (13, 14), and Corynebacterium diphtheriae (15) have also been 
characterized in regards to heme uptake.  C. diphtheriae is one such pathogen which utilizes a 
heme uptake pathway in conjunction with an ABC transporter to obtain host heme (15-18).  
The heme utilization (hmu) operon in C. diphtheriae includes the hmuT (substrate 
binding protein), hmuU (the permease), and hmuV (the ATPase) genes which make up the ABC-
type heme binding transporter system (19).  The pathway has previously been studied in detail; 
heme is transferred from HtaA (surface-exposed hemin binding protein) to HtaB (membrane-
anchored protein) (16, 17, 19-21). The third protein in the pathway, HmuT (the substrate binding 
protein), delivers the heme to the ABC transporter. 
BLAST analysis and sequence alignment shows that the HmuT heme binding motif is 
found throughout Corynebacterium species (17) and extends into other genuses including 
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Yersinia (22), Bradyrhizobium (23), and Propionibacterium (24).  Detailed studies on three 
HmuT protein homologs are available, those from Y. pestis (22), C. diphtheriae (17) and C. 
glutamicum (25).  These proteins are similar in many respects.  All three proteins are involved in 
heme transfer to the corresponding HmuUV ABC transporter; all three use a His/Tyr binding 
heme motif.  However, these three HmuT proteins also differ in fundamental aspects.  Both 
CdHmuT and CgHmuT utilize a histidine axial ligand from the N-terminal end of the protein and 
a tyrosine from the C-terminal end of the protein.  In contrast, YpHmuT binds heme in a reverse 
manner with an N-terminal tyrosine and a C-terminal histidine.  YpHmuT is also able to bind 
heme as a dimer; this has not been reported for CgHmuT.  In view of both the similarities and 
differences between these three closely-related proteins, our goal was to establish the roles of 
various conserved residues in the structure and function of HmuT, specifically by investigating 
the C. diphtheriae protein.  
CdHmuT coordinates heme through the conserved residues H136 and Y235 (17).  
Sequence alignment with other Corynebacterium species indicated other conserved residues in 
the HmuT heme pocket, including R237, Y272, M292, and Y349 (Figure S EBalign and Figure 
EBModel).  The homology model indicated that R237 and Y272 were in position to interact with 
the axial Y235 residue.  M292, while recently shown not to be an axial ligand (17) is still in the 
heme pocket and might play a role in the binding of this prosthetic group.  Y349, although 
conserved, was not near the proposed binding pocket as indicated by the x-ray structure of 
CgHmuT (25) and the homology model of CdHmuT (Figure EBModel).  Conservation of these 
residues implies the potential importance of these amino acids to the protein. 
Herein we report the roles of these conserved residues using UV-visible and resonance 
Raman (rR) spectroscopies along with electrospray ionization mass spectrometry (ESI-MS).  
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Thermal unfolding of these proteins, including the heme axial ligand mutants, is also 
investigated.  Additionally, reconstitution studies on the wild-type protein are performed.  The 
data indicate a protein that uses a number of residues in controlling heme binding and has 
significant plasticity in its structure.  
3.3 Materials and Methods 
3.3.1 Bacterial strains and media 
E. coli strains DH5α and TOP10 (Invitrogen) were used for routine cloning and plasmid 
maintenance, while XL-1 Gold (Stratagene) was used in the mutagenesis experiments.  
Chromosomal DNA from C. diphtheriae strain 1737 (30) was used as the source DNA for PCR.  
Luria-Bertani (LB) medium was used for culturing of E. coli strains.  Bacterial stocks were 
maintained in 20 % glycerol at -80o C.  Kanamycin (Sigma Chemical Co.) was added to LB 
medium at 50 g/ml.   
3.3.2 Plasmid construction 
  The HmuT expression construct was developed using the pET28a expression vector 
(Novagen) and is previously described (17).  A PCR-derived DNA fragment containing the C. 
diphtheriae hmuT coding region was initially cloned into the pCR-Blunt II-TOPO vector 
(Invitrogen).  The DNA fragment harboring the hmuT gene was subsequently ligated into the 
NcoI-EcoRI sites in pET28a and the expression plasmid was then transformed into BL21(DE3) 
cells.  The cloned hmuT gene in the pET28a vector lacked the 20-amino acid N-terminal 
secretion signal and contained an N-terminal Strep-tag, which was used for protein purification.  
The following primers were used in the PCR: hmuTF; 5’-CC ATGGCA AGC TGG AGC CAC 
CCG CAG TTC GAA AAG GGT GTC CAG GGC ACA TAT-3’; hmuTR; 5’-GAATTC CTA TAC 
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CTG TGG GTC ATAC-3’: underlined sequences indicate restriction sites and the sequence in 
italics encodes the 8-amino acid Strep-tag. 
3.3.3 Site-directed mutagenesis   
Site-directed mutants were made using the QuikChange Lightning kit (Stratagene) 
according to the manufacturer’s instructions as previously described (17).  Briefly, 125 ng of 
each primer containing the targeted base change and 50 ng of plasmid template were used in the 
QuikChange reaction.  Methylated template DNA was removed from the reaction by digestion 
with DpnI restriction endonuclease, and mutagenized DNA was recovered by transformation into 
XL1-Gold competent cells.  The presence of the base changes was confirmed by sequence 
analysis.  Plasmids used for site-directed mutagenesis were pET28a containing the cloned Strep-
tag-hmuT gene, and plasmid pCD842, which harbors the hmuT gene on the E. coli 
Corynebacterium shuttle vector pCM2.6 (27).    
3.3.4 Expression and purification of CdHmuT 
HmuT was expressed and purified from BL21(DE3) (pEThmuT) cells as previously 
described (17).  The N-terminal leader sequence was deleted and replaced with a Strep-tag.  The 
native construct started at residue 21 (Gly) and extended through the native stop codon.  The 
culture was prepared in a LB medium containing 50 µg/mL kanamycin.  Inoculation was done 
with an overnight pre-culture and cells were grown at 37 °C with shaking at 220 rpm.  When the 
OD600 of the culture reached 0.5 – 0.6, protein expression was induced by adding isopropyl β-D-
1-thiogalactopyranoside (IPTG) to a final concentration of 1.0 mM.  The culture was incubated 
for 3 h at 27 °C.  Cells were harvested by centrifugation at 8000 g.  The cell pellet was 
resuspended in lysis solution (100 mM Tris-Cl, 150 mM NaCl, pH 8.0) containing a protease 
inhibitor cocktail (Roche Complete Mini, EDTA-free, following the manufacturer protocol).  The 
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cells were broken using a cell disrupter or sonication.  The lysate was then centrifuged at 8000 g, 
and the supernatant was syringe-filtered with a 0.45 m filter.   
All of the following purification steps were conducted at 4 °C using fast protein liquid 
chromatography and all buffer solutions were pH 8.0 unless specified otherwise.  The protein 
sample was loaded onto a Strep-Tactin Superflow column (5 mL, IBA BioTAGnology) 
equilibrated with buffer A (100 mM Tris-Cl, 150 mM NaCl, pH 8.0).  Unbound material was 
washed out with 5 column volumes (CV) of buffer A.  HmuT was eluted with 10 CV of buffer B 
containing 100 mM Tris-Cl, 150 mM NaCl, 2.5 mM desthiobiotin, pH 8.0 applied via a linear 
gradient.  The purities of the fractions were evaluated using sodium dodecyl sulfate 
polyacrylamide gel electrophoresis.  HmuT and mutants are isolated in the ferric form as a 
mixture of holo and apoproteins.  
3.3.5 Heme extraction and reconstitution studies  
Apo-HmuT was prepared using the Teale method (32).  HmuT (10 µM) was mixed with 
cold 2-butanone and cold 1 M HCl was used to adjust the pH of the solution to 2.0.  The solution 
was mixed and the protein layer was dialyzed against 20 mM Tris-Cl, pH 7.0 at 4˚C.  The 
concentration of apo-HmuT was determined using the ExPASy ε280 = 15,930 M-1cm-1 (33). 
 Reconstitution was monitored via UV-visible spectroscopy.  Hemin solutions were 
prepared fresh by dissolving 1 mg of hemin in 5 mL of dimethyl sulfoxide (DMSO, EMD 
Chemicals) to prevent aggregation.  Hemin concentration was spectroscopically determined 
using the extinction coefficient of 188 M-1cm-1 at 404 nm (34).  The stock hemin solution was 
then titrated in 1 μL aliquots to the apo-HmuT (~5 μM) protein.  The reconstituted HmuT was 
checked spectrally for heme aggregation.  Reconstituted HmuT was then dialyzed using a 13,000 
MWCO dialysis bag in the appropriate buffer. 
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3.3.6 UV-visible absorption spectroscopy  
Samples of HmuT and mutants were analyzed by UV-visible absorption spectroscopy 
using a Varian 50 Bio spectrophotometer in 1 cm quartz cuvettes (Fisherbrand, Inc.) at room 
temperature.   
3.3.7 Resonance Raman spectroscopy  
Resonance Raman (rR) spectra were collected using the 441.6-nm emission line from a 
HeCd laser or either 406.7 nm or 413.1 nm emission from a Kr+ laser.  Spectra were recorded at 
ambient temperature using the 135° backscattering geometry with the laser beam focused to a 
line on a spinning 5 mm NMR tube.  Toluene, DMSO, and CH2Br2 were used as external 
standards for spectral calibration.  UV-visible absorption spectra were recorded before and after 
rR experiments to verify that the samples were not altered by exposure to the laser beam.  The 
final concentrations of all Fe(III) samples were between 25 and 80 μM protein in 100 mM buffer 
solution.  The buffers used were CHES, pH 10.0, Tris-Cl, pH 8.8 or 8.0, sodium phosphate 
buffer, pH 7.0 or 5.8, MES, pH 5.1, and sodium acetate buffer, pH 5.0. 
3.3.8 Collision-induced heme dissociation via ESI mass spectrometry   
Samples (50 μM) of WT, H136A, Y235A, R237A, Y272A, and M292A in 50 mM 
ammonium acetate, pH 6.8 ESI spectra were obtained using a Waters Micromass Q-TOF Micro 
mass spectrometer in the positive mode.  Samples were run at the following relative heme-
loading percentages: WT HmuT, 100%; H136A, 50%; Y235A, 20%; R237A, 25%; Y272A, 
100%; and M292A, 90%.  Spectra were recorded for each sample at the following collision 
energy voltages: 5, 10, 15, 20, 25, and 30 volts.  All other parameters were held constant.  
Deconvolution of the charged state was performed using the MaxEnt program with the 
MassLynx™ software.  Peaks were rounded to the nearest Dalton.  Peak heights were measured 
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in order to determine a relative estimation of holo protein percentages at each collision energy 
voltage.  
3.3.9 Thermal Unfolding   
Thermal denaturation experiments on WT HmuT and mutants were performed using a Carey 300 
Bio Spectrophotometer equipped with automated temperature control.  Supracil 1.5 mL screw-
top cuvettes (Spectracell) with 1 cm path lengths were utilized.  Protein samples were in 50 mM 
potassium phosphate, pH 7.0 and at the following wavelengths and concentrations: WT HmuT 
(406 nm; 5 µM), H136A (399 nm; 5 µM), Y235A (412 nm; 7 µM), R237A (407 nm; 8 µM), 
Y272A (406 nm; 8 µM), Y349A (406 nm; 4 µM), and Y349F (406 nm; 8 µM).  Spectra were 
recorded between 25 ˚C and 80 ˚C.   
 The data were fit to a two-state unfolding model using Equation 1 (35): 
 
𝑌(𝐴𝑏𝑠) =  
(𝐴𝐹+𝑚𝐹𝑇)+(𝐴𝑈+𝑚𝑈𝑇)𝑒𝑥𝑝[
∆𝐻𝑚
𝑅
(
1
𝑇𝑚
−
1
𝑇
)]
1+𝑒𝑥𝑝[
∆𝐻𝑚
𝑅
(
1
𝑇𝑚
−
1
𝑇
)]
             [1] 
 
where y is the absorbance at any point along the fitted denaturation curve, AF is the absorbance 
of the folded state, mF is the slope of the folded state, AU is the absorbance of the unfolded state, 
mU is the slope of the unfolded state, ΔHm is the enthalpy of the unfolding, Tm is the temperature 
at which the protein is half-unfolded, R is the gas constant, and T is the temperature (Kelvin). 
3.4 Results and Discussion 
3.4.1 Sequence alignment and homology modeling 
The heme axial ligands of CdHmuT are H136 and Y235 (17).  Sequence alignment of C. 
diphtheriae HmuT with homologs from various Corynebacterium species indicated three 
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conserved residues in the heme pocket which could potentially play a role in heme binding: 
R237, Y272, and M292 (Figure 3.9 S1).  R237 and M292 were conserved across all 
Corynebacterium species aligned (four other species); Y272 was conserved in all species except 
C. glutamicum.  Y349 was also conserved in all species, but homology modeling and comparison 
with the Y. pestis and C. glutamicum x-ray structures indicated that this residue was not near the 
heme binding pocket (Figure 3.1).   
It is common in tyrosine heme binding proteins for another residue (most frequently His, 
Tyr, or Arg) in the heme pocket to form a hydrogen bond with the axial tyrosine.  The recent 
study of CgHmuT proposed that R242 hydrogen bonds to the axial Y240 as they are 2.7 Å apart 
(25).  This is in line with earlier studies on YpHmuT, in which R72 was suggested as a potential 
hydrogen partner of axial ligand Y70 (2, 22).  For CdHmuT, R237 is the homologous reside that 
could hydrogen bond to Y235.  However, CdHmuT also has Y272 (not found in C. glutamicum 
and an Arg in YpHmuT) that could potentially serve as a hydrogen bond partner.   
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Figure 3.1 I-TASSER homology model of HmuT and heme binding pocket.  Shown are the 
locations of H136 (axial ligand), Y235 (axial ligand), R237, Y272, M292, and Y349.   
.    
3.4.2 UV-visible absorption spectroscopy and heme loading of HmuT mutants 
The heme loading of the as-isolated protein varies with the nature of the mutant.  WT 
HmuT and Y272A are approximately 100% heme loaded as-isolated.  M292A is about 90% 
heme-loaded.  R237A and Y349A are both approximately 25% heme loaded and Y349F is about 
55% heme loaded.   
The UV-visible absorption spectra comparison of WT, Y272A, and R237A are shown in 
Figure 3.2.  WT HmuT has a Soret at 407 nm with bands at 492, 546, 569, and 616 nm.  R237A 
has a Soret at 407 nm, similar to WT, but also gave four bands at 492, 541, 578, and 610 nm 
which are shifted compared to the WT.  Y272A gave a Soret maximum at 406 nm and has an 
altered α,β-region, with bands at 492, 556, 581, and 616 nm.  M292A has previously been shown 
to have a spectrum almost identical to that of WT (17).  Y349A and Y349F have similar UV-
visible absorption spectra with a Soret around 406 nm, with Y349A isolated mainly in the apo 
form of the protein (Figure 3.10 S2).  The four α,β-bands at 492, 538, 578, and 613 are in the 
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same positions for both mutants and are slightly shifted compared to the WT.  The observation of 
four α,β-bands in all of the spectra indicates the protein mutants are isolated as a mixture of high-
spin and low-spin heme as seen in the WT (17). 
 
Figure 3.2 UV-visible absorption spectra of Fe(III) WT HmuT (blue), R237A (green), and Y272A 
(red) normalized at the Soret.  The α,β-peaks are labeled for R237A and Y272A.  Samples were 
recorded in 50 mM Tris-Cl, pH 7.0.   
3.4.3 Buttressing of the heme pocket by M292 
Previous work by our group showed M292 to not be a heme axial ligand based on UV-
visible absorption spectroscopy and MCD spectral similarities between WT and M292A (17).  
However, this residue, essentially in the heme pocket, may still play a role in heme binding.  For 
the CO-bound ferrous forms of heme proteins, an inverse correlation plot of the frequency of the 
Fe-CO stretch versus that of the bound carbonyl gives insight into the axial ligands of the heme 
(Figure 3.3).  As shown previously (17), the spectrum of Fe(II)-CO WT HmuT is consistent with 
a single Tyr-Fe(II)-CO motif.  In contrast, replacement of M292 by alanine in the M292A mutant 
results in two Fe(II)-CO species, one of which falls along the Tyr-Fe(II)-CO line (Fe-CO and 
carbonyl stretches at 537 cm-1 and 1932 cm-1, respectively).   The second species falls along the 
His-Fe(II)-CO correlation lines (Fe-CO carbonyl stretch at 504 cm-1 and 1950 cm-1, 
respectively).  This indicates a role for M292 in buttressing the heme in the binding pocket.   
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Figure 3.3 Backbonding correlation plot of νFe-CO versus νC-O for ferrous carbonyls of heme 
proteins showing the dependences of their positions on axial ligation and distal pocket 
properties. As-isolated WT (blue), reconstituted HmuT (pink), H136A (green), Y235A (red), and 
M292A (purple) are shown as stars on the plot.  Catalase, hexagon; HasA(Y75A), ◊; HasA(WT), 
○; HasA(H83A), ○; HasA(H32A), ○.  The dashed line is the least squares line for six-coordinate 
Fe−CO adducts in which the proximal ligand is thiolate or imidazolate; the dotted line is the 
least squares line for Fe−CO adducts with proximal histidine (neutral imidazole); and the solid 
line represents a compilation of “five-coordinate” model complexes and heme proteins which 
the ligand trans to CO is coordinated through an oxygen atom. 
 
3.4.4 Thermal unfolding studies 
To assess the roles of each conserved residue of HmuT, thermal unfolding studies were 
performed on WT HmuT, H136A, Y235A, R237A, Y272A, M292A, Y349A, and Y349F 
(Figure 3.4 and Table 3.1).  After unfolding, samples were cooled to room temperature and 
folding was shown to be ~90% reversible.  The WT protein had a melting temperature (Tm) of 67 
˚C.  Mutation of the two axial ligands had very different effects on protein stability.  Mutation of 
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the axial histidine to alanine (H136A) resulted in only about 2 ˚C decrease in the Tm while 
mutation of the axial tyrosine (Y235A) decreased the Tm by more than 15 ˚C.  Mutation of Y272 
and M292 to alanine resulted in Tm decreases of only 1 ˚C and 2 ˚C, respectively. 
 
Figure 3.4 Fraction folded thermal unfolding titrations of WT HmuT (black triangles), H136A 
(dark blues squares), Y235A (orange open diamonds), R237A (cyan open squares), Y272A (red 
circles), M292A (pink, open triangles), Y349A (purple open circles), and Y349F (green 
diamonds).  Samples were in 50 mM potassium phosphate, pH 7.0.  The Tm values are in Table 
3.1.      
The R237A mutant also showed a significantly reduced Tm, 13 ˚C less than WT.  This is 
in line with the expectation, based on the C. glutamicum x-ray structure (25) and the Raman 
studies presented herein, that R237 is the hydrogen bonding partner to the axial tyrosine.  
Removal of axial ligand hydrogen-bonding partners for tyrosine-bound ferric heme proteins 
often affects the protein similarly to the removal of an axial ligand (36-38).  In the Y. pestis 
HmuT crystal structure, R72 is in position to hydrogen-bond to the axial Y70 ligand using an 
YxR motif, although this bond is not directly observed (2, 22).  In the C. glutamicum crystal 
structure, the imino nitrogen of R242 is 2.7 Å from the oxygen of Y240, indicating a hydrogen 
bond between these residues (25).  Other five-coordinate tyrosine ligated heme proteins utilize 
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arginine as a hydrogen-bonding partner such as P. aeruginosa PhuT (39), Plexaura homomalla 
cAOS (40), bovine liver catalase (41), and Mycobacterium avium ssp. paratuberculosis MAP 
(40).  With the exception of PhuT, these proteins have the arginine residue preceding the axial 
tyrosine in the sequence in an RxxxY motif.  In contrast, PhuT has an YxR motif, similar to the 
predicted hydrogen-bonds in YpHmuT, CgHmuT, and CdHmuT.  
 
Table 3.1 Thermal unfolding Tm values of WT HmuT and mutants shown in Figure 3.4. 
 
Protein Tm (°C) 
WT 66.8 ± 0.1 
Y272A 65.6 ± 0.1 
H136A 65.1 ± 0.1 
M292A 64.6 ± 0.1 
Y349F 64.2 ± 0.1 
Y349A 58.1 ± 0.1 
R237A 54.0 ± 0.1 
Y235A 50.5 ± 1.0 
 
3.4.5 Heme dissociation in the gas phase 
Heme dissociation in the gas phase was probed by recording mass spectra at increasing 
collision energy voltages (5 – 30 V) (Figure 3.5).  WT HmuT had the least heme loss over the 
range of collision energy voltages tested, still retaining approximately 90% of the bound heme 
even at a collision voltage of 30 V.  The axial ligand mutant H136A lost a significant amount of 
heme at higher collision voltages, being only about 40% heme loaded at 30 V.  The second axial 
ligand mutant, Y235A, had very little heme loading as-isolated, and did not appear as the 
holoprotein in this experiment, even at the lowest collision voltage.    
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Figure 3.5 Electrospray ionization mass spectrometry detection of heme-bound WT HmuT (black 
squares), H136A (blue diamonds), R237A (orange circles), Y272A (red triangles), and M292A 
(green open squares) as a function of collision energy voltage.  Holo-Y235A is not detected in 
the MS due to minimal heme-loading.  Samples were recorded in 50 mM ammonium acetate, pH 
6.8.    
 
R237A had a very similar pattern to H136A, again starting to lose heme after 10 V, and giving a 
species that was about 50% heme loaded by 30 V.  This significant loss of heme is in line with 
the expected role of R237A as a hydrogen bonding partner to the axial tyrosine.  Y272A retained 
heme until 15 V and then lost the majority of bound heme, having only about 10% bound heme 
at 30 V.  This residue might serve to buttress the heme in position, or it may play a hydrogen-
bonding role in the heme pocket.  Although methionine is neither an axial ligand nor, 
presumably, a hydrogen bonding partner to an axial ligand, this mutant (M292A) was the most 
susceptible to heme loss at low voltages, beginning to lose heme at 5 V and showing a greater 
loss at each increasing voltage.  Although there are individual differences in the patterns, these 
data taken together suggest that all of the studied residues have roles in maintaining the integrity 
of the heme pocket and keeping the heme bound to the protein.  A corollary of this is that 
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binding to a partner protein in the heme uptake process could induce a variety of minor changes 
in the heme pocket geometry and hydrogen bonding patterns, many of which could promote 
heme transfer.   
The thermal melting and collision-induced mass spectrometry data are complimentary.  
As expected from previous studies on myoglobin and cytochrome b5 (42), the gas phase and 
solution phase data do not show a direct correlation.  However, the gas phase data in particular 
can lead to new insights into residues that may be important in the heme transfer pathway.  For 
example, M292A has a UV-visible absorbance spectrum that is essentially identical to that of 
WT, with a Tm that is only two degrees lower than WT, leading to the tentative conclusion that it 
does not play a role in heme binding.  However, it shows a collision-induced loss of heme that is 
significant, indicating a buttressing role for this residue, as observed also in the Raman 
experiments. 
3.4.6 The plasticity of the HmuT structure 
It might be expected that heme transfer proteins would demonstrate some plasticity, in 
that their role is to repeatedly take up and release heme.  For HmuT, this possibility is indicated 
by the observation that the crystal structure of YpHmuT shows heme binding as a dimer (22) 
while that of CgHmuT shows heme binding as a monomer (25).  In solution, YpHmuT can bind 
heme both as a dimer and as a monomer (22).  We have observed dimer binding on occasion for 
CdHmuT, but only for samples of this protein that may have been compromised in terms of 
conformational stability (e.g., protein from the tails of FPLC peaks).   
To probe this further, we looked at reconstitution of CdHmuT with heme.  In initial 
experiments, WT CdHmuT was unfolded with standard protocols and then reconstituted with 
hemin.  UV-visible absorption spectroscopy (Figure 3.6) shows a similar spectral profile for the 
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two proteins, albeit with slight differences in the position of the α,β-bands.  However, the two 
forms of the protein were not the same.  As-isolated WT HmuT took over an hour to reduce in 
the presence of excess dithionite (17); reduction of reconstituted HmuT occurred within minutes.   
The inverse correlation plot of the reconstituted WT HmuT Fe(II)-CO species (Figure 3.4) 
showed two νFeCO bands at 496 and 533 cm-1, with one νC-O band at 1959 cm-1.  In contrast, as-
isolated HmuT has a single νFeCO band at 535 cm-1 and a single νC-O band at 1920 cm1.  In terms 
of spin-state assignment, as-isolated HmuT has a six-coordinate high-spin (6cHS) band at 1475 
cm-1 and a six-coordinate low-spin (6cLS) band at 1504 cm-1 (Figure 3.7).  Reconstituted HmuT 
has the same bands as-isolated HmuT with one additional five-coordinate high-spin (5cHS) band 
at 1490 cm-1.  These results indicate that heme reconstitution can lead to heme binding in a 
reconstituted protein that is not the same as when first isolated after purification.   The 
complexity of the system precludes identification of all the individual species, but these 
experiments, in conjunction with those in the literature, indicate that HmuT can adopt more than 
one heme-bound form.   
Sequence alignment of C. diphtheriae HmuT with closely related Corynebacterium 
species showed Y349 to be conserved, although homology modeling and the comparison C. 
glutamicum structure predicted that the residue was not near the binding site (Y. pestis does not 
have an aromatic residue at this sequence position).  Expression and purification of both Y349A 
and Y349F resulted in less heme-loading when compared to the WT, indicating that the ability of 
the protein to bind heme is somehow altered by these mutations.  Thermal unfolding studies gave 
reductions in Tm by three and nine degrees, respectively, for Y349F and Y349A.  Removal of 
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Y349 may result in altered protein folding, which could in turn result in reduced heme binding.
 
Figure 3.6 UV-visible absorption spectra of Fe(III) as-isolated (solid) and reconstituted WT 
HmuT (dashed line) normalized at the Soret. Samples were recorded in 50 mM Tris-Cl, pH 7.0.   
 
 
Figure 3.7 High frequency resonance Raman spectra of Fe(III) as-isolated and reconstituted 
HmuT.  Spectra were excited with a 413.1 nm Kr+ ion laser. 
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3.5 Conclusions 
In the case of CdHmuT, other residues in addition to the heme axial ligands are necessary 
for efficient heme binding. Following an emerging theme of tyrosine-ligated heme proteins, 
CdHmuT utilizes R237 to hydrogen-bond to the axial Y235 which was also indicated in previous 
studies on the CgHmuT and YpHmuT sister proteins.  Heme binding of Y272 was affected by 
collision energy and could be participating as a hydrogen-bonding partner in the pocket.  M292, 
although not an axial ligand, buttresses the heme as shown by resonance Raman and thermal 
unfolding.  Y349 mutations resulted in a much less heme-loaded protein.  Reconstitution alters 
the form of heme bound to HmuT and indicates the overall plasticity of the HmuT structure 
which could be indicative of in vivo function towards the ability of this heme transfer protein to 
bind and release heme molecules multiple times.     
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3.7 Supplemental Information 
3.7.1 Supplemental Figures 
 
Figure 3.8 S1 Sequence alignment of the HmuT amino acid sequence from various 
Corynebacterium species. Conserved residues which were subjected to site-directed mutagenesis 
are labeled: R237, Y272, M292, and Y349.   
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Figure 3.9 UV-visible absorption spectra of Fe(III) Y349A (dashed) and Y349F (solid line) 
normalized at the Soret. Samples were recorded in 50 mM Tris-Cl, pH 7.0.   
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4 ADDITIONAL STUDIES ON THE CHARACTERIZATION OF                                  
C. DIPHTHERIAE HMUT  
Chapter 1 gave a detailed overview of heme uptake in some of the most commonly 
studied pathogenic bacteria.  Chapter 2 was published work by our group which determined the 
heme axial ligands of HmuT.  Chapter 3 was additional work for publication expanding on our 
work of HmuT and other important residues involved in heme binding.  This chapter gives 
additional experimental data and literature discussions related to our previously published and 
unpublished work on HmuT.  All of the following experiments in this chapter were performed at 
Georgia State University.  
4.1 Experimental 
4.1.1 Expression and purification of HmuT and mutants 
Expression and purification of WT, H136A, Y235A, Y272A, R237A, M292A, Y349A, 
and Y349F were previously described (1).  Protein samples are isolated as a mixture of apo and 
holo forms.  Purity of the samples was evaluated by SDS-PAGE electrophoresis and performed 
as previously described (1).  Approximate heme loading was calculated based on the Soret to 280 
nm ratio.  
4.1.2 Optical spectroscopy 
Samples of apo- and holo-HmuT WT and mutants were analyzed by UV-visible 
absorption spectroscopy using a Varian 50 Bio spectrophotometer in 1 cm quartz cuvettes at 
room temperature unless otherwise noted.  Circular dichroism (CD) spectra were recorded using 
a Jasco J-810 Spectropolarimeter in quartz Suprasil cuvettes (Fisherbrand, Inc.) with a 1 mm 
path length.  Protein samples (10 μM) were recorded in 10 mM KH2PO4 buffer at pH 7.0 in a 
spectral window of 190 to 260 nm.  The final spectrum represents an average of 10 scans.  
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Estimations of secondary structure were obtained using the DichroWeb analysis program (2).  
Both SELCON and CONTIN databases were used to analyze the CD data.  Secondary structural 
content was reported as an average of the two databases.  
4.1.3 HmuT Y235A and M292A heme extraction 
Apo-Y235A and apo-M292A were prepared using the Teale method (3).  All samples 
during the extraction process were kept on ice.  Each HmuT mutant was mixed with 2 mL of 
cold 2-butanone and cold 1 M HCl was used to drop the pH to around 2.0.  The solution was 
vortexed and sat on ice for 30 min to allow separation.  The organic heme/butanone (top) layer 
was discarded.  The aqueous (lower) layer was placed into a 13,000 MWCO dialysis bag and 
dialyzed against 20 mM Tris-Cl, pH 7.0 for 6 h at 4˚C and then again overnight.  The 
concentration of apo-Y235A and apo-M292A were determined using the ExPASy ε280 = 14,440 
M-1cm-1 and 15,930 M-1cm-1, respectively. 
4.1.4 HmuT Y235A and M292A heme reconstitution  
Reconstitution was monitored using UV-visible absorption spectroscopy.  Hemin 
solutions were prepared fresh by dissolving 1 mg of hemin in 5 mL of dimethyl sulfoxide 
(DMSO, EMD Chemicals) to prevent aggregation.  Hemin concentration was spectroscopically 
determined using the extinction coefficient of 188 mM-1cm-1 at 404 nm (4).  The stock hemin 
solution was then titrated in 1 μL aliquots to the apoprotein (~5 μM) while the solution slowly 
stirred.  The solution stirred for 30 min in between each addition of heme.  Once a 2:1 ratio of 
the Soret band to the 280 band was reached, the sample was stored overnight at 4˚C.  The 
reconstituted HmuT mutant was checked spectrally for heme aggregation the next day.  
Reconstituted Y235A and M292A were then dialyzed into the appropriate buffer.  Samples 
which have not been reconstituted are referred to as “as-isolated” samples.  
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4.1.5 Electrospray ionization (ESI) mass spectrometry of HmuT mutants 
Samples (50 μM) of H136A and reconstituted M292A were concentrated into Nanopure 
water using a Millipore YM-3 centrifugal filtration unit (30,000 MWCO) following the 
manufacturer’s protocol.  Y235A, Y272A, R237A, and as-isolated M292A (50 μM) were 
concentrated into 50 mM ammonium acetate, pH 6.8, using an Amicon centrifugal filtration unit 
(30,000 MWCO) following the manufacturer’s protocol.  The samples were then dialyzed for 
five days in 50 mM ammonium acetate, pH 6.8, to remove residual salts.  Fresh buffer was used 
every 24 h.  
ESI spectra were obtained using a Waters Micromass Q-TOF Micro mass spectrometer in 
the positive mode.  Samples were prepared with either 50:50 acetonitirile to water and 0.1% 
formic acid or 10% methanol when indicated.  Deconvolution of the charged states were 
performed using the MaxEnt program with the MassLynx™ software.  Peaks were rounded to 
the nearest Dalton.  
4.1.6 pH titrations of as-isolated and reconstituted HmuT Y235A 
Samples of either as-isolated or reconstituted Y235A (5 µM) were monitored using UV-
visible absorption spectroscopy from pH 4 – 9.5 and 7 – 11, respectively, in a series of pH 
titrations.  For as-isolated Y235A, two titrations were performed; one from pH 4 – 7 and 6 – 9.5.  
The reconstituted Y235A was titrated from pH 7 – 11.  Aliquots of 1 M NaOH were used to 
adjust the pH in all titrations with the exception of the as-isolated Y235A pH 4 – 7 titration in 
which aliquots of 1M HCl were used to adjust pH.  The pH was adjusted between scans after a 
constant spectrum was obtained with an absorbance change of less than 0.002 at the Soret.  All 
data were fit to either a one or two pKa model with global fitting analysis software using 
Equations 1 or 2, respectively: 
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Absobs= 
AbsA × 10
(pH - pKa)+ AbsB
1 + 10(pH - pKa)
                                                                             [1] 
 
Absobs= 
AbsA+ 𝐴𝑏𝑠𝐵 × 10
(pH - pKa1)+ AbsC × 10
((2 ×𝑝𝐻)−𝑝𝐾𝑎1−𝑝𝐾𝑎2))
1 + 10(pH - pKa)+10((2 ×𝑝𝐻)−𝑝𝐾𝑎1−𝑝𝐾𝑎2))
            [2] 
 
4.1.7 Chemical unfolding studies of HmuT 
Chemical denaturation of WT HmuT (5 µM) was performed using guanidinium 
hydrochloride (GdnCl) and monitored at 406 nm via NanoDrop UV-visible absorption 
spectroscopy to approximate the D1/2.  A series of WT HmuT samples at various GdnCl 
concentrations were incubated at room temperature overnight in 50 mM Tris-Cl, pH 7.0.  A stock 
solution of 8.0 M GdnCl was prepared in 50 mM Tris-Cl, pH 7.0 and refractive index was used 
to verify the concentration of the stock (5).  The desired GdnCl concentration was achieved by 
varying the amount of buffer in the sample.   
The unfolding curve was analyzed using a two-state unfolding model, Equation 3 (2):  
 
y = [(AF + mF[D]) + (AU + mU [D])exp[m([D]-[D]1/2)/RT])]/1 + exp[m([D]-[D]1/2)/RT]        [3] 
 
where y is the absorbance at any point along the fitted denaturation curve, yF is the absorbance of 
the folded state, yU is the absorbance of the unfolded state, m is the slope at the midpoint, and 
also the dependence of the free energy of unfolding on the denaturant concentration, mF is the 
slope of the folded state, mU is the slope of the unfolded state, [D] is the concentration of GdnCl, 
[D]1/2 is the concentration of GdnCl at the midpoint of the unfolding curve, R is the gas constant, 
and T is the temperature (Kelvin). 
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In a separate set of experiments, solutions of 5 μM WT, Y235A, and H136A in 50 mM 
Tris-Cl, pH 7.0 were monitored via UV-visible absorption spectroscopy at the Soret as a function 
of time for 24 h at the estimated D1/2 concentrations.  The data were fit to a first-order reaction 
using Equation 4: 
 
Absobs = A exp(-kUt) + b                [4] 
 
where Absobs is the observed change in absorbance, A is the amplitude of the change 
corresponding to unfolding, kU is the rate constant of the unfolding, b is the offset, and t is time.  
4.2 Results 
4.2.1 Circular dichroism spectroscopy of HmuT and mutants 
CD studies were performed on WT, Y272A, Y349A, and Y349F HmuT.  Each sample 
varied in heme loading as detailed in the experimental.  All spectra indicated the presence of α-
helical content, with varied positions of the maxima and minima around 190, 208, and 222 nm 
(Figure 4.1).  Analysis of the CD data using DichroWeb showed WT HmuT to have 91% α-
helical content, 8% turns, and 1% unordered.  Each mutation, with the exception of Y272A, 
resulted in a decrease in α-helical content of the protein with Y349F having the largest reduction 
in α-helicity (Table EBIII75).  
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Figure 4.1 CD spectra of WT HmuT (purple), Y272A (blue), Y349A (red) and Y349F (green).  
Samples were measured in 10 mM potassium phosphate, pH 7.0. 
 
 
 
Table 4.1 DichroWeb CD estimated secondary structural deconvolution of HmuT and mutants. 
Protein α-Helix (%) Turns (%) Unordered (%) 
WT 91 8 1 
Y272A 91 5 4 
Y349A 78 13 9 
Y349F 45 28 27 
 
4.2.2   Reconstitution of Y235A and M292A 
Y235A was reconstituted in order to increase heme loading and reduce fluorescent signal 
due to the presence of apoprotein before use in resonance Raman experiments.  As-isolated 
Y235A heme loading varied with each expression.  The sample used for reconstitution was 
~20% heme loaded based on the Soret:280 nm ratio.  Reconstituted Y235A was 100% heme 
loaded after titration with heme.  Normalized UV-visible absorption spectral overlay (Figure 4.2) 
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of the as-isolated compared to the reconstituted sample showed minimal changes in regards to 
band positions.  Reconstituted Y235A gave a broader Soret compared to the as-isolated protein. 
 
Figure 4.2 Normalized UV-visible absorption spectra of as-isolated Y235A (solid line) and 
reconstituted Y235A (dashed line).  Both samples are in 50 mM Tris-Cl, pH 7.0. 
 
The same experiment was performed on HmuT M292A to reduce fluorescent signal due 
to a mixture of heme and protoporphyrin potentially bound to the protein which can cause noise 
in resonance Raman experiments.  M292A is ~90% heme loaded prior to reconstitution.  Figure 
4.3 normalized spectral overlay of the two samples showed relevant bands to be in the same 
position before and after reconstitution.  Reconstituted M292A had a slight shoulder next to the 
Soret compared to the as-isolated sample.   
104 
 
Figure 4.3 Normalized UV-visible absorption spectra of as-isolated M292A (solid line) and 
reconstituted M292A (dashed line).  Both samples are in 50 mM Tris-Cl, pH 7.0. 
 
4.2.3 Electrospray ionization (ESI) mass spectrometry of HmuT mutants 
Samples of H136A, Y235A, R237A, Y272A, and both as-isolated and reconstituted 
M292A were analyzed using ESI-MS.  H136A and reconstituted M292A were incubated with 
either a 50:50 mixture of acetonitrile/0.1% formic acid or 10% methanol.  Both conditions are 
used to increase signal to noise during MS data collection (6, 7).  It should be noted that the 
addition of formic acid reduces the sample pH below 2 and therefore can lead to heme loss and 
the detection of only apoprotein.  Y235A, R237A, Y272A, and as-isolated M292A were 
prepared in 50 mM ammonium acetate at neutral pH.   
The electrospray mass spectrum of H136A in acetonitrile and formic acid (Figure 4.4) 
showed a clean peak at 36,129 Da (the expected molecular weight of the apoprotein is 36,129 
Da).  The apoprotein is expected due to the addition of formic acid to the sample.  The spectral 
envelope gave clear peaks from charges +18 to +41 with the highest peak having a charge of 
+30.  
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Figure 4.4 Electrospray ionization mass spectrum in the positive mode of purified HmuT H136A.   
Protein was exposed to 0.1% formic acid to give the apoprotein. The top panel shows the 
spectral envelope. The bottom panel shows the deconvoluted region. The predicted mass of the 
apoprotein is 36,129 Da. The experimental mass is 36,129 Da and is consistent with the expected 
mass of the apoprotein. 
 
The Y235A deconvoluted electrospray mass spectrum (Figure 4.5) showed a peak at 
36,104 Da (the expected molecular weight of the apoprotein is 36,103 Da).  Charge states for the 
protein ranged from +13 to +40, with two distinct charged envelopes.   
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Figure 4.5 Electrospray ionization mass spectrum in the positive mode of purified HmuT Y235A. 
Bottom panel: The deconvoluted region shows HmuT Y235A at 36,104 Da. The predicted mass 
of the apoprotein is 36,103 Da. 
 
The electrospray mass spectrum of as-isolated M292A (Figure 4.6) showed a clean peak 
representing the apoprotein at 36,268 Da (the expected molecular weight of the apoprotein is 
36,265 Da).  Another peak representing the holoprotein is seen at 36,886 Da (the expected 
molecular weight of the holoprotein is 36,881 Da).  The charged envelope window consisted of 
two envelopes ranging from +12 to +23 with charges centered at +13 and +22.     
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Figure 4.6 Electrospray ionization mass spectrum in the positive mode of as-isolated HmuT 
M292A. Bottom panel: The deconvoluted region shows HmuT M292A at 36,268 Da and 36,886 
Da, indicative of apo- and holoprotein, respectively. The predicted mass of the apoprotein is 
36,265 Da and 36,881 Da for the holoprotein.  Samples were prepared in 50 mM ammonium 
acetate at neutral pH. 
 
ESI of reconstituted M292A also showed a mixture of apoprotein and holoprotein based 
on the two distinct spectral envelopes (Figure 4.7).  The positions for apo- and holo- 
reconstituted M292A differed from that of the as-isolated sample.  A peak at 36,185 Da (the 
expected molecular weight of the apoprotein is 36,265 Da) was seen for the apoprotein and a 
peak at 36,785 Da (the expected molecular weight of the holoprotein is 36,881 Da) was observed 
for the holoprotein (Figure 4.7, bottom panel).  The charged envelope ranged from +15 to +30 
and was centered at +23.   
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Figure 4.7 Electrospray ionization mass spectrum in the positive mode of reconstituted HmuT 
M292A. Middle and bottom panels: The deconvoluted region shows HmuT M292A at 36,185 Da 
and 36,785 Da, indicative of apo- and holoprotein, respectively. The predicted mass of the 
apoprotein is 36,265 Da and 36,881 Da for the holoprotein.  Samples were prepared in 
Nanopure water.  
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HmuT Y272A ESI gave two peaks representing the holo and apo forms of the protein 
(Figure 4.8).  The predominant peak representing the holoprotein was at 36,719 Da (expected 
molecular weight of the holoprotein is 36,719 Da).  The minor peak at 36,104 Da was the 
apoprotein (expected molecular weight of the holoprotein is 36,103 Da).  The charged envelope 
ranged from +19 to +40 and is centered at +30.  A smaller envelope was also observed around 
+13.   
 
Figure 4.8 Electrospray ionization mass spectrum in the positive mode of purified HmuT Y272A. 
Bottom panel: The deconvoluted region shows HmuT Y272A at both 36,104 Da and 36,719 Da, 
indicative of a mixture of apo- and holoprotein, respectively. The predicted mass of the 
apoprotein is 36,103 Da and 36,719 Da.  The sample was prepared in 50 mM ammonium acetate 
at neutral pH.  
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The ESI mass spectrum for R237A gave two clean peaks at 36,242 Da and 36,860 Da 
indicative of apo and holoproteins, respectively (Figure 4.9).  The expected molecular weight of 
the apoprotein was 36,240 Da and the holoprotein is 36,856 Da.  Two charged envelopes were 
observed ranging from +24 to +20 and from +14 to +11 with the latter being the predominant 
envelope based on peak intensity.    
 
Figure 4.9 Electrospray ionization mass spectrum in the positive mode of purified HmuT R237A. 
Bottom panel: The deconvoluted region shows HmuT R237A at both 36,242 Da and 36,860 Da, 
indicative of a mixture of apo- and holoprotein, respectively. The predicted mass of the 
apoprotein is 36,240 Da and 36,856 Da.  The sample was prepared in 50 mM ammonium acetate 
at neutral pH. 
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4.2.4 pH titrations of as-isolated and reconstituted HmuT Y235A 
Previous work from our group showed as-isolated HmuT Y235A to be sensitive to pH, 
while WT HmuT is not affected by pH (1).  To probe the pH effect on Y235A, UV-visible 
absorption titrations were performed on both as-isolated and reconstituted Y235A.   
As-isolated Y235A was titrated with HCl over a pH range of 4 – 7.  Only data from pH 5 
– 7 were used to determine the pKa due to protein precipitation around pH 4.8; the pI of Y235A 
is at 4.7.  The data were fit to a one-state pKa equation and gave a pKa of 6.3 ± 0.1 (Figure 4.10).   
  
Figure 4.10 pH titration fit of as-isolated Y235A from pH 4 – 7. The data were fit using a one-
state pKa equation.  The pKa is 6.3 ± 0.1.   
 
A second titration from pH 7 – 9.5 was also performed.  UV spectral data indicate heme 
loss as shown by the increase in the 280 and 380 nm bands and a slight decrease in the Soret 
absorbance (Figure 4.11).  The data were not fit. 
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Figure 4.11 UV absorbance spectra of as-isolated HmuT Y235A pH titration from pH 7 – 9.5.  
Minimal change at the Soret and increase in the 280 and 380 nm bands indicate heme loss from 
the protein.  The data were not fit. 
 
pH effects of reconstituted Y235A were also investigated from pH 7 – 11 (Figure 4.12).  
As the absorbance of the heme at 412 nm went down, the absorbance at 380 nm increased, 
indicative of heme loss from the protein.  The data were followed at 412 nm and fit to a two-state 
pKa equation with an appearance of a two-state pKa transition and were fitted to give a pKa1 = 7.8 
± 0.1 and a pKa2 = 10.6 ± 0.1.   
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Figure 4.12 UV-visible absorption pH titration of reconstituted Y235A from pH 7 – 11 
(accounted for dilution). Arrows indicate the change in absorbance as the pH was increased.  
Inset: The data were fit best to a two-state pKa model.  The pKa’s are 7.8 ± 0.1 and 10.6 ± 0.1.     
 
4.2.5 Chemical unfolding studies of HmuT 
WT HmuT was incubated in a series of GdnCl concentrations to determine the 
approximate D1/2 of the protein.  The change in absorbance was followed at 406 nm and fit to a 
two-state protein denaturation model with a D1/2 of 2.0 ± 0.1 M (Figure 4.13).   
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Figure 4.13 WT HmuT GdnCl denaturation curve fit to a two-state protein unfolding model.  
Samples were in 50 mM Tris-Cl, pH 7.0. The D1/2 is 2.0 ± 0.1 M. 
 
Based on the D1/2 study, WT HmuT was incubated in 2.0 M GdnCl and monitored at 406 
nm via UV-visible absorption spectroscopy for 24 h.  Change in absorbance at the Soret ceased 
after 10 h.  The unfolding curve was fit to a first-order reaction which gave an unfolding rate of 
0.011 ± 0.001 min-1 (Figure 4.14).  Fitting to a two sequential rate constant equation gave 
unreasonable extinction coefficients.    
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Figure 4.14 Time-scale unfolding curve for WT HmuT in 2.0 M GdnCl for 24 h.  The data were 
fit to a first-order reaction scheme giving an unfolding fast phase rate of 0.011± 0.001 min-1.  
The sample was in 50 mM Tris-Cl, pH 7.0. 
 
Both H136A and Y235A HmuT were also incubated at 1.0 M and 1.5 M GdnCl 
(estimated D1/2 concentrations), respectively, and followed at the Soret over time.  After 10 h, 
H136A was still unfolding while Y235A was completely unfolded.  The data sets were fit to a 
first-order unfolding reaction with H136A unfolding at 0.004 ± 0.001 min-1 and Y235A 
unfolding at 0.007 ± 0.001 min-1 (Figures 4.15 and 4.16, respectively).    
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Figure 4.15 Time-scale unfolding curve for H136A HmuT in 1.5 M GdnCl.  The data were fit to 
a first-order unfolding reaction scheme giving an unfolding rate of 0.004 ± 0.001 min-1.  The 
sample was in 50 mM Tris-Cl, pH 7.0. 
 
 
Figure 4.16 Time-scale unfolding curve for Y235A HmuT in 1.0 M GdnCl.  The data were fit to a 
first-order unfolding reaction scheme giving an unfolding rate of 0.007 ± 0.001 min-1.  The 
sample was in 50 mM Tris-Cl, pH 7.0. 
 
117 
4.3 Discussion 
4.3.1 Circular dichroism of HmuT and mutants 
A series of tyrosine mutants were created to investigate the potential roles these residues 
may contribute to HmuT heme binding (see Chapter 3).  Firstly, Y272 was mutated to an alanine 
to assess if this residue was acting as a hydrogen-bonding partner to the axial Y235.  Y272A 
exhibited similar heme loading as the WT, but gave an altered α,β-region compared to the WT.  
A sequence alignment of HmuT with a protein homolog of known structure, Y. pestis HmuT, 
shows YpHmuT to have an Arg residue in the same position as Y272 (8).  This arginine (R199) 
has been shown to form a van der Waals interaction with the heme propionate.  In addition, 
Y200 in YpHmuT forms a hydrogen-bond with the other heme propionate.  Based on this 
comparison, it could be the case that CdHmuT Y272 is participating in one of these types of 
interactions.   
Secondly, Y349A and Y349F mutants were constructed due to conservation across many 
Corynebacterium species although homology modeling predicted this residue to not be in 
proximity of the heme binding pocket.  Both Y349 mutants gave similar UV-spectral signatures 
compared to the WT, but were much less heme loaded than the WT protein (< 20%).  Therefore, 
CD spectroscopy was utilized to investigate protein secondary structural changes due to amino 
acid mutation.   
The CD spectral bands around 190, 210, and 222 nm in Figure EBIII35 were indicative 
of α-helical content in WT HmuT and mutants (9).  Changes in relative intensities at these 
wavelengths differed upon mutation.  For example, Y349A exhibited the most change in 
secondary structural content with the least pronounced 222 nm band among all of the samples.  
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Similarly, the 210 nm band shifted to about 208 nm and increased in intensity compared to the 
WT. 
Y349A is minimally heme loaded and a large presence of apoprotein could be the result 
of the observed spectral shift.  Shifts in CD spectra due to secondary structural alteration as a 
result of heme removal (or minimal heme loading) have been seen in other heme proteins. The 
data are limited and the change in the intensities of the 210 nm versus 222 nm bands in regards 
to heme loss varies.  For example, holo- and apo-cytochrome b562 from E. coli gave similar CD 
intensities at both 210 and 222 nm (10).  Serratia marcescens HasA CD spectra showed a more 
pronounced 222 nm, compared to the 210 nm, for both holo and apo forms of the protein (11).  
Alternatively, both S. pyogenes SiaA and FixLH from Bradyrhizobium japonicum had a more 
pronounced 210 nm band for the apoprotein compared to the holoprotein (12, 13), as seen in all 
of the HmuT mutants in Figure EBIII75.  It should also be noted that CD experiments were 
carried out on samples which varied in relative amounts of heme-loading.  If minimal heme-
loading results in alteration of CD spectra, it is not surprising that Y349A and Y349F experience 
the most spectral change in comparison to the WT as they are the least heme-loaded of all the 
samples.  
CD data were deconvoluted using DichroWeb to estimate the relative amounts of α-
helical content, although these results have not always been reliable in our hands (2).  The data 
were analyzed using both the CONTIN and SELCON3 analysis programs, both using two 
reference protein sets.  Percentage estimations for secondary structural content were obtained by 
an average of the two analysis programs.  Comparison of the estimations in Table EBIII75 to the 
CD spectra indicated discrepancies between the deconvolution and the raw data.  For example, 
Y349A is predicted to have 78% α-helical content while Y349F is predicted to have 45%, yet the 
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CD data for Y349A is the least similar to WT, which is predicted to have 91% α-helical content.  
Additionally, Y272A is predicted to have the same amount of α-helical content as the WT, yet 
the CD spectra are different between the two samples.    
4.3.2 ESI-MS of HmuT mutants  
In all cases except for H136A and Y235A, the ESI-MS of HmuT mutants detected both 
the presence of apo and holoproteins.  H136A did not give holoprotein as formic acid was used 
to increase the signal to noise and resulted in solely apoprotein detection.  Y235A under all 
conditions, either water or acetic acid, resulted in the detection of apoprotein as the heme loading 
of this protein is minimal and removal of the heme axial ligand diminishes the ability of the 
protein to bind heme effectively (see Chapter 3).   
For all samples in which both apo and holoproteins were detected, two charged envelopes 
were also observed in the lower m/z region.  It has been shown that charged envelopes can vary 
based on the extent of protein folding (14).  Generally, charged envelopes with smaller charge 
distributions are indicative of a more folded protein while larger charge distributions can be a 
result of a partially unfolded protein.  Heme removal alters the secondary structural content of 
proteins and has been shown to also alter protein conformation and fold (15).  HmuT and 
mutants are all mixtures of apo and holoprotein which could lead to multiple charged envelopes 
which vary in the extent of distribution.  For example, R237A in Figure 4.9 shows two envelopes 
at +24 to +20 and from +14 to +11, with the first being attributed to the apoprotein and the latter 
to the holoprotein.   
Mass spectrometry was also performed on both as-isolated and reconstituted M292A.  
Both samples indicated the presence of apo and holoprotein, but different masses for each 
protein species in the sample were obtained.  For example, the as-isolated apo-M292A gives a 
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mass at 36,268 Da (the correct mass for the protein), while the reconstituted apo-M292A gives a 
mass at 36,185 Da; a difference of 83 Da between the two apo-M292A samples.  A comparison 
of Figure 4.6 and Figure 4.7 showed a difference in spectral quality.  Figure 4.7 was a noisy 
spectrum as indicated by the increasing baseline in the second panel of the figure.  Additionally, 
in the expanded region of Figure 4.7, multiple peaks are observed around 36,185 Da, rather than 
one single peak.  This could be due to the fact that the reconstituted sample data were prepared in 
only water and not much care was taken into removing residual salts which could affect spectral 
signal to noise.  Alternatively, the as-isolated sample was prepared by dialysis in a series of fresh 
ammonium acetate solutions over a week-long period and resulted in the proper mass expected 
for apo-M292A with minimal signal to noise issues.   
4.3.3 Protein reconstitution and heme loading 
Our group has previously shown the potential disadvantages in utilizing a reconstitution 
method as a means of increasing protein heme loading (Chapter 3).  Although as-isolated and 
reconstituted samples may appear similar in the UV spectra, as seen for Y235A and M292A 
HmuT (Figures 4.2 and 4.3), the samples can have different spectral signatures in resonance 
Raman spectroscopy.  This could indicate the reconstituted heme is bound to the pocket in a 
different orientation than seen in the as-isolated protein.  Differences in heme orientations, either 
in the as-isolated or reconstituted form, have previously been seen in other b-type heme proteins, 
including by our group [Chapter 3 and (13)].  As a result of this finding, all published works 
were performed on as-isolated proteins, unless otherwise noted.   
The method in which to prepare proteins for reconstitution requires a large reduction in 
pH and the addition of an organic solvent to effectively unfold the protein and remove heme 
from the pocket.  Some hemoproteins are able to withstand this technique, as seen for HmuT and 
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mutants, while other proteins precipitate out of solution, such as S. pyogenes SiaA (see Chapter 
6).  As-isolated Y235A is only about ~20% heme loaded and reconstitution resulted in a fully 
heme-loaded protein with minimal spectral changes between the two samples (Figure 4.2).  
M292A did not respond as well to reconstitution as indicated by differences in as-isolated versus 
reconstituted UV spectra and the large shoulder at 380 nm for the reconstituted sample (Figure 
4.3).   
Alternative methods to increase heme loading of proteins involve supplementing 
expression media such as adding the heme precursor δ-aminolevulinic acid (ALA) to promote 
the production of holoprotein (16, 17).  ALA synthesis is the first committed step in heme 
synthesis (18).  Glycine and succinyl CoA condense to form ALA with CO2 and CoA released as 
byproducts.  Some protocols suggest adding ferrous ammonium sulfate, in addition to ALA (16).  
Previous attempts to make this work in our systems showed no appreciable difference between 
proteins exposed to ALA compared to those which were not.   
4.3.4 pH titrations of as-isolated and reconstituted Y235A 
Both as-isolated and reconstituted Y235A were monitored with UV-visible absorption 
spectroscopy as a function of pH.  Previous studies on as-isolated WT HmuT showed no spectral 
changes over a pH range of 6 – 11 (1).  MCD studies of as-isolated Y235A at acidic and basic 
pH environments were indicative of water binding trans to the axial histidine.  A comparison of 
pH titrations between the as-isolated and reconstituted Y235A samples gave different results and 
further indicated reconstitution alters heme orientation or binding in the pocket in some fashion.   
Titration of the as-isolated Y235A from pH 4 – 7 gave a pKa of 6.3 ± 0.1 (Figure 4.10).  
To our knowledge, this is the lowest known pKa for a heme protein with a bound water trans to a 
histidine (see Chapter 2).  Additional studies indicated an arginine in the pocket (R237) which 
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could be acting as a hydrogen-bonding partner to the axial tyrosine (1).  This low pKa value 
would ensure R237 is able to H-bond with the hydroxide in the Y235A form of HmuT. As-
isolated Y235A was also monitored over a pH range of 7 – 9.5.  Minimal changes were seen at 
the Soret and the data were not fit as the protein started to precipitate out of solution.   
A similar titration was performed on reconstituted Y235A, but from pH 7 – 11.  The data 
were fit and gave two pKa values at 7.8 ± 0.1 and 10.6 ± 0.1.  Unlike the as-isolated Y235A, the 
reconstituted Y235A did not precipitate out of solution as the pH was increased above a pH of 
9.5.   
Previous resonance Raman pH studies on both as-isolated and reconstituted Y235A 
indicated at high pH the protein is a mixture of high-spin and low-spin and at low pH is all 
converted to high-spin (1).  At pH 7 the protein is a partial mixture of high-spin and low-spin 
heme, indicated by the ratio of the ν3 high-spin peak at 1473 cm-1 to the low-spin peak 1501 cm-1.  
As the pH increases to 10, the low-spin ν3 marker at 1501 cm-1 continues to increase.  The first 
pKa around 7.8 in reconstituted Y235A could be due to this shift in spin-states.  This UV spectral 
shift between pH 7 and 10 was observed in both the Rodgers and Dixon labs. 
The second pKa at 10.6 could be due to the deprotonation of R237 which is proposed to 
H-bond to the axial Y235 ligand and is H-bonded to water in the Y235A mutant.  Removal of 
this H-bonding partner could result in a destabilization of the heme and may be why heme loss is 
observed in the UV as this transition occurs.  The titration could not be completed because the 
pH electrode utilized was not equipped to go above pH 11.   
4.3.5 Chemical unfolding studies of HmuT 
A GdnCl unfolding titration of WT HmuT indicated the protein to have a D1/2 of ≈ 2 M.  
As there are only few points along the curve, the titration would need to be repeated.  Chemical 
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unfolding D1/2 studies of other b-type heme proteins are limited. The hemophore HasA from S. 
marcescens unfolds at 2.7 ± 0.2 M GdnCl (19) and also utilizes a His/Tyr heme binding motif.  
Rat microsomal outer membrane cytochrome b5 and S. pyogenes SiaA are His/Met heme proteins 
which unfold at 2.6 ± 0.3 M GdnCl (20) and 3.1 ± 0.1 M (13), respectively.  Cytochrome b562 
from E. coli, also His/Met, unfolds at 2.2 ± 0.2 M GdnCl (21).  These comparisons put HmuT in 
line with other b-type heme proteins in regards to protein unfolding and indicate heme axial 
ligation does not necessarily dictate the ease of protein unfolding.  
Kinetic unfolding data of WT HmuT was fit to a first-order reaction giving a half-life of 
about one hour.  Attempts to fit the data to a biphasic first-order reaction and the sum of two-
term exponential functions were unsuccessful.  Kinetic unfolding studies of b-type heme proteins 
are also limited.  In the case of S. pyogenes SiaA, our group showed this protein slowly unfolded 
in two phases attributed to differences in heme orientation in the pocket (13).  The half-lives of 
the fast and slow phases ranged from 1 – 3 and 8 – 53 h, respectively.  This type of unfolding has 
also been seen in other proteins such as horse heart myoglobin and cytochrome b5 although these 
proteins unfolded with half-lives of seconds and less than five minutes for the fast and slow 
phases, respectively (22, 23).  Cytochrome b562 from E. coli also unfolded with one phase, with 
the unfolding completed in seconds (24).  In contrast, horseradish peroxidase and soybean 
peroxidase unfold with one phase, but the unfolding is very slow (25). 
Removal of either HmuT axial ligand altered the half-lives of HmuT unfolding.  HmuT 
H136A and Y235A gave half-lives of 3 h and 1.6 h, respectively.  The half-life of unfolding for 
the WT was 1 h which is less than the axial ligand mutants.  One explanation is that the D1/2 
values of H136A and Y235A were not accurately determined since the GdnCl concentrations 
used for the mutant unfolding experiments were approximations.  In order to have a complete 
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story on the effects which heme axial ligand removal has on HmuT unfolding, it would be best to 
have multiple unfolding profiles for the WT, H136A, and Y235A at different GdnCl 
concentrations (above and below the D1/2).  Those rates could then be plotted and extrapolated 
back to 0 M GdnCl.   
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5 HEME-BOUND SIAA FROM STREPTOCOCCUS PYOGENES: EFFECTS OF 
MUTATIONS AND OXIDATION STATE ON PROTEIN STABILITY 
This chapter is verbatim in press for a special issue in Akbas, N., Draganova, E. B., Block, D. R., 
Sook, B. R., Chan, Y. F., Zhuo, J., Eichenbaum, Z., Rodgers, K. R., and Dixon, D. W. (2015), 
Journal of Inorganic Biochemistry, http://dx.doi.org/10.1016/j.jinorgbio.2015.10.016.  The 
expression, purification, circular dichroism studies and chemical unfolding experiments were 
performed by E. B. Draganova at Georgia State University.  
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5.1 Abstract 
The protein SiaA (HtsA) is part of a heme uptake pathway in Streptococcus pyogenes.  In 
this report, we present the heme binding of the alanine mutants of the axial histidine (H229A) 
and methionine (M79A) ligands, as well as a lysine (K61A) and cysteine (C58A) located near 
the heme propionates (based on homology modeling) and a control mutant (C47A).  pH titrations 
gave pKa values ranging from 9.0 to 9.5, close to the value of 9.7 for WT SiaA.  Resonance 
Raman spectra of the mutants suggested that the ferric heme environment may be distinct from 
the wild-type; spectra of the ferrous states were similar.  The midpoint reduction potential of the 
K61A mutant was determined by spectroelectrochemical titration to be 61 ± 3 mV vs. SHE, 
similar to the wild-type protein (68 ± 3 mV).  The addition of guanidine hydrochloride showed 
two processes for protein denaturation, consistent with heme loss from protein forms differing by 
the orientation of the heme in the binding pocket (the half-life for the slower process was one to 
three days).  The ease of protein unfolding was related to the strength of interaction of the 
residues with the heme.  We hypothesize that kinetically facile but only partial unfolding, 
followed by a very slow approach to the completely unfolded state, may be a fundamental 
attribute of heme trafficking proteins.  Small motions to release/transfer the heme accompanied 
by resistance to extensive unfolding may preserve the three dimensional form of the protein for 
further uptake and release. 
5.2 Introduction 
Iron is a key nutrient for many bacteria [1].  Iron(III), however, has very low aqueous 
solubility [2,3], making strategies that do not involve direct uptake of uncomplexed iron 
imperative.  In the human body, about 95% of the iron occurs in the heme cofactor [4,5], which 
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serves as a significant source of iron for bacterial pathogens.  The most common protein source 
of heme iron in human bacterial infections is methemoglobin [6].   
Heme uptake is often key in the virulence of pathogenic bacteria [7].  Gram-positive and 
Gram-negative bacteria have evolved similar strategies for acquiring heme [1,8-17].  All 
pathways studied to date involve a series of proteins that transfer the heme from the exterior 
milieu into the cell interior.  Recent reviews have focused on the structures of heme transport 
proteins [5,18,19] and pathways in specific bacteria including Bacillus anthracis [20] and 
Staphylococcus aureus [21-24]. 
A large number of bacteria have been studied to determine their method of obtaining 
heme; some acquire heme from their environment, others have a biosynthetic pathway to 
produce the heme, and some use both approaches [25].  Using bioinformatics techniques, 
Cavallaro et al. found that approximately 5% of the species rely only on heme uptake, 30% use 
biosynthesis only, 50% use both pathways, and 15% use neither.  Those which use only heme 
uptake are of particular interest because absent a biosynthetic pathway, they may be susceptible 
to iron starvation via interruptions in external heme uptake.  Interference with heme uptake 
might reduce the virulence of infections with these organisms.  Cavallaro et al. have noted that 
heme uptake seems to be related to pathogenicity in Gram-positive bacteria, with approximately 
80% of bacteria that acquire heme being pathogenic [25].   
Streptococcus pyogenes is one of the few species of bacteria that can only obtain heme 
from its environment.  S. pyogenes, also known as Group A streptococcus (GAS), is a pathogenic 
Gram-positive bacterium that causes a variety of infections [26,27].  Iron is an essential nutrient 
for S. pyogenes and a number of heme-containing sources can support in vitro growth of this 
organism, including hemoglobin, the haptoglobin-hemoglobin complex, myoglobin, heme-
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albumin, and catalase [28].  The ability to obtain iron has been shown to affect the virulence of 
this pathogen as observed in mutants of S. pyogenes which are defective in heme uptake [29]; 
mutations resulted in attenuated virulence in animal models.  S. pyogenes is increasingly resistant 
to macrolide antibiotics [30-33], potentially posing significant risks for infected populations. 
In S. pyogenes, one pathway for heme import employs a dedicated ATP binding cassette 
(Figure 5.1).  This cassette has been termed the streptococcal iron acquisition or SiaABC system 
[34] and is also known as HtsABC (heme transport system) [35].   
 
Figure 5.1 Overview of the S. pyogenes Sia/Hts heme uptake pathway.    
 
In this ABC transporter, SiaA is the membrane-anchored heme binding protein that acquires 
heme and transfers it to SiaB which in turn carries the heme across the lipid bilayer.  In this 
process, energy is provided from ATP hydrolysis by SiaC, which is located on the inner side of 
the membrane. The SiaABC heme transport system is part of a conserved ten-gene cluster [34].  
The two genes upstream express Shr [34,36] and Shp [37,38].  Shr receives heme from 
hemoglobin [39,40] and transfers it to Shp [36].  Shp, which has two axial methionine ligands 
[37], transfers heme to SiaA [41] with rate constants that are similar in the oxidized and reduced 
forms [42-44].  Our previous biophysical studies on wild-type (WT) SiaA showed the heme was 
six-coordinate (6c) and low-spin (LS) in both the ferric and ferrous oxidation states of the protein 
with methionine and histidine as the axial ligands [45]; further spectroscopic analyses have 
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confirmed these findings [46].  Homology modeling (Figure 5.2), with IsdE from Staphylococcus 
aureus [48] as the closest homologous protein, indicated that the specific axial ligand residues 
were likely to be M79 and H229; site-directed mutagenesis studies have verified this [46,47]. 
 
Figure 5.2 Homology model of SiaA.  Shown are the locations of C47, C58, K61, M79, and 
H229. 
   
Elucidation of the factors controlling heme binding and release steps along heme 
acquisition pathways are benefiting from biophysical studies of the proteins.  The main 
controlling factors emerging from this work are the nature of the axial ligand(s), electrostatic 
interactions between the protein and the heme, through its propionates and the iron center, and 
hydrophobic interactions between the protein and the porphyrin face [5,49-53].  Herein, we 
describe the factors affecting the stabilities of heme-bound states of SiaA and selected mutants.  
We report results on two new mutants, C58A and K61A, as well as a control mutant, C47A, 
predicted to be at some distance from the heme.  Homology modeling suggests that C58 is near 
the heme propionates and K61 is close to the propionate that extends from the heme binding 
pocket.  In addition, we expand on recent studies of M79A and H229A [46,47].  The reduction 
potentials of the mutants of SiaA have been determined by spectroelectrochemical titration and 
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compared with that of WT SiaA.  Structural aspects of the heme pocket, states of the bound 
heme, and heme protein interactions have been probed by resonance Raman (rR) spectroscopy 
[16,54-56]. 
Unfolding studies, using guanidine hydrochloride (GdnHCl) as a denaturant, have been 
used here to probe the influence of residues near the heme on the relative stabilities of the heme-
bound states of WT SiaA and its aforementioned mutants.  Unfolding studies of heme protein 
mutants have been used to gain information on the contributions of specific residues to heme 
binding in other b-type heme proteins.  For example, the roles of various residues in myoglobin 
were probed by unfolding specific mutants [57].  Similar studies have also been performed on 
cytochrome b562 [58,59] and cytochrome b5 [60,61].  These types of studies provide insight into 
the overall stability of the protein in which specific heme pocket residues, predicted to interact 
with the heme, are probed.  In the case of heme binding and transport proteins, we anticipate that 
disrupting these interactions by unfolding can lead to a better understanding of the important 
residues involved in the heme uptake and release mechanism of the protein. 
5.3 Experimental 
5.3.1 Homology modeling 
The homology model of SiaA was built by using I-TASSER, a secondary structure 
prediction program [62].  IsdE from Staphylococcus aureus [48] was the closest homologous 
protein (PSI-BLAST results for SiaA show 45% identity to IsdE with 69% positives); the root 
mean square difference (RMSD) between the model and IsdE was 1.35 Å.  The model was 
visualized using PyMOL [63].   
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5.3.2 Materials 
E. coli strain Top10 competent cells, ShuAf, ShuAr primers and Top10/pSiaA-His cells 
were made as described previously [45].  The QuikChange II Site-Directed Mutagenesis Kit was 
from Stratagene (La Jolla, CA).  The Plasmid Mini Kit, Taq PCR Master Mix Kit, and 
QIAquick® Gel Extraction Kit were from QIAGEN (Valencia, CA).  Oligonucleotides for site-
directed mutagenesis were synthesized by Invitrogen (Carlsbad, CA).  L-arabinose was 
manufactured by Acros Organic (Gell, Belgium). 
5.3.3 Preparation of plasmids 
Site-directed mutagenesis was used to construct recombinant SiaA proteins with C47A, 
C58A, K61A, M79A or H229A amino acid substitutions.  A QuikChange II kit was used to 
prepare the mutants essentially according to the manufacturer’s instructions using the pSiaA-His 
plasmid as a template [34].  The forward and reverse primers (underlined letters indicate the 
mismatches) for each mutant are shown in Table 1. The constructed plasmids were introduced 
into E. coli Top10 competent cells by chemical transformation and clones were selected on 
Luria-Bertani (LB) plates containing 100 µg/mL ampicillin.  The resulting plasmids express the 
corresponding SiaA mutant as an N-terminal fusion to His-Xpress epitope from the arabinose-
regulated promoter, PBAD as described previously [34].  Taq PCR Master Mix Kit was used to 
amplify SiaA DNA segments, and the sequence of the wild type and mutant proteins was 
determined by Applied Biosystems model ABI 377 DNA sequencer at the DNA Core Facility at 
Georgia State University.  Sequencing confirmed the presence of the mutant gene in the correct 
orientation in each of the plasmids.  
 
133 
Table 5.1 Forward and reverse primers for the mutants in this work. 
5.3.4 Expression and purification of mutants 
The proteins were expressed and purified from the appropriate plasmids as previously 
described [45] with small modifications.  A representative description is given for the C58A 
mutant.  C58A expression was induced with 0.02% arabinose for 4 h.  The cell pellet was 
ruptured with two cycles of  French press in 45 mL of buffer containing 20 mM Tris-HCl (pH 
8.0), 100 mM NaCl, 0.1% Triton X-100, 10% v/v glycerol, and four tablets of protease inhibitor 
(Roche Complete Mini, EDTA-free).  The solution was centrifuged for 20 min at 8,000 g, and 
the supernatant was syringe-filtered with a 0.45 μm filter (surfactant-free cellulose acetate 
membrane, Nalgene).  All of the following purification steps were conducted at 4 °C using a GE 
Healthcare ÄKTA fast protein liquid chromatography instrument (FPLC, Amersham 
BioSciences), and all buffer solutions were pH 7.4 unless specified otherwise.  The sample was 
loaded onto a GE Healthcare HisTrap™ HP column (5 mL, Amersham BioSciences) equilibrated 
with binding buffer (20 mM sodium phosphate, 500 mM NaCl, and 20 mM imidazole).  
C47Af 5'-CCACTTCGGTTGCTGTGGTTGATATCGCTGACCGTTTAAATTTA-3' 
C47Ar 5'-TAAATTTAAACGGTCAGCGATATCAACCACAGCAACCGAAGTGG-3' 
C58Af 5'-TTTAGACCTCGTTGGGGTTGCTGATAGTAAA TTATATACCCTTCC-3' 
C58Ar 5'-GGAAGGGTATATAATTTACTATCAGC AACCCCAACGAGGTCTAAA-3' 
H229Af 5'-CTTGATTTTACGAACAGCTGCTGCCATTCCAGACAAGG-3'   
H229Ar 5'-CCTTGTCTGGAATGGCAGCAGCTGTTCGTAAAATCA AG-3' 
M79Af 5'-GCGTGTGGGTTTACCCGCCAATCCTGATATAGAGTTGATTG-3'  
M79Ar 5'-CAATCA ACTCTATATCAGGATTGGCGGGTA AACCCACACGC-3' 
K61Af 5'-CCTCGTTGGGGTTTGTGATAGTGCATTATATACCCTTCCTAAACGC-3'   
K61Ar 5'-GCGTTTAGGAAGGGTATATAATGCACTATCACAAACCCCAACGAGG-3'  
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Unbound material was washed out with 5 column volumes (CV) of binding buffer.  C58A was 
eluted with buffer containing 20 mM sodium phosphate, 500 mM NaCl, and 500 mM imidazole 
via a 20 CV linear gradient.  The purities of the fractions were evaluated using sodium dodecyl 
sulfate polyacrylamide gel electrophoresis.  Fractions containing the individual SiaA mutants 
were combined, and imidazole and salts were removed by centrifugal filtration (Amicon Ultra-
15, 5 kDa molecular weight cut-off, Millipore) using a buffer of 50 mM Tris-HCl, pH 7.0.  The 
protocols for the other mutants were similar with the exceptions that M79A was purified using a 
HiTrap Q column (GE Healthcare) equilibrated with a buffer of 20 mM Tris-HCl and 10% v/v 
glycerol (designated as Buffer A).  Unbound material was washed out with 8 CV of Buffer A.  
M79A was eluted with 10 CV of Buffer A containing 1 M NaCl via a linear gradient (0 – 100% 
NaCl).  
5.3.5 Heme loading 
Purified SiaA and mutants were a mixture of holo and apo forms. The holo protein was 
isolated in the ferric state.  The extinction coefficients and heme loading of SiaA mutants were 
measured using the pyridine hemochrome assay [64].  The extinction coefficients are as follows: 
C47A ε414 = 145.3 mM-1 cm-1; K61A ε406 = 135.9 mM-1 cm-1.  Total protein concentration was 
determined using the Bradford assay (Thermo Fisher Scientific, Inc.) with bovine serum albumin 
as a standard.  The WT extinction coefficient was previously reported [35,46].  M79A and 
H229A were also previously reported [46,65]. 
5.3.6 SiaA heme extraction and refolding 
Apo-SiaA was prepared using the Teale method [66].  A solution of SiaA (10 µM) in 
PBS buffer, pH 7.4, was reduced to pH 2 in a drop-wise fashion using 3 M HCl.  The acidic SiaA 
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solution was mixed with cold 2-butanone and placed on ice for 15 min. The heme layer was 
discarded.   
To aid in protein refolding, urea was added to the apoprotein solution to give a final 
concentration of 8 M urea [67].  The solution sat at room temperature for 2 h.  The apo-SiaA 
solution was dialyzed at 4 ˚C against 4 M urea (in PBS) for 24 h, against 2 M urea (in PBS) for 2 
h, and against 10 mM potassium phosphate, pH 7.0, for 24 h.  The apoprotein solution was 
centrifuged at 4 ˚C for 15 min at 5,000 g to remove any precipitate.  The concentration of apo-
SiaA was determined using the ExPASy ε280 = 37,360 M-1cm-1 [68]. 
5.3.7 UV-visible absorption spectroscopy 
UV–visible absorption spectra were recorded on a Varian 50 Bio spectrophotometer with 
a thermostated cell compartment.  A TC125 temperature control unit (Quantum Northwest, 
Spokane, WA) was used to set the temperature of the cuvette compartment to 25 ˚C.  Quartz 
black-masked Suprasil cuvettes (Spectrocell, Inc.) with a 1 cm path length were used.  
5.3.8 Circular dichroism spectroscopy 
Circular dichroism (CD) spectra were recorded using a Jasco J-810 Spectropolarimeter.  
Quartz Suprasil cuvettes (Fisherbrand, Inc.) with a 1 mm path length were used.  Holo-SiaA (10 
μM) and apo-SiaA (10 μM) were recorded in 10 mM potassium phosphate buffer, pH 7.0 in a 
spectral window of 190 to 260 nm.  The final scan represents an average of ten scans.  
5.3.9 Resonance Raman spectroscopy 
Resonance Raman spectra were recorded at ambient temperature using a 0.67-m 
spectrograph equipped with a 2400 g/mm holographic grating and a LN2 cooled CCD detector.  
Spectra were excited with 413.1 nm emission from a Kr+ laser or 441.6 nm emission from a 
HeCd laser.  The beam was focused to a line at the sample and scattered light was collected in 
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the 135˚ backscattering geometry using f1 optics and a holographic notch filter to remove 
Rayleigh scattered light.  Samples were contained in 5 mm NMR tubes and spun at ~20 Hz to 
minimize the risk of laser-induced damage to the samples.  Sample integrity after laser 
irradiation during the rR experiment was verified by comparing UV-visible absorption 
absorbance spectra with those recorded before laser exposure.  Spectra were calibrated against 
the Raman shifts of pure toluene and CH2Br2 and are reproducible to one wavenumber or less. 
5.3.10 Denaturation studies 
The following proteins were monitored with UV-visible absorption spectroscopy at the 
indicated wavelengths and concentrations upon the addition of GdnHCl: C47A (414 nm, 7 µM), 
C58A (409 nm, 7 µM), K61A (412 nm, 4 µM), M79A (402 nm, 9 µM), and H229A (403 nm, 7 
µM).  The refractive index of GdnHCl was used to verify the concentration of the stock GdnHCl 
solutions (50 mM Tris-Cl, pH 7.0) [69].  GdnHCl was titrated into each protein until the 
unfolding reached equilibrium which was considered to have been established when the 
absorbance did not change by more than 0.002 from the previous measurement.   
The unfolding curves were analyzed using Equation 1 [69]:   
 
y = [(AF + mF[D]) + (AU + mU [D])exp[m([D]-[D]1/2)/RT])]/1 + exp[m([D]-[D]1/2)/RT]  [1]   
 
where y is the absorbance at any point along the fitted denaturation curve, AF is the absorbance 
of the folded state, AU is the absorbance of the unfolded state, m is the slope at the midpoint, and 
also the dependence of the free energy of unfolding on the denaturant concentration, mF is the 
slope of the folded state, mU is the slope of the unfolded state, [D] is the concentration of 
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GdnHCl, [D]1/2 is the concentration of GdnHCl at the midpoint of the unfolding curve, R is the 
gas constant, and T is the temperature (Kelvin).   
In another set of experiments, samples of WT SiaA (5 μM) in 50 mM Tris-Cl, pH 7.0 
were incubated for 29 h at room temperature in various concentrations of GdnHCl (5.93 M stock 
solution).  Each sample was monitored by UV-visible absorption spectroscopy before loading 
onto a washed PD-10 desalting column (GE Healthcare).  The column was equilibrated with 25 
mL of 50 mM Tris-Cl, pH 7.0.  Each SiaA sample (2.5 mL) was allowed to enter the column bed 
before eluting with 3.5 mL of 50 mM Tris-Cl, pH 7.0.  Fractions of 500 µL were collected.  The 
protein eluted in the third fraction.  The Soret:280 nm ratios of the desalted protein samples were 
fit to an unfolding curve.  Control experiments were also run on horse heart myoglobin (Sigma-
Aldrich). 
5.3.11 Studies of unfolding rates 
Solutions (5 µM) in 50 mM Tris-Cl, pH 7.0 of WT, C47A, C58A, and K61A were 
monitored by optical absorbance at the Soret as a function of time for 24 h at the pre-determined 
D1/2 concentrations.  The unfolding was fit to the sum of two exponential processes using 
Equation 2: 
 
At = Af exp 
–kf t + As exp 
–kst          [2] 
 
where At is the total absorbance of the solution, Af is the relative absorbance of the fast phase, kf 
is the rate of the unfolding for the fast phase, As is the relative absorbance of the slow phase, ks is 
the rate of the unfolding for the slow phase, and t is time.  Attempts to fit the data to a model 
with an intermediate were not successful. 
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5.3.12 Spectrophotometric pH titrations 
The pH titrations were performed by the addition of 1.0 M NaOH aliquots to the protein 
solutions (5 µM).  A buffer of CAPS (20 mM), CHES (20 mM), and Tris-Cl (20 mM) was 
utilized throughout the titration.  Changes in absorbance in the Soret region were analyzed with 
Kaleidagraph using Equation 3 [70]: 
 
Aobs = (AA ∙ 10(pKa – pH) + AB)/[1 + 10(pKa – pH)]      [3] 
 
where Aobs is the experimental absorbance observed, AA is the absorbance of the acidic form, and 
AB is the absorbance of the basic form. 
5.3.13 Reduction potential determination 
Midpoint potentials were determined by spectroelectrochemical titration of the protein in 
a homemade cell using a Pt working electrode, a Ag|AgCl reference electrode, and a standard pH 
meter in its mV mode.  The absorbance contributions of all non-heme chromophores had been 
subtracted from each spectrum for the following experiments.  The cell was loaded with ~6 mL 
of solution at holoprotein concentrations such that absorbance at the Soret maximum was 
between 0.2 and 0.6.  The solution was exhaustively equilibrated under an atmosphere of H2O-
saturated N2 and the absorbance spectrum of the ferric protein was recorded.  The heme was then 
completely reduced by anaerobic addition of 20 mM aqueous S2O4
2− and the absorbance 
spectrum of the ferrous heme was recorded.  Electron transfer dye cocktail was added to the 
protein solution to reach a final concentration of 10 μM in each dye.  The resulting solution was 
titrated with S2O4
2− until the UV-visible absorption spectrum of the heme no longer changed and 
the dyes were completely reduced.  Cell potential was monitored using a strip chart recorder to 
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make it easily apparent when equilibrium had been established, at which point the absorbance 
spectrum was recorded between 350 and 800 nm.  The reduced solution was then titrated by 
anaerobic additions of 40 mM [Fe(CN)6]
3− to oxidize the dyes and heme.  Cell potentials and 
spectra were recorded after each titrant addition and equilibration.  Finally, the solution was 
titrated again with 20 mM S2O4
2−.  After the second cathodic titration, the reference electrode 
was calibrated against the quinhydrone half cell so that cell potentials could be corrected to the 
SHE reference.  Absorbance at the Soret maximum for the ferrous heme was plotted vs. cell 
potential and fit to the Nernstian relationship in Equation 4 for both the cathodic and anodic 
titrations.  The resulting midpoint potentials were within 10 mV of one another. 
 
A434 = [A∞ + A0 exp([E – Em]/0.0257 V)]/1+ exp([E – Em]/0.0257 V)                          [4] 
 
5.4 Results 
5.4.1 Spectroscopic studies 
WT SiaA and the C47A, C58A, and K61A mutants were purified as red colored proteins 
(Figure 5.3).  The Soret band of the WT SiaA was observed at 413 nm, consistent with previous 
reports [41,45].  UV-visible absorption absorbance spectra of the C47A and K61A mutants were 
very similar.  The Soret maximum of the C58A mutant occurred at 409 nm.  All three mutants 
and WT SiaA showed α- and β-bands near 532 and 567 nm. 
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Figure 5.3 UV-visible absorption spectra of the Fe(III) forms of C47A, C58A, K61A, M79A, 
H229A and WT SiaA normalized at the Soret.  The solutions were in 50 mM Tris-Cl, pH 7.0. 
 
In contrast to these three mutants, the purified mutants having axial ligand mutations 
(M79A and H229A) were pale yellow in color, suggesting low heme loading.  Additionally, 
M79A and H229A had much larger spectral shifts than the other mutants, with Soret bands at 
402 and 403 nm, respectively, similar to those reported in the literature [47].   
CD spectroscopy was used to probe the overall fold of holo-SiaA versus apo-SiaA 
(Figure 5.4).  Both proteins contained bands around 190, 210, and 222 nm, indicative of α-helical 
content.  The band at 210 nm was more pronounced for the apoprotein compared to the 
holoprotein.  This indicates that the overall fold of the protein is altered upon heme removal from 
the protein [47].   
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Figure 5.4 CD spectra of holo-SiaA (solid line) and apo-SiaA (dashed).  The spectra were 
recorded in 10 mM potassium phosphate, pH 7.0.   
 
5.4.2 Guanidine-induced denaturation of WT SiaA and mutants 
Preliminary studies indicated that unfolding of SiaA was very slow.  Therefore, unfolding 
was followed as a function of time for WT, C47A, C58A, and K61A.  Fast and slow unfolding 
phases were observed for all four proteins.  Figure 5.5 shows the data for WT at the GdnHCl 
midpoint concentration; plots of the data for the mutants are in the Supplemental Information 
(Figures S1 – S3).  For WT, fitting the data to the sum of two exponential processes gave the rate 
of the fast process (15%) as 0.32 ± 0.02 h-1 and the rate of the slower process (85%) as 0.026 ± 
0.001 h-1.  The percentages of the faster process ranged from 10 – 30% (Table 5.2).  Faster rate 
constants for the first phase correlated with smaller abundance of this fast phase and slower rate 
constants for the second phase.  C58A showed the largest difference between the two phases, 
with half-times of 1.5 h for the fast phase (12%) and 46 h for the slow phase (88%). 
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Figure 5.5 Time-scale unfolding of WT SiaA at the D1/2 (3.1 M GdnHCl).  Data were taken in 
50 mM Tris-Cl, pH 7.0. The data were fit using the sum of two exponential processes.   
 
 
Table 5.2 D1/2 unfolding rate constants and relative abundances for SiaA and mutants. 
 
In the measurements of D1/2, waiting the times necessary to reach equilibrium resulted in 
anomalies due to changes in protein concentration.  Therefore, a single cuvette titration 
technique was utilized [71-75] in which increasing concentrations of GdnHCl were added to a 
single cuvette.  This technique can give the approximate relative ease of denaturation in a series.  
Fitting the C58A data to a two-state model gave a midpoint denaturant concentration of 2.4 ± 0.1 
M GdnHCl.  The C47A, K61A and M79A proteins were also investigated with the same 
143 
technique and gave D1/2 values of 2.9 ± 0.1 M, 2.5 ± 0.1 M, and 1.5 ± 0.1 M, respectively (Figure 
5.6).  WT SiaA had a D1/2 of 3.1 ± 0.1 M as previously reported [45]. 
 
Figure 5.6 Fraction of folded WT SiaA and mutants as a function of the concentration of 
GdnHCl.  Data from the titrations were fit via nonlinear least squares to a two state unfolding 
model.  Protein samples were in 50 mM Tris-Cl, pH 7.0. 
 
The H229A mutant spectrum did not show clear α,β-bands during the titration.  For this 
protein, equilibrium was reached in less than 20 min after each GdnHCl addition.  This was a 
substantially shorter amount of time than that required for WT SiaA to reach equilibrium (which 
in the transition region was well over one hour).  This is consistent with weak binding of the 
heme to the protein.  The Soret absorbance decreased and shifted toward the red as guanidine 
was added up to 1.5 M GdnHCl.  Fitting the data from 0 to 1.5 M GdnHCl gave a D1/2 of 
approximately 1.1 M.  
The unfolding of WT SiaA was also investigated by incubating samples with various 
concentrations of GdnHCl and then passing the solution through a desalting column to remove 
loosely-bound heme (Figure S4) [73].  Fitting to a two-state model gave a D1/2 of 2.6 ± 0.1 M, 
somewhat lower than the 3.1 ± 0.1 M in the experiment above, consistent with this not being an 
equilibrium measurement.   
144 
It should be noted that unfolding of WT SiaA and mutants was performed on samples 
that contained both holo and apo forms of the protein.  Freshly prepared apo-SiaA largely 
precipitated by 24 h after isolation.  Thus, it was presumably decreasing in concentration over 
the long time of the unfolding experiments.  However, the effects of protein concentration on 
unfolding are often small and depend on the exact mechanism of the unfolding process [76].   
5.4.3 Spectrophotometric pH titrations   
For the three mutants not involving the heme ligands (C47A, C58A, and K61A), 
titrations with aliquots of 1 M NaOH gave a Soret absorbance that decreased as the pH increased 
(representative data from C47A are shown in Figure 5.7).  The transitions were isosbestic for pH 
< 11.  The absorbance at 280 nm also increased above pH 11.  This is consistent with high pH 
leading to unfolding of the protein which in turn results in exposure and deprotonation of some 
of the 14 tyrosines in the sequence (the extinction coefficient of tyrosinate (2500 M-1 cm-1 at 295 
nm) is higher than that of tyrosine (1400 M-1 cm-1 at 275 – 280 nm) [77]).  Data from pH 7 to 
approximately pH 10.9 were fit using a two state model to give pKa values of 9.22 ± 0.03, 9.04 ± 
0.03 and 9.45 ± 0.05 for C47A, C58A, and K61A, respectively.  The pKa of WT SiaA is 9.7 ± 0.1 
[45].   
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Figure 5.7 Spectrophotometric pH titration of C47A, titrated with 1.0 M NaOH, in a buffer of 20 
mM each CAPS, CHES and Tris-Cl.  UV-visible absorption spectra are shown from pH 7.0 to 
10.7. The inset shows the nonlinear least squares fit of the data at 409 nm to a single pKa; the 
value was 9.22 ± 0.03. 
 
5.4.4 Resonance Raman spectra of ferric and ferrous SiaA mutants   
The spectra of ferrous and ferric C58A SiaA are shown in Figure S5 in the 
Supplementary Material.  In contrast to WT SiaA [45], this mutant is susceptible to photo-
induced reduction during spectral acquisition.  Consequently, the spectra were recorded with low 
laser power (3.7 mW), and exhibit only a modest signal-to-noise ratio.  The spectra are 
characteristic of hexacoordinate, low-spin (6cLS) hemes and reminiscent of those previously 
reported for WT SiaA.  Thus the spectral signatures for ferric and ferrous C58A SiaA are 
consistent with the heme conformations and axial ligand set being the same as those for the WT 
protein.  However, the shifted Soret maximum (6 nm to the blue of the WT SiaA) as well as the 
photolability of the ferric state suggest that its heme environment may be distinct from WT SiaA.  
By contrast, the spectral signatures and behaviors of the ferrous proteins are rather similar. 
Because the K61A SiaA was not photolabile, it was possible to record higher quality rR 
spectra, as shown in Figure 5.8.  Like the WT protein, it also exhibits rR fingerprints 
146 
characteristic of 6cLS ferric and ferrous heme proteins.  In fact, the rR spectra of WT SiaA and 
K61A SiaA are nearly identical for both the ferric and ferrous forms.  Although homology 
modeling suggests that K61 is able to interact with one of the heme propionate groups in the WT 
protein, the loss of that interaction is not apparent in the rR spectra of K61A SiaA.  Specifically, 
comparison of the WT and K61A rR spectra reveal that the propionate bending bands are 
virtually identical in the ferric and ferrous forms.  Thus, loss of the electrostatic interaction 
between K61 and the heme periphery does not drive significant changes in propionate 
conformation.  This result is consistent with the insensitivity of the reduction potential (§ 3.5) to 
the mutation of K61. 
 
Figure 5.8 Soret-excited rR spectra of ferric (top) and ferrous (bottom) K61A SiaA.   
The in-plane porphyrin stretching (high frequency) and low frequency regions are shown.  
Samples were 250 μM in holo-SiaA and in 20 mM Tris-Cl at pH 8.0.  Ferrous K61A SiaA was 
generated by anaerobic introduction of a 15-fold molar excess of buffered dithionite to the ferric 
protein.  Complete reduction was verified by UV-visible absorption absorbance spectroscopy. 
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5.4.5 Spectroelectrochemical titrations 
In previous work on WT SiaA, we reported an irreversible midpoint potential that lies 
between 64 and 83 mV vs SHE [45].  Reanalysis of those data revealed more than one 
Fe(III)|Fe(II) couple, as shown in Figure S6.  After oxidation with [Fe(CN)6]
3−, the reductive 
titration with S2O4
2− showed a single midpoint potential of 68 ± 3 mV vs SHE.  Following 
complete reduction with S2O4
2−, the reverse (oxidative) titration with [Fe(CN)6]
3− revealed two 
potentials, one at 15 ± 5 mV, accounting for ~60% of the heme, and the other at 72 ± 10 mV, 
accounting for ~40% (see Figure S6 for further details).  The 68 and 72 mV potentials are 
indistinguishable with these uncertainties.  This finding is consistent with heme oxidation 
triggering a redox-coupled change in structure or conformation that (a) changes the Fe(III)|Fe(II) 
potential and (b) is kinetically sluggish to reverse, even after reoxidation of the heme. 
Spectroelectrochemical titration of K61A revealed a reversible potential of 61 ± 3 mV.  
Absorbance spectra and the absorbance at the ferrous Soret maximum are shown in Figure 5.9.  
The forward and reverse titrations are superimposable and well modeled by the Nernstian 
expression shown in Equation 4.  Consistent with the rR spectra of WT and K61A, these 
reduction potentials indicate that the replacement of K61 (which homology modeling suggests is 
near a heme propionate) with the small hydrophobic methyl group of alanine has only a small 
effect on the relative stabilities of the oxidized and reduced heme states.  Even though the change 
in reduction potential in response to the loss of the positive charge from K61 is only −7 mV, it is 
in the direction consistent with stabilization of the ferric heme, which is expected upon loss of 
the cationic side chain from K61. 
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Figure 5.9 UV-visible absorption absorbance spectra of K61A SiaA during the course of the 
spectroelectrochemical titration with dithionite. Spectral contributions from the dyes, 
ferricyanide, ferrocyanide and dithionite ions have been subtracted from each spectrum to show 
the clean isosbestic behavior of the system.  The inset shows absorbance at the Soret maximum 
for ferrous K61A SiaA (423 nm) as a function of cell potential (vs SHE reference).  The oxidative 
and reductive titration curves are superimposable and fitting to a single Nernstian wave 
(Equation 4) yielded a midpoint potential of 61 ± 3 mV vs SHE.  Titrations were carried out in 
50 mM Tris/Tris-Cl at pH 8.0, 100 mM NaCl. 
 
In contrast, the reduction of the C58A mutant was < 0 V vs. SHE, significantly more 
negative than that of the WT protein and irreversible (Figure S7).  Although the irreversibility of 
the reduction precluded reliable determination of its potential, its negative potential indicates that 
replacement of cysteine 58 with alanine changes the heme pocket so as to destabilize the ferrous 
state and/or stabilize the ferric state relative to the WT protein.  Given that the spectroscopic 
behavior of the ferric protein is distinct from that of WT SiaA, it is concluded that the negative 
reduction potential is likely attributable to destabilization of the ferric heme in C58A SiaA. 
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5.5 Discussion 
5.5.1 Guanidinium-induced unfolding 
WT SiaA in the ferric form undergoes guanidinium-induced unfolding with a D1/2 of 3.1 
M [45].  To probe specific heme-protein interactions and their influence on heme binding, we 
looked at the unfolding of five mutants:  C47A, C58A, K61A, M79A, and H229A.  Because 
homology modeling predicts C47 to be distant from the heme, the C47A mutation was studied as 
a control.  The D1/2 value of C47A was 2.9 M, similar to the WT D1/2 at 3.1 M.  
The K61A mutant was chosen because homology modeling showed the residue to be at 
the entrance to the pocket on the side of M79, close to the propionic acid that is less buried in the 
protein.  K61 is in a similar position to K62 in IsdE (Figure S8), for which the crystal structure is 
known [48].  In the IsdE structure, K62 hydrogen bonds to a water molecule, which in turn 
hydrogen bonds to both propionates.  K62 in IsdE is also involved in a complex network of non-
bonded interactions wherein K62 forms a salt bridge with E265, which in turn hydrogen bonds to 
H229 via water.  E265 also hydrogen bonds directly with Y61 (which corresponds to Y63 in 
SiaA).  Y61 hydrogen bonds to one of the heme propionates, as does the adjacent S60 (conserved 
in the SiaA model).  In view of this complex hydrogen bonding network, it was expected that 
mutation of the K61 in SiaA would change the stability of the holoprotein.  Indeed this was 
observed, with the K61A mutant (D1/2 of 2.5 M) being less stable than the WT protein (D1/2 of 
3.1 M).  The reduction in stability may also be due to loss of a salt bridge between the positively 
charged lysine and the negatively charged heme propionate.  Heme propionates often form salt 
bridges with nearby cationic residues, with the most prevalent amino acid being arginine; lysine 
and histidine are common as well [5,49-53,78].  We note, however, that the resonance Raman 
data indicate that mutation of K61 to alanine in this protein does not induce measurable changes 
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in the propionate vibrational signatures, although it does affect the overall stability of the 
holoprotein. 
Homology modeling also suggested that C58A is near the heme propionates on the 
methionine side of the heme.  Although there is no expected electrostatic interaction between 
C58 and the heme, loss of this residue clearly lowers the thermodynamic cost of unfolding this 
protein.  Cysteine 58 is near the H-bonding network involving S60, described above.  It is also 
near a second hydrogen bonding network involving S40, S271 and a water molecule (T40, T271 
and H2O in IsdE).  In IsdE, the water molecule in this network hydrogen bonds to one of the 
heme propionates [48].  Mutation of the cysteine to alanine in SiaA results in a decrease in the 
D1/2 value to 2.4 M, consistent with disruption of these hydrogen-bonding patterns.   
The two axial ligand mutants (M79A and H229A) released heme more easily than the 
other three mutants.  The M79A protein was expected to be significantly less stable than WT, 
because the presumed contribution of the Fe−SMet79 bond to the stability of the protein fold is 
eliminated in this mutant.  Consistent with this reasoning, the midpoint of the transition occurred 
at 1.5 M GdnHCl, indicating the importance of this iron-ligand bond in stabilizing the holo-SiaA 
fold.  Spectroscopy has indicated that the M79A is hexacoordinate, presumably with a water 
molecule replacing the methionine [46].  Finally, the H229A mutant had the lowest D1/2 of 
approximately 1.1 M, consistent with the expected importance of the H229-heme interaction (the 
heme is pentacoordinate in this mutant [46]).  This order of unfolding is consistent with previous 
studies using other techniques; Ran et al. found that the extent of heme transfer from holo-SiaA 
to an apo-myoglobin mutant was H229A > M79A > WT [46].  The acid-induced unfolding 
showed the same pattern.  H229A and M79A both showed single kinetic processes with the 
former faster than the latter.  These were both faster than the WT protein (considering the slower 
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step of the two step process was for the WT) [47].  Equilibrium dialysis and inductively coupled 
plasma mass spectrometry (ICP-MS) experiments indicate that the relative order of heme affinity 
is WT > M79A > H229A [47]; Ran et al. have concluded that all three of these proteins have 
binding constants of > 1012 M-1 [46,65]. 
Heme protein unfolding of b-type heme proteins can have intermediates in which the 
heme is bound to a partially unfolded structure.  For example, in an early study, it was postulated 
that ferric hemoglobin unfolds in a way that allows the heme to be released while the protein is 
unfolding [79].  In contrast, it was proposed that carboxyhemoglobin unfolds completely while 
the heme moiety stays bound at the active site until its release [79].  Data for horse heart 
myoglobin unfolding as a function of GdnHCl concentration were interpreted as an initial 
unfolding (D1/2 = 1.5 M) followed by loss of heme only at high concentrations of denaturant (> 5 
M) [73].  Sperm whale myoglobin unfolding has been fit to a model involving native, 
intermediate, and unfolded states as well as their hemin-bound counterparts [57,76].  
5.5.2 The time-scale of protein unfolding 
The kinetic data for WT SiaA and its mutants were well fit by a two-term exponential 
function with the majority of the protein (~60 – 90%) unfolding with the slower rate constant. 
This two-phase process may reflect forms of the protein with two different orientations of the 
heme in the pocket related by a 180˚ rotation around the α,δ-meso axis [80].  The fast and slow 
phases had half-lives of 2 – 3 and 70 – 90 h, respectively.  Although there are extensive studies 
of guanidinium denaturation of heme proteins, kinetic studies are more limited.  For example, 
bovine microsomal cytochrome b5 has major and minor heme-bound forms that occur in an 8:1 
ratio, as shown by NMR [81,82].  Unfolding of this protein had a fast and slow phase, interpreted 
as arising from the two forms of the protein with different heme orientations, with a half-time of 
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~ 30 sec for the first process and a second process that was 3 – 4 times slower at the D1/2 of 3 M 
GdnHCl [60,83].  Horse heart myoglobin shows a similar pattern, with a the first process (20%) 
having a half-time of seconds and the second process (80%) ~10 times slower at the D1/2 of 1.6 
M GdnHCl [73].  Circular dichroism studies on the horse heart protein were in line with this ratio 
of isomers.  Sperm whale myoglobin has a heme isomer ratio of 15:1 [84], and thus unfolding 
would not be expected to show two isomers.  Olson and co-workers have looked at the unfolding 
process in detail and proposed a kinetic scheme with one form of the protein, but with one or 
more intermediates in the unfolding pathway [57,76,85].  Horseradish peroxidase (HRP) exists 
almost exclusively as a single isomer [80].  HRP has a t1/2 of 520 sec at 6.0 M GdnHCl (pH 7) 
[86,87]; the apparent D1/2 is 5.5 M.  Soybean peroxidase unfolds approximately 200 – 300-fold 
more slowly than horseradish peroxidase [87].  The rates for bovine microsomal cytochrome b5 
and horse heart myoglobin differed approximately by a factor of ten.  WT SiaA and C47A are 
similar.  These results are consistent with the two unfolding phases of SiaA being attributable to 
the two heme orientations.  The amplitude ratios of the faster and slower processes for SiaA are 
in the order of C58 > K61 > WT > C47, with the values of 46 > 34 > 12 > 7.3, respectively.  
Mutations near the propionates of the heme edge (C58A and K61A) gave the largest ratios and 
largest percentages of the slow phase. 
For SiaA and its mutants, we have observed that the unfolding steps are sensitive to 
mutations in the heme pocket, where bonded and non-bonded interactions must be made and 
broken in the course of fairly rapid heme transfer reactions.  However, overall unfolding rates as 
probed by GdnHCl denaturation are very slow, with half-lives for the slower process of one to 
three days at the D1/2.  This slow intrinsic heme loss may protect the organism from the 
deleterious effects of free heme.  Heme transfer would be accomplished only by direct transfer to 
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a partner protein, along a facile heme release coordinate for which the kinetic barrier is relatively 
low.  This would allow a change of conformation sufficient to release the heme without the risk 
of the protein proceeding along a steep, cooperative unfolding pathway that could leave it 
extensively unfolded and perhaps dysfunctional. 
5.5.3 Spectrophotometric pH titrations 
When titrated with base, all of the mutants gave spectra that were isosbestic from pH 7 to 
~10.9.  The data from each mutant were fit with a two state model to give pKa values for C47A, 
C58A, and K61A of 9.22 ± 0.03, 9.04 ± 0.03, and 9.45 ± 0.05, respectively.  These are all 
somewhat lower than the pKa of WT SiaA (9.7 ± 0.1).  We have proposed [45] that this pKa is 
due to deprotonation of the axial histidine, which falls in the range of 8 – 11 for heme proteins 
[88-94].   
The largest effect is seen for the C58A mutant.  As described above, homology modeling 
indicates that C58 is near the heme propionates; mutation of this residue to alanine reduces the 
pKa by approximately 0.7 units from the WT protein.  In IsdE, the corresponding residue is a 
proline [48].  This P58 is near P77, which is adjacent to the axial methionine.  P80 is also very 
near the axial methionine (PMEP).  SiaA has homologous prolines in the sequence near the axial 
methionine (PMNP).  These clusters of prolines may result in rigidity of the protein structure 
near the heme.  This rigidity may allow significant change in the pKa of the protein upon 
replacement of C58 with alanine.  Even mutation of cysteine 47 has a significant effect on the 
pKa, indicating that long range effects of slight changes in protein structure are being transmitted 
to the heme binding site. 
K61 in SiaA aligns with K62 in IsdE.  In IsdE, K62 is part of a complex network of 
hydrogen bonds involving the axial histidine, Y61, E265, two water molecules, and both heme 
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propionates [48].  The reduction in pKa for the K61A mutant may have to do with changes in the 
hydrogen bonding network arising from the substitution.   
5.5.4 The effect of redox state 
For heme protein unfolding that is reversible, a thermodynamic cycle can be constructed 
from reduction potentials of the free heme and holoprotein, and the free energies of folding of 
the two oxidation states [95-97].  This cycle is illustrated for SiaA in Figure 5.10.  The difference 
in the free energies of folding of SiaA around the ferric and ferrous hemes (ΔΔGfld(III−II)) is given 
simply as the difference in the free energies of heme reduction in the unfolded protein and in the 
native holoprotein, as shown in Equation 5.  In this work, chemically induced unfolding was not 
reversible, as shown experimentally.  However, the reduction potentials can still be used to 
estimate the difference in folding free energies of oxidized and reduced SiaA.  Reduction 
potentials of the holoprotein that are similar to that of free heme give systems in which the 
energy costs of unfolding of the two oxidation states are similar.  For WT SiaA, the reduction 
potential is 68 ± 3 mV.  Taken together with the −60 mV reduction potential of free heme [98], 
the thermodynamic cycle indicates that the folding of SiaA around the ferrous heme is more 
strongly driven than folding around hemin, albeit by only ~12.4 kJ∙mol-1 for the WT; the 
corresponding driving force for the K61A mutant is similar at 11.7 kJ∙mol-1.   
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Figure 5.10. Thermodynamic cycle of heme binding in SiaA.   
 
The heme donor to SiaA in vivo is Shp [34,35,41].  It is not yet known in which oxidation 
state the heme is transferred.  Our electrochemical data indicates that the two oxidation states are 
similar with respect to the free energy of unfolding.  Nygaard et al. have looked at the transfer of 
both heme and hemin from Shp to SiaA [42].  They fit the kinetics to a model involving an 
equilibrium for complexation of the two proteins, followed by intracomplex transfer of the iron 
porphyrinate from Shp to SiaA.  The reported dissociation constants for ferrous and ferric Shp 
with apo-SiaA are 120 ± 18 μM and 48 ± 7 μM, respectively.  Thus, the two oxidation states of 
Shp differed only by a factor of 2.5 in their binding affinity for apo-SiaA.  The heme transfer rate 
constants within the Shp:SiaA complex were calculated to be 28 ± 6 s-1 and 43 ± 3 s-1, 
respectively.  Thus, this model indicates that the ferric and ferrous hemes are transferred within 
their respective complexes with similar rate constants.  This kinetic result is consistent with our 
thermodynamic electrochemical data, indicating that both oxidation states of the heme should be 
released with comparable thermodynamic and kinetic ease. 
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5.6 Conclusions 
SiaA is part of a pathway that facilitates heme acquisition by S. pyogenes.  Guanidinium-
induced denaturation showed that, as expected, the axial ligands (M79 and H229) play 
significant roles in the stability of the holo-SiaA fold.  Other residues near the heme, specifically 
C58 and K61, which are near the propionic acids, are also important in stabilizing the protein 
fold.  Guanidinium-induced denaturation occurred from two forms of the protein, with the slower 
process having a half-time of one to three days.  The very slow unfolding may indicate that heme 
transfer proteins can unfold sufficiently to release heme, but are resistant to further unfolding 
that might result in conformations that could not easily bind heme for further heme transfer 
reaction cycles.  Spectrophotometric pH titration studies gave pKa values ranging from 9.0 to 9.5 
for the mutants studied; these may be due to deprotonation of the axial histidine.  Spectroelectro-
chemical titrations showed that the midpoint reduction potential of the K61A SiaA was 61 ± 3 
mV, similar to the 68 ± 3 mV potential of WT SiaA.  The midpoint potential differs from that of 
free heme by 125 mV, indicating that the reduced protein is only ~12 kJ/mole more difficult to 
unfold than the oxidized protein.  These results, together with kinetic data from the literature, 
reveal that the thermodynamic stabilities of the surface-bound heme acquisition protein SiaA are 
balanced so as to be nearly insensitive to the oxidation state of the heme.  This result is 
consistent with the system having the flexibility to acquire heme in both its ferrous and ferric 
oxidation states. 
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5.9 Supplemental Information  
5.9.1 Supplemental Figures 
 
Figure 5.11 S1 Unfolding of K61A SiaA at the D1/2 (2.5 M GdnCl). The protein was unfolded in 
50 mM Tris-Cl, pH 7.0. The data were fit using the sum of a two exponential processes.   
 
 
Figure 5.12 S2 Unfolding of C47A SiaA at the D1/2 (2.95 M GdnCl). The protein was unfolded 
in 50 mM Tris-Cl, pH 7.0. The data were fit using the sum of a two exponential processes.   
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Figure 5.13 S3 Unfolding of C58A SiaA at the D1/2 (2.42 M GdnCl). The protein was unfolded 
in 50 mM Tris-Cl, pH 7.0. The data were fit using the sum of a two exponential processes. 
 
 
Figure 5.14 S4 GdnHCl unfolding of WT SiaA using a desalting column.  The protein was 
unfolded in 50 mM Tris-Cl, pH 7.0. The data were fit using a two-state model and gave a D1/2 of 
2.6 ± 0.1 M.     
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Figure 5.15 S5 Soret-excited rR spectra of ferric (top) and ferrous (bottom) C58A SiaA.   
The high frequency (in-plane porphyrin stretching) and low frequency regions are shown.  
Samples were 50 μM in holo-SiaA and 10 mM in Tris-HCl at pH 8.0.  Ferrous C58A SiaA was 
generated by anaerobic introduction of a 10-fold molar excess of buffered dithionite to the ferric 
protein.  Complete reduction was verified by UV-visible absorption absorbance spectroscopy. 
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Figure 5.16 S6 Spectroelectrochemical titrations of WT SiaA.  Normalized absorbance at the 
Soret maximum for ferrous WT SiaA (424 nm) is plotted versus cell potential (vs SHE), revealing 
electrochemical irreversibility of the Fe(III)|Fe(II) couple.  The oxidative titration curve (∆, 
blue) was best modeled by three Nernstian waves.  Midpoint heme potentials at 15 and 72 mV 
are shown by vertical red lines.  The 72 mV potential is somewhat uncertain in the oxidative 
curve due to the truncation of its small amplitude wave at ~100 mV.  A third, very negative, 
potential resulted from the fitting in order to account for absorbance changes at the lowest cell 
potentials.  This may be due to dithionite absorbance in this potential range.  The reductive 
titration curve (, green) was well modeled by a single Nernstian wave having a midpoint 
potential of 68 mV.  The 68 and 72 mV potentials are taken to represent the same reversible 
Fe(III)|Fe(II) couple, which accounts for only ~40% of the heme during the titrimetric 
reoxidation.  This behavior suggests that, following reduction and equilibration in the reducing 
solution, WT SiaA adopts a structure or conformation having a lowered potential of 15 mV.  The 
small fraction of the heme having the higher potential upon reoxidation suggests the reduced 
conformer is kinetically slow to revert back to that of the ferric protein before reduction.  
Titrations were carried out in 50 mM Tris at pH 8.0, 100 mM NaCl. 
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Figure 5.17 S7 Spectroelectrochemical titration of C58A.  A solution of 2 μM SiaA C58A was 
initially reduced, oxidatively titrated with ferricyanide to yield a midpoint potential of -96 ±15 
mV, reductively titrated with dithionite to yield a midpoint potential from global analysis of 1±8 
mV, and oxidatively titrated with ferricyanide to yield a midpoint potential from global analysis 
of -120±1 mV.  Titration curves at the indicated wavelengths are shown below for each titration.  
This suggests that the redox behavior for the protein is irreversible (similar to WT), and the 
oxidative potential is reproducible. 
 
 
Figure 5.18 S8 Comparison of the A) S. pyogenes SiaA and B) S. aureus IsdE heme binding sites.  
Images are displayed using PyMOL.  The structure of IsdE was downloaded from the Protein 
Data Bank (PDB ID: 2Q8Q). 
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6 ADDITIONAL STUDIES ON THE CHARACTERIZATION OF S. PYOGENES SIAA 
Chapter 1 gave a detailed overview of heme uptake in some of the most commonly 
studied pathogenic bacteria.  Chapter 5 was published work by our group which expanded on 
initial studies of the Sia heme uptake pathway involving work on WT SiaA and a series of 
mutants.  This chapter gives additional experimental data and literature discussions related to our 
previously published work on SiaA.  All of the experiments in this chapter were performed at 
Georgia State University.  
6.1 Experimental 
6.1.1 Expression and purification of SiaA and mutants 
Expression and purification of WT, M79A, H229A, K61A, C58A, and C47A were 
previously described (Chapter 5).  Purity of the samples was evaluated by SDS-PAGE 
electrophoresis and performed as previously described in Chapter 5.  Extinction coefficients and 
heme loading were also calculated as previously described in Chapter 5.  
6.1.2 Heme extraction and refolding of SiaA 
Apo-SiaA was prepared using the Teale method (1).  A solution of SiaA (2 mL) in PBS 
buffer, pH 7.4, was reduced to pH 2 in a drop-wise fashion using 3 M HCl.  The acidic SiaA 
solution was mixed with cold 2-butanone for 30 s and placed on ice for 15 min.  The heme layer 
was discarded.   
To aid in protein refolding, urea was added to the apoprotein solution to a final 
concentration of 8 M urea (2).  The solution sat at room temperature for 2 h.  The apo-SiaA 
solution was dialyzed at 4˚C against 4 M urea (in PBS) for 24 h, against 2 M urea (in PBS) for 2 
h, and against 10 mM KH2PO4, pH 7.0, for 24 h.  The apoprotein solution was centrifuged at 4˚C 
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for 15 min at 5,000 g to remove any precipitate.  The concentration of apo-SiaA was determined 
using the ExPASy ε280 = 37,360 M-1cm-1 (3). 
6.1.3 Optical spectroscopy 
Samples of holo- and apo-SiaA were analyzed by UV-visible absorption spectroscopy 
using a Varian 50 Bio spectrophotometer in 1 cm quartz cuvettes at room temperature.  Circular 
dichroism (CD) spectra were recorded using a Jasco J-810 Spectropolarimeter using quartz 
Suprasil cuvettes (Fisherbrand, Inc.) with a 1 mm path length.  Holo- and apo-SiaA (10 μM) 
were recorded in 10 mM KH2PO4 buffer at pH 7.0 (adjusted with KOH) in a spectral window of 
190 to 260 nm.  The final spectrum represents an average of 10 scans. 
6.1.4 Stability of holo-SiaA and apo-SiaA 
Holo-SiaA (5 μM) in 50 mM Tris-Cl, pH 7.0, sat covered in a 1 cm cuvette at room 
temperature.  A UV-visible absorption scan was taken every 48 h to monitor protein degradation 
for a total of 228 h.  Apo-SiaA (10 μM) in 10 mM KH2PO4, pH 7.0, sat at room temperature in 
an Eppendorf tube for three days.  A CD spectrum was taken every 24 h to monitor protein 
degradation. 
6.1.5 Denaturation of apo-SiaA via guanidinium hydrochloride 
A series of apo-SiaA samples (10 μM) were incubated in 10 mM KH2PO4, pH 7.0, and 
GdnCl.  A stock solution of 7.83 M GdnCl in 10 mM KH2PO4, pH 7.0 buffer was prepared (4). 
The desired GdnCl concentration was achieved by varying the amount of buffer in the sample. 
All total sample volumes were 300 μL with a final concentration of 8 μM protein.  The samples 
were incubated at room temperature overnight.  CD spectra were recorded for each sample.  
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6.1.6 Denaturation of apo-SiaA via urea 
A series of apo-SiaA samples (10 μM) were incubated in 10 mM KH2PO4, pH 7.0, and 
urea.  A stock solution of 5.83 M urea in 10 mM KH2PO4, pH 7.0 was prepared (4).  The desired 
urea concentration was achieved by varying the amount of buffer in the sample.  All total sample 
volumes were 300 μL with a final concentration of 2.0 μM protein for the small-scale titration 
and 5.0 μM protein for the large-scale titration.  The samples incubated at room temperature 
overnight.  CD spectra were recorded for each sample.  The raw data (millidegrees) at 222 nm 
were converted to molar ellipticity and plotted as a function of urea concentration. 
6.1.7 Electrospray ionization (ESI) mass spectrometry  
Samples of C47A (50 μM) and K61A (30 μM) were concentrated into 50 mM 
ammonium acetate, pH 6.8, using an Amicon centrifugal filtration unit (30,000 MWCO) 
following the manufacturer’s protocol.  Each sample was then dialyzed for five days in 50 mM 
ammonium acetate, pH 6.8, to remove residual salts.   
ESI spectra were obtained using a Waters Micromass Q-TOF Micro mass spectrometer in 
the positive mode.  Samples were prepared with 50:50 acetonitirile to water and 0.1% formic 
acid.  Deconvolution of the charged state was performed using the MaxEnt program with the 
MassLynx™ software.  Peaks were rounded to the nearest Dalton.  
6.1.8 Myoglobin and SiaA unfolding and desalting 
Samples of equine skeletal muscle myoglobin (2.65 μM) (Sigma-Aldrich) [extinction 
coefficient ε410 = 188,000 M-1 cm-1 (5)] in 50 mM Tris-Cl, pH 7.0 were incubated for 20 min at 
room temperature in solutions of 1.0, 1.5, 2.0, and 2.5 M GdnCl (5.93 M stock solution).  Each 
sample was monitored by UV-visible absorption spectroscopy before loading onto a washed PD-
10 desalting column (GE Healthcare).  The column was equilibrated with 25 mL of 50 mM Tris-
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Cl, pH 7.0.  Each myoglobin sample (2.5 mL) was allowed to enter the column bed before 
eluting with 3.5 mL of 50 mM Tris-Cl, pH 7.0.  Fractions of 500 µL were collected.  The protein 
eluted in the third fraction.  The Soret:280 nm ratios of the desalted myoglobin samples were fit 
to an unfolding curve in KaleidaGraph using Equation 1: 
 
y = [(AF + mF[D]) + (AU + mU [D])exp[m([D]-[D]1/2)/RT])]/1 + exp[m([D]-[D]1/2)/RT]              [1] 
 
where y is the absorbance at any point along the fitted denaturation curve, AF is the absorbance 
of the folded state, AU is the absorbance of the unfolded state, m is the slope at the midpoint, and 
also the dependence of the free energy of unfolding on the denaturant concentration, mF is the 
slope of the folded state, mU is the slope of the unfolded state, [D] is the concentration of 
GdnHCl, [D]1/2 is the concentration of GdnHCl at the midpoint of the unfolding curve, R is the 
gas constant, and T is the temperature (Kelvin).   
The same experiment was repeated using 5 μM SiaA, as described above.  The samples 
incubated for 29 h and the data were fit using Equation 1.  
6.2 Results 
6.2.1 Heme extraction and refolding of SiaA 
Removal of heme from holo-SiaA using the Teale method resulted in 60% recovery of 
the SiaA protein with a final concentration of 12 μM.  The absorbance spectrum of apo-SiaA is 
shown in Figure 6.1.  Initial protocols used to remove the heme resulted in precipitation of the 
protein during the refolding process.  Dialysis using urea during refolding diminished protein 
denaturation.  However, apo-SiaA samples slowly precipitated out of solution over an 
approximately 24 h time period at 4˚C.  
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Figure 6.1 UV-visible absorption absorbance spectrum of apo-SiaA in PBS buffer, pH 7.4.  The 
apoprotein is represented by the peak maxima at 280 nm.  The final apo-SiaA concentration is 
12 μM. 
 
6.2.2 Circular dichroism spectroscopy of holo- and apo-SiaA 
A comparison of normalized holo- and apo-SiaA CD spectra is shown in Figure 6.2.  
Both proteins contain bands around 190, 210, and 222 nm, indicative of α-helical content.  The 
band at 210 nm is more pronounced for the apoprotein compared to the holoprotein.  This would 
indicate that the overall fold of the protein is altered upon heme removal from the protein.  
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Figure 6.2 Normalized circular dichroism spectra of holo-SiaA (solid line) and apo-SiaA 
(dashed line).  Samples (10 μM) were recorded in 10 mM phosphate buffer, pH 7.0. 
 
6.2.3 Stability studies of holo- and apo-SiaA 
Holo- and apo-SiaA were allowed to sit at room temperature for twelve and three days, 
respectively.  Holo-SiaA was monitored every 48 h using UV-visible absorption spectroscopy 
while apo-SiaA was monitored every 24 h using CD spectroscopy.  Holo-SiaA showed a slow 
increase of the 280 nm band over the twelve day time period (Figure 6.3).  Apo-SiaA slowly 
precipitated out of solution (Figure 6.4).  The normalized apo-SiaA spectra of each time point 
showed the protein to have the same secondary structure over the three days (Figure 6.5).  
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Figure 6.3 UV-visible absorption spectra of WT SiaA at 48 h time intervals (total time 228 h). 
The protein solution sat covered at room temperature in 50 mM Tris-Cl, pH 7.0 between 
readings. Protein degradation is shown by the increase in the 280 nm band over time indicated 
by the arrow.   
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Figure 6.4 Circular dichroism spectra of apo-SiaA over a 72 h period.  The protein solution sat 
covered in a cuvette at room temperature.  A scan was taken every 24 h to monitor changes.  The 
sample was in 10 mM potassium phosphate, pH 7.0.  The scans are as follows: 24 h (blue), 48 h 
(red), and 72 h (green). 
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Figure 6.5 Normalized circular dichroism spectra of apo-SiaA from the previous figure.  Spectra 
are normalized at 208 nm. 
 
6.2.4 Denaturation of apo-SiaA 
Holo-SiaA unfolds very slowly with a midpoint GdnCl concentration of 3.1 M (6).  In an 
initial small-scale titration, freshly prepared apo-SiaA samples were incubated for 2 h with 
GdnCl at varying concentrations to determine an approximate D1/2.  The protein appeared to 
unfold between 0 and 1.5 M GdnCl (Figure 6.6).  To ensure the samples incubated long enough, 
spectra were recorded again after 16 h; unfolding was complete after 2 h (Figure 6.7). 
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Figure 6.6 Circular dichroism spectra of apo-SiaA samples at different GdnCl concentrations 
for D1/2 determination. Samples are as follows: 0 M GdnCl (blue), 0.5 M GdnCl (purple), 1.0 M 
GdnCl (green), and 1.5 M GdnCl (red).  Spectra were recorded in 10 mM potassium phosphate, 
pH 7.0.  All of the samples were incubated at room temperature for 16 h.  
 
 
Figure 6.7 Circular dichroism spectra of apo-SiaA (8 μM) incubated for 2 h (blue) and for 16 h 
(red) with 1.0 M GdnCl.  Samples were recorded in 10 mM potassium phosphate, pH 7.0 and 
incubated at room temperature. 
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Incubation of the same apo-SiaA stock used for the small-scale experiment (but after 
sitting at 4˚C for 24 h) with GdnCl was used to complete a full titration.  The data showed the 
protein had started to precipitate out of solution.  To confirm this, spectra comparing apo-SiaA at 
0.5 M GdnCl from the small-scale titration were compared to the large-scale titration apo-SiaA 
at 0.5 M GdnCl (Figure 6.8).  The decreases in negative intensity indicate protein precipitation.  
 
Figure 6.8 Circular dichroism spectra of 8 μM apo-SiaA in 0.5 M GdnCl after incubation at 
room temperature for 16 h.   Guanidinium was added either directly after preparation (blue) 
(from Figure 6.7) or after standing at 4 °C for 24 h (red). 
 
GdnCl is a strong denaturant and may unfold the protein too readily; it is common to 
investigate the unfolding of apo heme proteins with urea which is a milder denaturant (2). 
Freshly prepared apo-SiaA was used within the first 24 h after completion of the refolding 
process to diminish the amount of precipitation in the sample.  An initial small-scale titration 
(using very little protein) was performed to determine an approximate midpoint value (Figure 
6.9).  The results indicated apo-SiaA to have a D1/2 ~ 1.5 M.  A complete titration of apo-SiaA 
with urea (Figure 6.10) gave a shallow unfolding curve (Figure 6.11).  The apparent D1/2 is ~ 1.4 
to 1.7 M.  
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Figure 6.9 Circular dichroism spectra of an initial urea unfolding titration with apo-SiaA (2.0 
μM). Samples were scanned in 10 mM potassium phosphate, pH 7.0. Urea concentrations were 
from 0 to 2.8 M as follows: 0 M (dark blue), 0.75 M (red), 1.49 M (green), 2.2 M (purple), and 
2.8 M (light blue). The samples incubated for 2 h at room temperature. 
 
 
Figure 6.10 Circular dichroism spectra of a urea-induced apo-SiaA (5.1 μM) unfolding titration. 
Samples were made in 0 to 3 M urea. Samples were recorded in 10 mM potassium phosphate, 
pH 7.0 and incubated at room temperature for 16 h.  
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Figure 6.11 Circular dichroism molar ellipticity at 222 nm versus urea concentration. 
The full spectra are given in the previous figure. The data were fit to the unfolding equation 
given in the Experimental.  The apparent D1/2 is between 1.5 and 1.7 M urea.  
 
6.2.5 Myoglobin and SiaA unfolding and desalting 
A solution of myoglobin was divided into aliquots to which different concentrations of 
GdnCl were added.  These solutions were passed through a desalting column to remove any 
heme not tightly bound to the protein.  The Soret:280 nm ratios of the eluents were plotted 
against GdnCl concentration to obtain an unfolding curve with a D1/2 of 1.9 ± 0.6 M.  The 
guanidinium-induced D1/2 for this myoglobin assessed via UV/visible spectroscopy was 1.38 ± 
0.02 M (data not shown).   
The same experiment was also performed using holo-SiaA which has a reported D1/2 
value of 3.1 M (6).  The D1/2 value assessed via the desalting technique was 2.59 ± 0.05 M. 
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6.2.6 ESI mass spectrometry  
Mass spectrometry data were obtained for C47A and K61A. The deconvoluted spectrum 
of C47A gave an observed mass of 36,062 Da.  The expected mass of the holo-protein is 36,071 
Da (Figure 6.12).  C47A gave charge state window from +12 to +21.  
 
Figure 6.12 Electrospray mass spectrum of SiaA C47A. The sample was prepared in 50:50 
acetonitrile:ammonium acetate and 0.1% formic acid. Top panel: charge distribution spectrum. 
Bottom panel: The SiaA C47A peak is seen at 36,062 Da. The expected peak is 36,071 Da. 
 
The deconvoluted spectrum of K61A gave an observed mass of 36,037 Da.  The expected mass 
of the holo-protein is 36,046 Da (Figure 6.13).  K61A also gave a charge state window range of 
+13 to +20, similar to C47A.   
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Figure 6.13 Electrospray mass spectrum of SiaA K61A. The sample was prepared in 50:50 
acetonitrile:ammonium acetate and 0.1% formic acid. Top panel: charge distribution spectrum. 
Bottom panel: The SiaA C47A peak is seen at 36,037 Da. The expected peak is 36,046 Da. 
 
6.3 Discussion 
6.3.1 Heme extraction and refolding of SiaA 
SiaA was very sensitive to the extraction and refolding process. Heme extraction requires 
the use of a strong acid to successfully remove the heme from the active site by reducing the pH 
of the environment and therefore eliminating interactions between the heme moiety and the 
protein (1). Butanone (methyl ethyl ketone) is used to separate the heme from the aqueous 
protein layer and to ensure the free heme stays in solution after separation. The exposure of 
proteins to acidic environments and organic chemicals such as butanone can damage the protein 
during the extraction process.  
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Initial attempts to prepare apo-SiaA involved extracting the heme and then allowing the 
protein to dialyze first in sodium bicarbonate and then by the buffer of choice. Using this 
protocol, apo-SiaA precipitated out of solution once the heme was removed and did not go back 
into solution.  
Protein precipitation during the refolding process results from the presence of protein 
aggregates and other inactive forms of proteins in solution (2). It has been shown that using urea 
(or any other denaturant) during the refolding process allows the protein to properly fold and 
diminish or prevent precipitation (7). The refolding of apo-SiaA using urea proved to be 
successful, although not all of the protein stayed in solution. Protein precipitation upon heme 
removal has been seen in other systems. For example, cytochrome c551 from Pseudomonas 
aeruginosa precipitates out of solution during refolding after heme extraction (8). The same 
result was also seen in cytochrome P450 from rat liver microsomes (RLM) (9).  
6.3.2 Circular dichroism spectroscopy of holo- and apo-SiaA 
Circular dichroism comparison of holo- vs. apo-SiaA showed different protein 
conformations between the two forms of the protein (Figure 6.2). Both apo- and holo-SiaA gave 
bands around 190, 210, and 222 nm, indicative of α-helical structure. This is consistent with the 
I-TASSER homology modeling predictions discussed above. Holo-SiaA gave two negative 
bands at 210 and 222 nm, with the 222 nm band a more negative minima than the 210 nm band. 
Apo-SiaA also has two negative bands at 208 and 222 nm with the most negative minima at 208 
nm, rather than at 222 nm as seen with holo-SiaA. There is also a positive peak at 192 nm 
compared to holo-SiaA which has a more intense positive peak at 195 nm and is indicative of 
increased α-helical content.  
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An increase in α-helical content upon the binding of heme has also been seen in other 
systems. Apo-cytochrome b562 from Escherichia coli was shown by circular dichroism to also go 
under a conformational change once heme is bound (10). CD data were interpreted using 
CONTIN and showed that apo-cytochrome b562 has ~60% helicity while the holoprotein has 
~80%. For sperm whale myoglobin, an increase is seen in helicity from 60% for apo-myoglobin 
compared to 71% for holo-myoglobin (11). This trend is also seen in RLM cytochrome P450 in 
which the apoprotein loses α-helical content upon heme removal (9).  In contrast, previous 
studies on SiaA were interpreted as indicating significantly more helical structure in the 
apoprotein (12). Additionally, proteins involved in heme transfer are more open in the apo form, 
as shown by crystallography (13).  This is expected, as they must fluctuate between an open and 
closed form during the heme binding and release processes.    
6.3.3 Denaturation and stability studies of Holo- and apo-SiaA 
Using circular dichroism, it was confirmed that apo-SiaA slowly precipitates out of 
solution over time. Figure 6.4 shows apo-SiaA to precipitate out by about 20% every 24 h at 
room temperature. Although the protein is precipitating, Figure 6.5 shows the protein is not 
changing in overall conformation over time.  
The precipitation of apo-SiaA was also seen during denaturation studies with GdnCl. 
Initial GdnCl unfolding experiments were performed using apo-SiaA prepared on the same day 
as incubation of the samples for the titration. The full-scale titration was performed two days 
later using the same stock solution made for the small-scale titration. Therefore, samples from 
either titration, at the same GdnCl concentration, should give the same CD spectra. Figure 6.6 
shows that the samples do not give the same spectra. Since the signal intensity is decreased for 
the large-scale titration, it appears that the stock solution had begun to precipitate out of solution. 
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Overall, it may be the case that apo-SiaA cannot be stored for long periods of time and must be 
freshly prepared for each experiment.   
The stability of the holo-SiaA was investigated, as shown in Figure 6.3, with UV-visible 
absorption spectroscopy. Over a period of twelve days, heme continued to stay bound to the 
protein, as indicated by the position and shape of the Soret and the presence of well-defined α,β-
bands. The appearance of free heme can be monitored spectrally by the appearance of a shoulder 
around 380 nm and the loss of defined bands in the α,β-region. These features were not observed 
for holo-SiaA, indicating heme is still bound at the active site after twelve days. However, the 
absorbance at the 280 nm band continuously increased over time. This could possibly be 
insoluble apo-SiaA slowly going into solution. In the case of apo-SiaA, protein samples were 
kept in buffers of low ionic strength for CD purposes. Holo-SiaA is purified and stored in buffers 
with much higher ionic strengths. Holo-SiaA may be purified with partial amounts of insoluble 
apo-SiaA that go into solution over time.  
Preliminary studies showed GdnCl to be too strong of a denaturant and completely 
unfolded the protein, even at concentrations less than 0.1 M.  Alternatively, urea was used to 
study the unfolding of apo-SiaA. A small-scale unfolding titration on freshly prepared apo-SiaA 
indicated the D1/2 was between 1.4 - 1.7 M. A full-scale unfolding titration was then performed 
on the same stock of apo-SiaA prepared the same day as the titration to diminish the chances of 
precipitation. The unfolding curve (Figure 6.11) shows a shallow curve with an apparent D1/2 
range of 1.5 - 1.7 M. The errors in the fit indicate that this is not a good fit for the data. This is 
expected if the protein is slowly precipitating out of solution.  
The D1/2 for apo-SiaA in urea is considerably less than the D1/2 for holo-SiaA of 3.1 M in 
GdnCl. Urea is not as strong of a denaturing agent as GdnCl and has been used to unfold apo-
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hemoproteins, which tend to be easier to unfold when the heme is not bound to the protein (14). 
There are a few examples of unfolding studies comparing apo vs. holo heme proteins (Table 6.1). 
Apo-SiaA unfolding is most similar to cytochrome c551 from P. aeruginosa (not shown in Table) 
which becomes unstable in the apo-form and unfolds around the same midpoint as apo-SiaA (1.6 
M in urea) (8). In all of the studies, the apoprotein was easier to unfold than the holoprotein, as 
seen for SiaA.  
Rates of holo vs. apoprotein unfolding are known in a few instances; as expected, the 
apoprotein unfolds much faster than the holoprotein. For example, apo-horseradish peroxidase 
and apo-soybean peroxidase unfold rapidly while their holo counterparts unfold slowly (15). 
Apo-Mc cyt b5 unfolds much faster than holo-Mc cyt b5, with rates of ~0.2 s
-1 and ~ 4.5 x 10-6 s-1, 
respectively (16).  For SiaA, the apoprotein unfolds completely in ~2 h while the holoprotein has 
a half-life ~24 h (this work).  
6.3.4 D1/2 determination of myoglobin and holo-SiaA desalting 
It has been shown that heme protein unfolding and heme release can occur in different 
ways. For example, ferric hemoglobin unfolds in a way that allows the heme to leave the active 
site while the protein is unfolding (17). In this case, protein unfolding leads to heme release. 
Carboxyhemoglobin unfolds completely while the heme moiety stays bound at the active site 
before release (17). Myoglobin unfolding is shown to fit to a six-state model, indicative of a 
more complicated unfolding process with heme-bound intermediates (18). 
To investigate protein heme retention upon unfolding, the protein with various 
concentration of denaturant was run through a desalting column, which is expected to remove 
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Table 6.1 Comparison of D1/2 values of b-type holo- and apo-hemoproteins. 
 
Protein 
Source of 
Protein 
Method Conditions 
GdnCl D1/2 (M) Urea D1/2 (M) 
Holo Apo Holo Apo 
Cytochrome 
b562 
E. coli 
Absorbance 
pH 5.0,  
20 ˚C 
2.15 ± 0.2 (19) -- -- -- 
Absorbance pH 7.0 1.8 (20) -- -- -- 
CD 
pH 7.0,  
22 ˚C 
-- -- ~ 4.9 (10) ~ 2.3 (10) 
OM  
Cytochrome b5 
Rat 
microsomal 
NMR 
pD 7.0,  
in D2O 
2.6 ± 0.3 (21) -- -- -- 
Absorbance  pH 7.0,  
25 ˚C 
3.64 ± 0.1 (22) -- -- -- 
Fluorescence 3.51 ± 0.1 (22) 1.2 ± 0.2 (22) -- -- 
MC  
Cytochrome b5 
Bovine 
microsomal 
Absorbance 
pH 7.0,  
25 ˚C 
3.05 ± 0.1 (22) -- -- -- 
Fluorescence  2.99 ± 0.1 (22) 1.6 (22) -- -- 
FixLH B. japonicum CD 
pH ~ 8.8,  
20 ˚C 
-- -- 4.2 ± 0.3 (23) Not reported 
Myoglobin 
Sperm whale 
Absorbance 
pH 8.0 
2 (24) -- -- -- 
CD -- ~ 1.6 (24) -- -- 
Equine 
Skeletal 
Muscle 
UV/DSTD 
pH 6.6, 25 ˚C 1.8 (14;25) -- 3.9 (25) -- 
pH 5.7, 25 ˚C -- -- 6.6 (14) -- 
pH 7.0, 25 ˚C 2.44 (14;26) -- -- -- 
pH 7.0, 20 ˚C 1.5 (14;27) -- -- -- 
pH 7.2, 20 ˚C 1.7 (14) -- 7.6 (14) -- 
SiaA S. pyogenes 
Absorbance 
pH 7.0,  
22 ˚C 
3.1 (6) -- -- -- 
CD -- -- -- 
~ 1.5-1.7  
(this work) 
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unbound heme.  When the experiment was performed on myoglobin, a D1/2 of 1.9 M was 
obtained.  This is very similar to values in the literature, which range between 1.5 M (27) and 1.8 
M (25).  However, these results were very different than observed previously by Moczygemba et 
al., who observed that the heme remained bound up to 5 M GdnCl, indicating that the heme stays 
bound to both the partially unfolded and fully unfolded protein (27).  The difference in these 
experiments may indicate a significant role of the experimental conditions and type of resin in 
this type of experiment.    
A control experiment using partially denatured myoglobin and the desalting column were 
performed.  The unfolding of myoglobin in the literature has been extensively characterized and 
various D1/2 values have been reported between 1.5 M (27) and 1.8 M (25). These values are less 
than the D1/2 for myoglobin (1.9 M) which has been passed through a desalting column. This 
would indicate that heme stays bound to the protein as it unfolds which is in correlation with 
previous studies of myoglobin unfolding described above.  Heme binds very tightly to 
myoglobin. Therefore, it is not unexpected that the heme will stay bound to the protein, even 
once the protein has been partially unfolded.  
In comparison, SiaA shows a lower D1/2 measured using the desalting column compared 
to that measured via optical spectroscopy. The apparent decrease in the D1/2 is consistent with the 
unfolding process priming the release of the heme molecule. Unfolding may act as a trigger for 
the protein to pass the heme off to the next acceptor in the pathway, in preparation for loading of 
another heme molecule.  
6.3.5 ESI mass spectrometry 
Mass spectrometry of C47A gives two charge state envelopes in the charge state window; 
one from +12 to +14 and the other from +15 to +21.  The deconvoluted region gives a mass of 
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36,062 Da which corresponds to the mass of the expected holoprotein (36,071 Da).  Only the 
holoprotein is detected by the spectrometer indicating the two charge envelopes are both forms 
of holo-C47A SiaA.  
A similar result is obtained in the mass spectrum for K61A.  The charge state window 
shows two envelopes: +13 to +14 and +16 to +20 with maxima at +13 and +18, respectively.  
The deconvoluted region gives a mass of 36,037 Da which corresponds to the mass of the 
expected holoprotein (36,046 Da).  Only the holoprotein is detected by the spectrometer 
indicating the two charge envelopes are both forms of holo-K61A SiaA.  
Multiple charge state envelopes representing the same form of the protein have also been 
seen in myoglobin (28).  Fully folded holo-Mb exhibits a small charge envelope from +10 to +7, 
centered at +9.  As acetic acid is added to the protein, the pH decreases and the Mb begins to 
unfold.  This results in an expanded charge envelope with multiple peaks representing partially 
unfolded holo-Mb. As the protein completely unfolds, heme leaves the protein, the number of 
peaks in the charge window increases, and the entire charge envelope shifts to lower m/z ratios 
representing the unfolded apo-Mb.  
It could be the case for both C47A and K61A that the spectra represent a mixture of 
folded holoprotein and partially unfolded holoprotein.  Acetonitrile and 0.1% formic acid were 
added to the samples to enhance signal to noise and to reduce the pH to ensure protonation, 
respectively.  Addition of the organic solvent and exposure to low pH could have induced the 
alternative fold of the protein and led to different protonation states of the protein samples.  
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7 THE FIRST HEME-BINDING NEAT DOMAIN OF SHR IN STREPTOCOCCUS 
PYOGENES 
This chapter is intended for publication and is verbatim of the manuscript in progress. The 
expression, purification, UV-visible absorption spectroscopy, and thermal unfolding were 
performed by E. B. Draganova at Georgia State University.  
7.1 Abstract 
The hemoprotein receptor Shr, of the Streptococcus pyogenes Sia heme uptake pathway, 
contains two heme-binding NEAT domains.  Herein, we report the biophysical characteristics of 
the NEAT domain closest to the N-terminus (Shr-N1).  A combination of UV-visible absorption, 
magnetic circular dichroism, and resonance Raman spectroscopies reveal Shr-N1 to have a 
bismethionine heme axial ligation set.  pH titrations show Shr-N1 to be sensitive to pH with a 
predominantly six-coordinate low-spin species in acidic environments and five-coordinate high-
spin species in alkaline conditions.  Spectroelectrochemical titrations of Shr-N1 give 260 ± 9 mV 
(reductive) and 230 ± 26 mV (oxidative) vs. SHE.  Stability of this domain towards heme release 
is analyzed via guanidinium and thermal denaturation studies of oxidized and reduced Shr-N1.  
Overall, sequence alignment, homology modeling, and spectral signatures are consistent with 
two axial methionines as the heme ligands of this novel heme binding NEAT domain. 
7.2 Introduction 
Many bacterial pathogens require iron for survival and virulence (1-3).  In the human 
host, iron is commonly found in the form of heme (protoporphyrin IX) and bound to proteins 
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such as hemoglobin (3).  Therefore, bacteria have evoked various strategies to obtain needed iron 
through the use of heme.  Bacteria can acquire heme through biosynthesis, uptake pathways, or 
utilize both strategies (4-6).  
 Pathogens which rely on heme uptake utilize multiple cellular surface proteins to bind 
and transfer heme to be brought into the cell from the extracellular space (3, 7-13).  In Gram-
positive bacteria (14), studies have focused particularly on Corynebacterium diphtheriae (15, 
16), Staphylococcus aureus (17-20), Bacillus anthracis (21) and Streptococcus pyogenes [Group 
A Streptococcus (GAS)] (22-27).  The latter three species employ near iron transporter (NEAT) 
domains for heme uptake and transfer (28-30).  NEAT domains have conserved secondary 
structural features including β-strands and a 310 α-helix, preceded by a serine which hydrogen 
bonds to one of the heme propionates, which assist in the binding of heme (30).   
Almost all NEAT domains characterized to date utilize a five coordinate heme binding 
geometry with an YXXXY pattern arising from the β-8 strand in which the first Tyr serves as an 
axial ligand and the second is hydrogen bonded to the first.  These include S. aureus IsdA (31), 
IsdB-N2 (32), IsdC (33), and IsdH-N3 (34) as well as B. anthracis IsdX1 and IsdX2-N5 (30, 35, 
36).  In addition, the NEAT protein BslK from B. anthracis has the YXXXY motif according to 
sequence alignment studies (37).  
 Proteins utilizing this motif, but with slight variations in the heme axial ligands, include 
IsdB-N2 with a six coordinate Met/Tyr heme center under some conditions (32) and IsdA with a 
tyrosine ligand in the ferric state and a histidine ligand in the ferrous state (38, 39).  Recently, the 
second NEAT domain from the proposed hemophore Hbp2 of Listeria monocytogenes (Hbp2-
N2) has been described (40).  The axial tyrosine of Hbp2-N2 differs from other known NEAT 
domains in that it is located in the β-7 strand, rather than the β-8 strand.  This NEAT domain also 
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lacks the second tyrosine in the conserved YXXXY motif, which is replaced with an alanine.  
HalA from B. anthracis also lacks the second tyrosine, using a YXXXF motif instead (41).  
Honsa and coworkers have proposed, based on sequence analysis, that additional heme binding 
motifs will be discovered in the NEAT family (30). 
 S. pyogenes is a hemolytic bacterium with a heme uptake pathway that employs NEAT 
domains.  S. pyogenes causes a wide variety of invasive and non-invasive infections including 
necrotizing fasciitis, pharyngitis, and toxic shock syndrome (25, 42).  This pathogen is found 
increasingly resistant to macrolide antibiotics (43, 44), potentially posing significant risks for 
infected populations.  S. pyogenes requires iron to survive and can only obtain heme from the 
environment (5, 45-47).  Since S. pyogenes is not able to synthesize heme, and the pathogen 
heme uptake pathway may therefore be a target for inhibition in the development of new 
therapies. 
The Sia heme uptake system in S. pyogenes consists of two cell surface heme binding 
proteins, Shr (streptococcal hemoprotein receptor) (24, 48) and Shp (streptococcal cell surface 
protein) (49, 50), in conjunction with an ABC (ATP-binding cassette) heme transporter 
comprised of SiaA (HtsA, the periplasmic binding protein) (23, 51-54), SiaB (the permease), and 
SiaC (the ATPase).  Shr can acquire heme from hemoglobin (24) and transfer the heme to Shp 
(26, 48); Shp donates heme to SiaA (22, 55-57).  The heme is then brought into the intracellular 
space by the SiaBC proteins.  
Shr is a large protein of 1,275 amino acids that has been shown to span the cell wall and 
be exposed to the extracellular environment (58).  Shr has two NEAT domains, Shr-NEAT1 
(Shr-N1) and Shr-NEAT2 (Shr-N2), both of which can bind heme (24).  The two Shr NEAT 
domains are separated by an EF-hand motif and a leucine rich repeat region.  Shr has a signal 
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region in the N-terminus and two domains of unknown function (DUF1533) preceding the first 
NEAT domain.  The C-terminus of the protein has a hydrophobic segment with a positively 
charged tail; presumably to anchor the protein to the cytoplasmic membrane.  Null shr mutants 
displayed attenuated virulence in both zebrafish (47) and murine models of skin and systemic 
infection (59), indicating the possible role of this protein in pathogenicity.  
Sequence alignment of Shr-N1 showed only one tyrosine in the predicted heme binding 
region.  This corresponded to the first tyrosine of the YXXXY pattern as seen in other 
characterized NEAT domains, with threonine in the position of the second tyrosine.  Thus, in 
comparison to the classical heme binding NEAT domains, Shr-N1 may have a novel set of 
ligands binding the heme.  Sequence alignment and homology modeling indicated the likelihood 
that a methionine (M22) is the N-terminal axial ligand.  There are four potential heme binding 
amino acids on the opposite side of the proposed heme binding pocket: M107, H116, Y117, and 
K119.   
Herein we report the biophysical characterization of the heme binding of Shr-N1.  This 
extends work from our laboratories showing that a protein fragment containing the N-terminal 
domain plus the first NEAT domain is sufficient to sequester heme directly from methemoglobin 
(24).  We have characterized the Shr-N1 domain in terms of UV-visible absorption, magnetic 
circular, and resonance Raman spectroscopies, as well as reduction potential; these lead to the 
conclusion that Shr-N1 has a bismethionine ligand set, novel ligands for a NEAT domain.  The 
presumed role of Shr-N1 in vivo is to take heme from hemoglobin and transfer it to the next 
heme binding domain in the heme uptake pathway.  In this regard, we report thermal and 
guanidinium denaturation of the oxidized and reduced Shr-N1 to assess stability of this domain 
towards heme release.   
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7.3 Materials and Methods 
7.3.1 Homology modeling and molecular dynamics 
A homology model of Shr-N1 (Figure 7.2) was built using I-TASSER (60).  IsdX2-N5 
from B. anthracis was the closest protein with an identity percentage of 24%; the root mean 
square difference (RMSD) between the model and IsdX2-N5 was 1.38 Å.  The model was 
visualized using PyMOL (61).  
Dynamic simulations using S. aureus IsdC as a model used an explicit TIP3P (62) water 
cubic box in the Amber 8 program (63).  The all-atom parm99SB force field parameters (64) and 
the heme all-atom force field parameters (65) were used.  During the simulation, a 50 ps 
minimization step with an integration time step of 0.001 ps followed by two steps with an 
integration time step of 0.002 ps at 300 K (a 50 ps MD step and a 50 ps equilibration step) were 
used to minimize and equilibrate the system in a NTP ensemble to a pressure of 1 bar (1 bar = 
100 kPa) and a temperature of 300 K.  This was followed by a 15 ns dynamic simulation step at 
300 K with an integration time step of 0.002 ps.  Structures were visualized in PyMOL (61) and 
VMD (66).   
7.3.2 Construction, expression and purification of Shr-N1 and Shr-N1 K119A 
The recombinant Shr-N1 protein expressed from plasmid pEB11 was previously 
described (24).  Site-directed mutagenesis was used to construct a recombinant Shr-N1 mutant 
with K119A amino acid substitution (Shr-N1-K119A).  The mutant was constructed using a 
QuickChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies) according to the 
manufacturer’s instructions. DNA amplification was performed with the mutation-containing 
primers ZE641 (5' GATTTAAACCACTATGACGCATACACCAAACTTGACATG 3') and 
ZE642 (5' CATGTCAAGTTTGGTGTATGCGTCATAGTGGTTTAAATC 3') using plasmid 
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pEB11 as a template, generating plasmid pCN2.  The proteins were expressed in E. coli XL1 
blue strains grown in a Luria-Bertani (LB) medium containing 100 µg/mL ampicillin.  
Inoculation was done with an overnight pre-culture and cells were grown at 30 °C.  When the 
OD600 of the culture reached 0.5 – 0.6, protein expression was induced by adding 
anhydrotetracycline (AHT) to a final concentration of 200 ng/mL.  The culture was incubated 
overnight at 27 °C.  Cells were harvested by centrifugation at 8000 g and 4 °C.  The cell pellet 
was resuspended in extract solution (20 mM Tris-HCl, 100 mM NaCl, Triton X-100 0.1%).  
Protease inhibitor (Roche Complete Mini, EDTA-free) cocktail was added to the cell suspension 
(1 tablet per liter of culture).  The cells were lysed by French press (SIM AMINCO).  The cell 
lysate was centrifuged at 8000 g and 4 °C.   
All of the following purification steps were conducted at 4 °C using fast protein liquid 
chromatography and all buffer solutions were pH 8.0 unless specified otherwise.  The protein 
supernatant was loaded onto a Strep-Tactin Superflow column (5 mL, IBA BioTAGnology), 
washed with 15 column volumes of buffer A (100 mM Tris-HCl, 150 mM NaCl, pH 8.0) and 
eluted with 10 column volumes of buffer B (100 mM Tris-HCl, 150 mM NaCl, 2.5 mM d-
desthiobiotin, pH 8.0) via a linear gradient.  Protein fractions were collected and analyzed for 
purity using sodium dodecyl sulfate polyacrylamide gel electrophoresis.  Minor differences in 
the optical spectra were observed as a function of the buffer type.  The Shr-N1 protein has been 
isolated in the ferric state and in some instances isolated as a mixture of ferric and ferrous states.  
Native-PAGE gel electrophoresis and size exclusion chromatography (Sephacryl S-200, 
GE Healthcare) were used to determine protein oligomerization state.  Shr-N1 was passed 
through a column with 50 mM sodium phosphate and150 mM NaCl at pH 7.0.  Fractions that 
200 
contained protein were also analyzed using Native-PAGE and UV-visible absorption 
spectroscopy.  
7.3.3 Magnetic circular dichroism spectroscopy 
Magnetic circular dichroism (MCD) spectra were measured with a magnetic field 
strength of 1.41 T by using a JASCO J815 spectrophotometer.  The instrument was equipped 
with a JASCO MCD-1B electromagnet and interfaced with a Silicon Solutions PC through a 
JASCO IF-815-2 interface unit.  Data acquisition and manipulation using Cary or Jasco software 
has been previously described (67).  To ensure homogeneity of ferric oxidation for the proteins, 
ferricyanide was used to fully oxidize the heme center, followed by desalting chromatography.  
The resulting spectra were compared to data from other heme-containing proteins with known 
active site structures and optical spectra.  All spectral measurements for all proteins were carried 
out with a 0.2 cm quartz cuvette at 4 °C in 50 mM sodium phosphate.  Complete reduction of the 
heme iron was accomplished by adding a few microliters of concentrated sodium dithionite 
solution (25 mg/mL of H2O) with a microliter syringe.  Ferrous−CO adducts were prepared by 
bubbling CO gas into the ferrous protein samples.  UV−visible absorption spectra were recorded 
with a Cary 400 spectrophotometer interfaced to a PC, before and after the MCD measurements 
to verify sample integrity. 
7.3.4 Resonance Raman spectroscopy 
Resonance Raman (rR) spectra were collected using excitation at 413.1 nm from a 
krypton ion laser whose power was adjusted to 2 – 5 mW at the sample.  The spectra of the 
proteins were recorded following oxidation with ferricyanide and buffer exchange by centrifugal 
concentration and dilution to remove excess oxidant and glycerol.  The pH was adjusted by 
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diluting a concentrated stock solution of protein into 20 mM MES, 20 mM TAPS, and 20 mM 
CAPS adjusted to the specified pH. 
7.3.5 Spectrophotometric pH titrations 
Shr-N1was diluted into buffers containing 20 mM MES, 20 mM TAPS, and 20 mM 
CAPS adjusted to pH 6.5.  The sample was titrated to pH 9.5 using 0.5 M NaOH.  In a separate 
titration, the sample was titrated from pH 9.5 to 13 using 0.5 M NaOH.  The data were analyzed 
by global analysis. 
7.3.6 Electrochemistry 
Shr-N1was diluted to 10 μM with 50 mM Tris-HCl, pH 8 and 100 mM NaCl.  A 
mediator solution was prepared by dissolving phenazine methosulfate, 2,6-dimethyl 
benzoquinone, 2-methyl-1,4-benzoquinone, 1,2-napthoquinone-4-sulfonate, and quinhydrone in 
DMSO for a final concentration of 10 mM for each dye.  The final concentration of the mediator 
was 10 μM in the sample cuvette and covered the potential range of 80 – 280 mV.  The titrations 
were carried out under a nitrogen atmosphere using 0.05 M dithionite as the reductant and 0.02 
M ferricyanide as the oxidant.  The Ag/AgCl reference 216 electrode was calibrated using 
buffered quinhydrone at pH 7 (Em = 292 mV vs. NHE) (68).  The UV-visible absorption 
absorbance spectra were recorded at each experimental potential after equilibrium had been 
established, as judged by the cell having reached a constant potential.  
The samples were initially treated with enough dithionite to completely reduce the heme.  
The solution was then titrated with ferricyanide to follow the heme oxidation spectroelectro-
chemically.  The reverse, reductive titration was then carried out by stepwise addition of 
dithionite.  The data were subsequently analyzed by global analysis and fit to a single potential 
model, as the mediator dyes contribute minimally to the overall absorbance changes observed. 
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7.3.7 Guanidinium hydrochloride (GdnHCl) denaturation studies 
Protein unfolding experiments were performed using GdnHCl as the denaturant, 
according to the standard protocols (69).  The unfolding process was followed by UV-visible 
absorption spectroscopy in 50 mM Tris-HCl, pH 7.0 (Varian 50 Bio spectrophotometer, 1.5 mL 
quartz Supracil cuvettes (Spectracell) with 1 cm path lengths), following changes at the Soret, 
using the single cell technique (70-73).  The GdnHCl stock solution concentration was 8.32 M 
(50 mM Tris-HCl, pH 7.0) measured by refractive index (69).  Data were analyzed using 
Equation 1 describing a two-state process (69):   
 
y = [(AbsF + mF[D]) + (AbsU + mU exp[m([D]-[D]1/2)/RT])]/1 + exp [m([D]-[D]1/2)/RT]          [1] 
 
where y is the absorbance at any point along the fitted denaturation curve, AbsF is the absorbance 
of the folded state, AbsU is the absorbance of the unfolded state, m is the slope at the midpoint, 
and also the dependence of the free energy of unfolding on the denaturant concentration, mF is 
the slope of the folded state, mU is the slope of the unfolded state, [D] is the concentration of 
GdnHCl, [D]1/2 is the concentration of GdnHCl at the midpoint of the unfolding curve, R is the 
gas constant, and T is the temperature (Kelvin).   
7.3.8 Thermal denaturation studies 
Thermal denaturation of Shr-N1 was carried out with a UV-visible absorption 
spectrophotometer (Cary 50 Bio) equipped with a temperature control (TC 125, Quantum 
Northwest).  Quartz Supracil cuvettes (Spectracell) with 1 cm path lengths were used.  The 
protein (~5 M) was unfolded in sodium phosphate (50 mM, pH 7.5) and the spectrum (250 – 
800 nm) was recorded every 2 °C from 20 °C to 60 °C after the sample was equilibrated for each 
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temperature.  The samples were cooled to room temperature and observed via UV-visible 
absorption spectroscopy for refolding.  In both the ferric and ferrous proteins, the protein was 
prone to precipitation above 60 °C.  The data were fit to a two-state unfolding model in Equation 
2 (74): 
 
Yabs = {(YF + mFT) + (YU + mUT) exp[ΔHm/R(1/Tm - 1/T)]}/{1 + exp(ΔHm/R(1/Tm - 1/T)]}    [2] 
 
where the ΔHm is the enthalpy of unfolding, Tm is the temperature at which the protein is half 
unfolded and the remaining variables are as described above.  The extent of protein unfolding is 
presented as the fraction of folded protein.  
7.4 Results 
7.4.1 Sequence alignment and homology modeling 
Figure 7.1 shows the ClustalW (75) alignment of Shr-N1 with the following homologous 
NEAT proteins: S. pyogenes Shr-NEAT2 (Shr-N2) and Shp, S. aureus IsdA, IsdB-N2, IsdC, and 
IsdH-N3, B. anthracis IsdX1 and IsdX2-N5, and L. monocytogenes Hbp2-N2.  The alignment 
shows significant differences in the conservation of amino acids and motifs utilized in heme 
binding.  First, Shr-N1 does not contain the YXXXY heme binding motif as seen in the Isd and 
IsdX systems, rather it is an YXXXT sequence.  Second, the SXXXXY/SXXXXF 310 helix 
motif, conserved in the Isd, IsdX and Hbp2 proteins, is not complete, i.e., the Shr-N1 has an 
alanine rather than an aromatic acid at the end of this sequence.  In addition, Shr-N1 does not 
have a tyrosine that corresponds to the β-7 axial tyrosine in L. monocytogenes Hbp2-N2.  All of 
these differences imply that the axial ligands in Shr-N1 are different than those in previously 
described NEAT domains.   
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Figure 7.1 Alignment of the amino acid sequence of Shr-N1 with homologous proteins (selected 
portions shown). The proposed Shr-N1 ligand positions (M22 and M107) are indicated by the 
red triangles. The conserved Isd YXXXY heme binding motif is shown by the blue box. The 
conserved 310 helix SXXXXY motif is shown by the green box. The orange box shows the position 
of the β7 axial tyrosine from L. monocytogenes Hbp2-N2. 
 
Figure 7.2 shows an I-TASSER model of the protein.  The heme cavity is taken to be in 
the lower right corner of the structure as drawn.  Logical axial ligands are M22 on the N-terminal 
side of the protein and one of M107, Y117, H116, or K119 on the C-terminal side.  Structurally, 
the model predicted Shr-N1 to have a β-strand secondary structure.  A small α-helix is also 
observed, with M22 extending from the helix, and the other potential heme binding residues are 
positioned on an unstructured loop opposite M22.   
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Figure 7.2 I-TASSER homology model of Shr-N1.  Shown in magenta are the two proposed heme 
axial ligands, M22 and M107.  Nearby residues H116, Y117, and K119 are also shown in blue, 
orange, and cyan, respectively.  
 
7.4.2 Molecular dynamics 
Molecular dynamics were performed on a homology model of Shr-N1 (Figure 7.3).  In 
the resulting structure, four residues were close enough to bind to the putative heme: M22, 
M107, Y117 and K119.  In the final third of the simulation, M22 was consistently within 5 – 8 Å 
of the heme.  M107 also spent substantial time near the heme iron on the opposite side.  Both 
Y117 and K119 also spent part of this time near the heme.  Thus, the molecular dynamics are 
consistent with M22 and M107 as potential axial ligands, but do not rule out Y117 or K119 in 
the relatively unstructured portions of the three dimensional structure as axial ligands.  
M107 
K119 
Y117 
M22 
H116 
206 
 
Figure 7.3 The distance in Shr-N1 between the side chains of potential heme binding amino 
acids and the heme iron center over time. 
 
7.4.3 Oligomerization of Shr-N1 
Size exclusion chromatography was utilized to determine the oligomerization state of 
Shr-N1 (Figure 7.4).  The elution in Figure 7.4A showed three major bands, two smaller peaks at 
approximately 36 (F1) and 40 mL (F2) and a large peak at 48 mL (F3).  Each fraction was 
analyzed via UV-visible absorption spectroscopy (Figure 7.4B).  Fraction 1 showed very little 
holoprotein; Fractions 2 and 3 were similar and exhibited significantly more heme loading.  An 
SDS-PAGE of each fraction showed a band of approximately 58 kDa (Figure 7.4C) indicating 
each fraction was Shr-N1 (expected molecular weight of 58,944 Da).  Native PAGE showed 
fractions 1 and 2 had a large concentration of multimeric species as seen by the multiple bands 
on the gel (Figure 7.4D).  Fraction 3 (the largest SEC elution peak) gave a single band consistent 
with the dimeric form of the protein (~120 kDa).  The elution volume was also consistent with a 
dimer.   
Additional size exclusion chromatography experiments were performed on protein 
samples with very little protein concentration (maximum peak absorbance at 280 nm of < 0.01).  
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No significant peaks eluting later than the dimer were observed, indicating the protein is found in 
dimers or higher multimers even in dilute solutions (data not shown).  Overall, these results 
indicate Shr-N1 exists predominantly as a mixture of dimer and multimer in solution.   
 
Figure 7.4 Size exclusion chromatography of Shr-N1.(A) The elution trace monitored at 280 nm. 
Three major fractions were observed and collected as F1, F2 and F3. (B) UV-visible absorption 
spectra of the three fractions: F1 (blue), F2 (red), and F3 (black).  Shr-ntdN1 before SEC is 
shown in green. (C) SDS-PAGE of Shr-N1 before SEC and the SEC elution fractions. All bands 
are around 60 kDa. The molecular weight of Shr-N1 is expected to be 58 kDa. (D) Native-PAGE 
of the fractions and Shr-N1 before SEC. 
 
7.4.4 Spectroscopic studies of Shr-N1 
Fe (III) Shr-N1. UV-visible absorption spectroscopy (Figure 7.5) gave a Soret at 409 nm 
and four α,β-bands at 506, 540, 585, and 645 nm in 50 mM Tris-HCl, pH 7.0.  In 50 mM sodium 
phosphate, pH 6.5, the Soret is at 412 nm and the α,β-bands are slightly shifted (505, 535, 570, 
and 640 nm). 
A B
C D
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Figure 7.5 UV-visible absorption absorbance spectra of ferric (solid line) and ferrous (dashed) 
Shr-N1 in 50 mM Tris-HCl, pH 7.0. 
 
MCD spectroscopy was utilized to assist in heme axial ligation determination for Shr-N1.  
The spectra did not match standard axial ligand sets of His, His/His, His/Met, Tyr, or His/Tyr 
(76).  Ferric Shr-N1 at pH 6.5 was then compared to derivatives of the H93G myoglobin (Mb) 
cavity mutant ligated by tetrahydrothiophene (THT) (Figure 7.6).  H93G Mb can bind to THT 
using either five-coordinate thioether or a six-coordinate bis-thioether axial ligation (77).  The 
MCD of Shr-N1 at pH 6.5 resembles the six-coordinate low-spin (6cLS) active site environment 
of the bis-THT H93G Mb, perhaps with some of the heme adopting the mono-THT coordination.  
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Figure 7.6 MCD and UV-visible absorption spectra of Fe (III) Shr-N1 (red), H93G Mb bis-THT 
(blue), and H93G Mb mono-THT (black) at pH 6.5. 
  
Resonance Raman spectroscopy provided additional detail into the heme ligation of Shr-
N1.  The rR spectra of ferric Shr-N1at pH 6.25 is shown in Figure KRxxx.  Ferric Shr-N1 gave 
the following bands: ν3 at 1500, ν11 at 1566, and ν10 at 1622 cm-1.  These frequencies indicate 
predominantly 6cLS heme in an acidic environment.  
Fe(III) K119A Shr-N1.  Homology modeling indicated K119 to be opposite the proposed 
M22 heme binding ligand.  A mutant protein with K119A amino acid substitution gave the same 
spectral signatures as WT Shr-N1 (Figure 7.11 S1) with a Soret at 409 nm and four bands in the 
α,β region.  This finding ruled out K119 as a potential heme binding ligand.  
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Fe(II) Shr-N1.  Shr-N1 is readily reduced by both dithionite and dithiothreitol to give the 
ferrous form of the protein with a Soret at 427 nm as well as α,β-bands at 530 and 560 nm 
(Figure 7.5).  The position of the reduced Soret is the same with both reducing agents.  A weak 
optical band at approximately 640 nm was also observed.   
In the MCD, the reduced Shr-N1 was compared to the H93G Mb mono-THT and bis-
THT model systems spectra at pH 6.5 (Figure 7.12 S2) (77).  The MCD spectrum for the bis-
THT Mb complex is similar to Shr-N1, indicating a bis-Met coordination system for the Fe(II) 
species.  Fe(II) Shr-N1 was also studied at pH 10, but no changes were observed in the spectra as 
a function of pH (data not shown).  
In the Raman spectra, the heme was also shown to be is 6cLS as evidenced by ν3 at 1493 
cm-1 (Figure 7.13 S3) (full reduction with dithionite was shown by the position of ν4 at xxxx).  
This assignment from the rR data of a 6cLS state for the ferrous protein is consistent with the 
visible spectrum and MCD of reduced Shr-N1. 
Fe(II)-CO Shr-N1. Shr-N1was reduced with dithionite in the presence of CO.  The UV-
visible absorption and MCD spectra are shown in Figure 7.14 S4.  Shr-N1 Fe(II)-CO complexes 
at both pH 6.5 and 10.0 exhibit the same spectral signatures.  Comparison with the ferrous-CO 
complex of mono-THT H93G Mb indicate a Met-Fe(II)-CO coordination environment.  In the 
MCD, the intensities of the characteristic peaks and the troughs for Shr-N1 are similar to the 
mono-THT ferrous-CO model system; the only difference is a slight blue-shift (5 nm) for the 
entire spectrum compared to the mono-THT H93G Mb system.  This indicates that upon binding 
of exogenous CO, Shr-N1loses a methionine ligand and adopts a 5C Met-Fe(II)-CO motif.  The 
resonance Raman spectrum of the Fe(II)-CO protein was also consistent with a 6c LS CO 
complex.  
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7.4.5 Shr-N1 pH studies 
A spectrophotometric pH titration of ferric Shr-N1from pH 6 to 9.5 is shown in Figure 
DB9.4.  The data were analyzed by global analysis and were fit to a single acid-base equilibrium.  
Figure DB9.4B shows titration curves at select wavelengths and the fit of the data to this model.  
The residuals are calculated and shown at the bottom of the figure.  The data were fit and gave a 
pKa of 8.15 ± 0.06. 
 
Figure 7.7 Resonance Raman spectra of ferric Shr-N1 as a function of pH.  Soret-excited (413.1 
nm) spectra were recorded in the (A) low frequency and (B) high frequency regions.  Samples 
are 40 μM and prepared in 20 mM MES, 20 mM TAPS, 20 mM CAPS adjusted to pH 6.25 
(black), 8.0 (red), 9.4 (blue), and 11 (pink).  The 6cLS and 5cHS bands are labeled accordingly.   
 
The rR spectra of ferric Shr-N1 over the pH range from 6.25 to 11 are shown in Figure 
7.7.  Figure 7.7A shows the low frequency region, where no pH dependent changes are observed.  
Figure 7.7B shows the high frequency region where porphyrin core size marker bands are 
observed.  At pH 6.25 the heme is primarily 6c and LS (ν3 at 1500 cm-1).  As the pH increases, 
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the intensity of the ν3 corresponding to 6cLS heme decreases, while that due to five-coordinate 
high-spin (5cHS) heme (1487 cm-1) increases.  Thus, the Raman data are consistent with the UV-
visible absorption spectroscopic data.   
MCD was also used to study Fe(III) Shr-N1 at pH 10 (Figure S DC6.3).  In the bottom 
UV-visible absorption panel, a peak is displayed at 605 nm which is due to the presence of a HS 
species, as seen in the rR data.  The MCD spectral comparison to the same Mb derivatives as 
described above showed Shr-N1 to be similar to the five-coordinate, mono-THT model.  These 
results, along with UV-visible absorption and rR data, indicate Shr-N1 has a 6cLS bis-Met heme 
ligation motif at pH 6.5, but loses a methionine as the pH is increased above 10 and to give a 
5cHS mono-Met coordination. 
7.4.6 Electrochemistry 
Figure 7.8 shows the oxidative titration of ferrous Shr-N1with arrows indicating the 
direction of change in absorbance.  The sample was subsequently titrated reductively with 
dithionite (data not shown).  Both sets of data were analyzed by global analysis to yield midpoint 
potentials of 260 ± 9 mV (reductive vs. SHE) and 230 ± 26 mV (oxidative vs. SHE).  Figure 
7.8B shows the titration curves constructed from normalized absorbance at the wavelength for 
maximum Soret absorbance for the reduced heme as a function of potential.  The solid line 
represents the best fit of the data to a single potential model. 
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Figure 7.8 Spectrophotometric redox titration of Shr-N1.  (A) Oxidative titration of ferrous Shr-
N1 with ferricyanide.  The arrows indicate the direction of absorbance change.  The * indicates 
where the mediator dyes have absorbance.  (B)  Titration curves form global analysis of the 
oxidative (▪) and reductive titrations (●) at 427 and 429 nm, respectively.  The midpoint potential 
is reversible with an oxidative Em = 230 ± 26 mV and reductive Em = 260 ± 9 mV.  
 
7.4.7 Unfolding studies of Shr-N1 
Ferric Shr-N1 was treated with GdnHCl to evaluate the denaturant-induced unfolding of 
the protein.  The data fit well to a standard two state transition model (Figure 7.9) with a 
midpoint of the transition at 0.90 ± 0.01 M GdnHCl.  The unfolding of the ferrous Shr-N1 gave a 
D1/2 value of 1.10 ± 0.01 M.  Thus, the ferrous protein is only slightly more stable to chemical 
denaturation than the ferric protein. 
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Figure 7.9 Fraction of folded ferric (diamonds) and ferrous (circles) Shr-N1 as a function of 
GdnHCl concentration.  The absorbance changes were monitored at 411 and 427 nm for the 
ferric and ferrous data, respectively.  Data from the titrations were fit via nonlinear least 
squares to a two state unfolding model.  Protein samples were in 50 mM Tris-HCl, pH 7.0. 
 
Thermal denaturation provides another method of assessing the ease of heme loss due to 
protein unfolding.  The normalized thermal denaturation curve as a function of folded protein for 
ferric Shr-N1 is shown in Figure 7.10.  The data were fit to a two state unfolding process, giving 
a Tm value of 47.0 ± 0.1 °C.  The sample could be recooled beneath 60 °C; spectral analysis 
indicated only approximately 75% refolding.  Thus, thermal unfolding for this protein is not a 
completely reversible process.   
Unfolding data for the ferrous form of the protein are shown in Figure 7.10.  Fitting the 
denaturation as a two state process gave a Tm of approximately 55 °C.  The sample precipitated 
above this temperature.  As with chemical denaturation, the reduced protein appears to be 
slightly more stable toward unfolding than the oxidized protein.   
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Figure 7.10 Normalized fraction folded of ferric Shr-N1 (diamond) and ferrous Shr-N1 (square) 
as a function of temperature followed by UV-visible absorption absorbance.  Data from the 
unfolding were fit via nonlinear least squares to a two state unfolding model.  Protein samples 
were in 50 mM potassium phosphate, pH 7.5.  In both the ferric and ferrous, proteins were prone 
to denaturation after 60 °C. 
7.5 Discussion 
7.5.1 Heme ligation 
Heme binds to proteins via linkages between the iron center and the atoms from adjacent 
amino acid side chains (78).  Common axial ligands are His, Met, Cys, and Tyr, with others 
employed in selected instances (e.g., Asn, Gln, Lys, and the N-terminal amine).  All canonical 
NEAT proteins reported to date have axial tyrosine ligands (30).  Our data, however, are not 
consistent with an axial tyrosine ligand, but rather ligation by two methionine residues.  Aranda 
et al. predicted Shp, the protein that receives heme from Shr-N1, is related to NEAT proteins 
(50).  Shp is a bismethionine protein.  Although Shr-N1 and Shp have only 19% amino acid 
sequence identity (75), bioinformatics analysis by Honsa et al. (30) indicated that these two 
proteins may be considered as distantly related to the canonical NEAT proteins.   
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At physiological pH, ferric Shr-N1 has bands at 412, 500 and 533 nm, consistent with the 
presence of both LS and HS hemes.  The spectrum is similar to that of known bismethionine 
proteins including E. coli (79) and Pseudomonas aeruginosa (80) bacterioferritin;  S. pyogenes 
Shp (56); and the H102M and R98C/H102M variants of cytochrome b562 (in which a methionine 
replaces the axial histidine to give a possible bismethionine ligand set) (80) (Table 7.1).  
Titration of the model system H93GMb with high concentrations of THT and cooling to 4 oC 
allowed characterization of a ferric (bis-THT) H93GMb six-coordinate LS structure (79).  In 
each of these cases, the Q-band to the blue was significantly larger of the two (Table 7.1).   
The Raman spectra were also consistent with a mixture of 5c HS and 6c LS species. The 
bismethionine heme center has been characterized by resonance Raman spectroscopy for the 
oxidized state of bacterioferritin from A. vinelandii (81) and for the N-acetylmethionine 
complexes of both ferrous and ferric microperoxidase (82).   
The most widely studied bis-methionine protein is bacterioferritin, in which the heme is 
bound to two axial methionine residues from different subunits (83, 84).  This protein can adopt 
various conformations with somewhat different biophysical characteristics.  For example, 
Desulfovibrio desulfuricans bacterioferritin has both HS and LS forms, depending on the buffer 
(85).  Additionally, E. coli covR98C/H102M bacterioferritin can exist as a mixture of LS and HS 
in solution (80). 
In the MCD, for both Shr-N1 and bis-THT H93G Mb, the major trough in the visible 
region is located at 570-575 nm, while the mono-THT model trough is substantially red-shifted 
and at 627 nm.  Overall, the ferric Shr-N1 MCD spectra are similar to both mono-THT and bis-
THT H93G with the bis-thioether a somewhat better fit.  This is consistent with a mixture of the 
five-coordinate and six-coordinate methionine species observed in the Raman spectra.  The
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Table 7.1 Optical absorption bands for proteins with one and two methionine ligands.  Bands 
with the symbol “≈”were approximated from published spectra.  The relative intensities 
(compared to the ≈ 530 nm band) for the ferric Q-bands are given.   
Protein [Fe(III)] Organism Soret 
α,β-Region (≈ 530 nm intensity = 
1.0) 
Reference 
Bacterioferritin 
E. coli 418 -- 531 570 -- (86) 
P. aeruginosa 
417 -- 527 
562 
(0.7) 
-- (86) 
A. vinelandii 
Shp 
S. pyogenes 
420 
≈ 510 
(0.7) 
≈ 
530 
≈ 560 
(0.6) 
≈ 630 
(0.1) 
(56) 
Shp M66A 406 
≈ 490 
(1.2) 
≈ 
530 
-- 
≈ 605 
(0.9) 
Shp M153A 402 ≈ 485 -- -- ≈ 600 
H102M 
cytochrome b562 
E. coli 404 
495 
(1.2) 
530 -- 
610 
(0.9) 
(80) 
R98C/H102M 
cytochrome b562 
(acidic) 
E. coli 
418 -- 528 
≈ 555 
(0.7) 
-- 
(80) 
R98C/H102M 
cytochrome b562 
(basic) 
401 
≈ 486 
(1.2) 
≈ 
530 
≈ 555 
(0.8) 
604 
(0.9) 
H93GMb bisTHT 
Sperm whale 
415 -- 535 
562 
(0.8) 
-- 
(79) 
H93GMb 
monoTHT 
408 
500 
(1.2) 
532 
565 
(0.7) 
603 
(0.7) 
ShrN1 (acidic) 
S. pyogenes 
412 
505 
(0.9) 
535 
570 
(0.6) 
640 
(0.3) 
This work 
ShrN1 (basic) 408 
490 
(1.4) 
535 -- 
605 
(1.1) 
Protein [Fe(II)] Organism Soret α,β-Region Reference 
Bacterioferritin 
Pseudomonas 
aeruginosa 
420 519 554 (86) 
Shp S. pyogenes 428 ≈ 528 ≈ 561 (56) 
ShrN1 (acidic) S. pyogenes 427 530 560 This work 
H102M 
cytochrome b562 
E. coli 430 530 561.5 (80) 
R98C/H102M 
cytochrome b562 
E. coli 426 528 557 (80) 
H93GMb bisTHT Sperm whale 427 528 558 (79) 
  
MCD of ferric H102M cytochrome b562 (also a mixture of 5-coordinate and 6-coordinate species) 
is similar to both ferric Shr-N1 and bis-THT H93G Mb (80).  Ferric Shr-N1 coverts to a HS 
species with a pKa of 8.15.  The R98C/H102M variant of cytochrome b562 is similar, converting 
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to a HS species as the pH is raised (pKa of 7.1) (80).  The ferric Shr-N1 species formed at high 
pH is presumably the five-coordinate mono-methionine heme.   
The spectrum of ferrous Shr-N1 (427, 530 and 560 nm) is consistent with those of other 
ferrous bismethionine hemes (Table 7.1).  Specifically, the spectrum of Shr-N1 is almost 
identical in wavelength and relative Q-band intensity to those of Shp (428, 528 and 561 nm) 
(56), P. aeruginosa bacterioferritin (420, 519 and 554 nm) (86), H102M cytochrome b562 (430, 
530 and 561.5 nm) (80) and the ferrous bis-THT H93G Mb complex (427, 529, and 558 nm, 
fully formed at -40 oC in 60% vol/vol ethylene glycol but with little apparent temperature 
dependence of the spectrum) (77).  In the MCD, the spectrum of the mono-THT H93G Mb was 
not in agreement with that of Shr-N1, indicating that both methionines bind in the ferrous state in 
the protein.  
The ferrous-CO Shr-N1 complex was also investigated.  UV studies in acidic and basic 
pH gave the same spectral profile.  The spectrum of the ferrous Shr-N1 carbon monoxide 
complex (421, 539 and 568 nm) is also consistent with that of the H93G Mb THT/CO complex 
(432, 541 and 572 nm).  In the MCD, comparison with the CO adduct of mono-THT H93G Mb 
gave similar intensities of characteristic peaks and the troughs between the two proteins.  These 
results indicated upon reduction of the heme iron and addition of exogenous CO, Shr-N1 loses an 
axial methionine to form a Met-Fe(II)-CO ligand set.   
The probability of M22 and M107 as Shr-N1 axial ligands is enhanced by the alignment 
of the sequences of the known heme binding NEAT domains: IsdA, IsdB-N2, IsdC, IsdH-N3, 
Shr-N1 and Shr-N2 along with the heme binding protein Shp.  In this alignment, M22 and M107 
of Shr-N1 are at the sequence positions, respectively, of the axial ligands of Shp: M66 and M153 
(50).  The molecular dynamics simulations are also consistent with this conclusion.   
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7.5.2 Electrochemistry 
Shr-N1 has midpoint potentials of 260 ± 9 mV (reductive) and 230 ± 26 mV (oxidative) 
vs. SHE.  Tyrosine-ligated hemes have negative reduction potentials, because the axial tyrosinate 
stabilizes the ferric form of the protein.  Thus, the reduction potential of Shr-N1 rules out 
tyrosine as a potential heme axial ligand.  In contrast, hemes with two axial methionines show a 
very wide range of reduction potentials.  The reduction potential of the bis-methionine H102M 
mutant of cytochrome b562 was +440 mV at pH 4.8, with reduction coupled to coordination-state 
changes (80).  The reduction potential for D. desulfuricans bacterioferritin was +140 mV and 
independent of whether the protein was in the HS (50 mM phosphate buffer) or LS (300 mM 
phosphate buffer) forms (85).  The D. desulfuricans protein has iron uroporphyrin, rather than 
iron protoporphyrin, as the prosthetic group, though it has been proposed that the effect of this 
change on the reduction potential is minor (85).  In contrast to the D. desulfuricans protein, the 
reduction potentials of Azotobacter vinelandii bacterioferritin were -225 and -475 mV for the apo 
and iron loaded forms, respectively (87), while bacterioferritin from Rhodopseudomonas 
sphaeroides had a reduction potential of -204 mV (88).  Thus, the reduction potential of SHR-N1 
is consistent with a bismethionine axial ligand set, although the range of known reduction 
potentials for the members of this class is very wide. 
7.5.3 Oligomerization 
For Shr-N1, protein oligomerization and heme loading were related, with the more 
aggregated form showing less heme loading.  The relationship between these two observations is 
not clear.  There are examples of proteins involved in heme transfer that bind heme at sites other 
than the primary binding site.  For example, ChaN from Campylobacter jejuni has two cofacial 
hemes bound between the two monomers of a ChaN dimer (89).  The x-ray structure of Shp 
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shows a dimer; each of the two monomers binds a heme and two additional hemes are found at 
the interface between the two monomers (50).  Of most direct relevance, Watanabe et al. have 
found that IsdHN3 binds with multiple hemes in two configurations.  They also found that excess 
heme promoted that multimerization of the NEAT domains.  Our work and that of Watanabe et 
al. indicated that multimerization and heme binding seem to be associated processes for NEAT 
domains, although the details may vary depending on the exact system (34).   
7.5.4 Unfolding Studies of Shr-N1 
Shr-N1 can obtain heme from hemoglobin (24).  Presumably it then transfers the heme to 
Shp, unless it is exposed to an abundance of heme; under such conditions, it has been proposed 
that the heme can be transferred from Shr-N1 to Shr-N2 for storage until needed by the cell (26).  
It is of interest to determine how easily the protein releases heme to gain a better understanding 
of the overall heme protein to heme protein transfer process.   
Denaturation with guanidinium hydrochloride is widely used to probe the stability of 
heme proteins (90, 91).  The ferric Shr-N1 D1/2 of 0.90 ± 0.01 M can be compared with other b-
type heme proteins (D1/2) including the hexacoordinated proteins cytochrome b562 (1.5 – 1.8 M) 
(92, 93); OM cytochrome b5 (2.6 – 3.6 M) (70, 94); HasA (2.7 M) (95); MC cytochrome b5 (3.1 
M) (96); SiaA (3.1 M) (23) and the pentacoordinated proteins horse heart myoglobin (1.6 -1.8 
M) (97, 98) and sperm whale myoglobin (2 – 2.5 M) (97-99).  Shr-N1 unfolds the most easily of 
all of these examples; of note also is the steepness of the unfolding transition (m-value of 
approximately 10).  This high m-value presumably is observed because Shr-N1 is found as 
dimers and multimers in solution; the m-values generally increase with the number of 
hydrophobic interactions disrupted in the denaturation (100, 101).  The irreversible nature of the 
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denaturation, and the existence of multimers, precluded calculations of the thermodynamics of 
unfolding (69).   
The unfolding of the ferrous Shr-N1 gave a D1/2 value of 1.10 ± 0.01 M.  Thus, the 
ferrous protein is only slightly more stable to chemical denaturation than the ferric protein.  
Other b-type hexacoordinate proteins have greater D1/2
red - D1/2
ox differences, e.g.,  cytochrome 
b562 has a D1/2
red - D1/2
ox difference of ~ 4.2 M (93) while SiaA has a difference value of 1.9 M 
(23).   
In thermal unfolding studies, Tm values for the ferrous and ferric protein Shr-N1are 
essentially the same.  We are aware of a few other heme proteins for which thermal denaturation 
has been measured in both the ferrous and ferric forms.  Four of these are cytochrome c 
derivatives (His-Met axial ligands), with Tm
red  - Tm
ox of almost 30 °C (102-104).  Cytochrome 
b562, a b-type heme protein with His-Met ligands, has a Tm
red  - Tm
ox value of 15 °C (105).  For 
hemopexin, a b-type heme protein with two histidine ligands, the reduced protein unfolds more 
easily than the oxidized, but by a relatively small margin of about 3 °C (ferric of 64.6 °C and 
ferrous of 61.4 °C) (106).  The similarity of the Tm values of the two oxidation states is 
consistent with the similarity of the D1/2 values in the unfolding induced by guanidinium. 
7.5.5 Role of methionine in heme binding 
 A possible reason for bismethionine ligation of Shr-N1 is to allow uptake of not only 
ferric, but also ferrous, heme.  In general, thioethers bind ferrous heme more tightly than ferric 
heme.  Early model studies with methionine derivatives showed significantly more binding of the 
ligand to the ferrous than to the ferric heme (107, 108). The difference in the affinity of 
methionine for the heme as a function of oxidation state has been used to study protein folding 
(109).  In protein models for bismethionine ligation, the H102M mutant of cytochrome b562 has 
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bisMet ligation in the reduced state.  In the oxidized state, both methionines are bound at neutral 
pH, but addition of base results in only one of the methionines being coordinated to the heme in 
the ferric state (80, 110).  Ferrous H93G Mb forms a monoTHT complex with a Kd value of 10 
µM; a second THT binds with a Kd value of 66 mM at 4°C (77).  The ferric protein forms a 
monoTHT with a Kd value of 2.1 mM at 4°C; preparation of the bisTHT complex required 90 
mM THT at 4°C (79). It should be noted that although a number of lines of experimental 
evidence indicate that thioethers bind Fe(II) more tightly than Fe(III), the crystal structures of 
Fe(II) and Fe(III) iron porphyrins bisligated with tetrahydrothiophene and pentamethylene 
sulfide show essentially no difference in the iron-sulfur bond distances as a function of oxidation 
state (111). 
 Heme transfer studies in the Sia/Hts pathway also indicate that both oxidation states of 
the heme can be transported (22, 26, 48, 56, 57, 112).  It has been shown that Shr-N1 can bind 
heme from methemoglobin (24).  Heme transfer from ferric Shr-N1 to apo-Shp had both a fast 
and a slow phase with rates of 2.50 ± 0.04 s-1 µM-1 and 0.017 ± 0.004 s-1 µM-1, respectively.  
Transfer of ferric heme gave ferrous Shp, apparently arising from autoreduction of this protein 
(26).  The transfer process from Shp to SiaA was fit with initial formation of a complex, 
followed by heme transfer.  The dissociation constants of ferric and ferrous Shp to apo-SiaA, 48 
± 7 μM and 120 ± 18 μM, respectively, indicated that complex formation had little dependence 
on the oxidation state of the heme (22).  Similar rate constants of Shp to SiaA heme transfer were 
reported: 43 ± 3 s-1 for ferric heme and 28 ± 6 s-1 for ferrous heme.  Transfer of either Fe(II) or 
Fe(III) heme from Shp resulted in ferric heme in SiaA, apparently due to spontaneous 
autooxidation (22).  These kinetic results and observations demonstrate the versatility of this 
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heme uptake pathway to allow the binding of not only ferric heme, but also ferrous heme, and 
may be conducive of a method of survival which ensures the cell has heme availability.  
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7.7 Supplementary Information 
7.7.1 Supplementary Figures 
 
Figure 7.11 S1 UV spectral comparison of Fe(III) WT Shr-N1 (solid line) and Fe(III) K119A 
Shr-N1 (dashed line).  Both samples were recorded in 50 mM Tris-Cl, pH 7.0 and oxidized with 
potassium ferricyanide.    
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Figure 7.12 S2 Comparison of the MCD spectra for Fe(II) Shr-ntdN1 at pH 6.5 with mono-THT 
(top panel) and bis-THT H93G Mb (bottom panel).  Experiments were completed in 50 mM Tris-
Cl buffer at 4˚ C.   
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Figure 7.13 S3 Resonance Raman spectra of ferric and ferrous Shr-ntdN1.  Soret-excited (413.1 
nm) spectra were recoreded for the ferric and ferrous forms.  Samples were prepared in 20 mM 
Tris-Cl, pH 8, 0.1% glycerol.  The ferric 6cLS, 5cHS, and ferrous 6cLS marker bands are 
labeled accordingly. 
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Figure 7.14 S4 Comparison of the MCD and UV-visible spectra for Fe(II)-CO Shr-ntdN1 at pH 
6.5 with Fe(II)-CO mono-THT H93G Mb.  Experiments were completed in 50 mM Tris-Cl buffer 
at 4˚ C. 
 
 
8 THE SECOND HEME-BINDING NEAT DOMAIN OF SHR IN STREPTOCOCCUS 
PYOGENES 
This chapter is intended for publication and is verbatim of the manuscript in progress. The site-
directed mutagenesis of the lysine mutants, expression, purification, UV-visible absorption 
spectroscopy, mutant pH titrations, and thermal unfolding were performed by E. B. Draganova at 
Georgia State University. 
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8.1 Introduction 
Iron is a required metal for many living organisms, including pathogenic bacteria (1-3).  
In the human body iron is majorly found in the form of heme (protoporphyrin IX) and bound to 
proteins such as hemoglobin (2).  Pathogens have therefore developed different strategies to 
obtain the necessary iron in the form of heme (3-6).  It has been shown that pathogens can 
synthesize heme, obtain heme from the environment, or evoke both strategies (7, 8).  
Numerous studies have been performed on pathogenic bacteria which utilize 
sophisticated protein machinery to bind and transport heme to the intracellular space (2, 3, 5, 9-
13).  Specifically, Gram-positive bacterial heme uptake pathway studies have focused on 
Corynebacterium diphtheriae (14, 15), Bacillus anthracis (16), Staphylococcus aureus (17, 18), 
and Streptococcus pyogenes [Group A Streptococcus (GAS)] (19-22).  With the exception of C. 
diphtheriae, the heme uptake pathways in B. anthracis, S. aureus, and S. pyogenes employ the 
use of near iron transporter (NEAT) domains (23, 24).  NEAT domains assist in heme binding 
and consist of conserved secondary structural features including β-strands and a 310 α-helix (24).     
The majority of NEAT domains studied to date have been from the Isd heme uptake 
systems such as S. aureus IsdC (25) and IsdH-N3 (26) and B. anthracis IsdX1 and IsdX2-N5 
(24, 27, 28).  These NEAT domains bind heme in a five-coordinate fashion utilizing an YXXXY 
motif in which the first Tyr from the β-8 strand is a heme axial ligand and the second Tyr is 
hydrogen bonded to the first.  Some Isd NEAT domains slightly vary from this canonical heme 
binding motif.  For example, S. aureus IsdB-N2 binds heme with a Tyr in the fifth position and 
sometimes a methionine coordinating the sixth position to form a Met/Tyr ligation (29) and IsdA 
binds tyrosine in the ferric state and histidine in the ferrous state (30).  B. anthracis HalA utilizes 
a YXXXF motif, rather than YXXXY (31).  The proposed hemophore Hbp2 (Hbp2-N2) from 
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Listeria monocytogenes differs in that the axial tyrosine extends from the β-7 strand, rather than 
β-8 (32).  Hbp2-N2 does not utilize a hydrogen-bonding tyrosine to the axial tyrosine and instead 
employs an alanine.   
Recently, our group reported a novel type of NEAT domain from S. pyogenes, Shr-N1, 
which utilizes a bis-methionine axial ligation pair (Chapter 7).  Shr-N1 lacks the YXXXY motif 
and is replaced with YXXXT.  This domain is sensitive to pH, in that at acidic pH it is six-
coordinate low-spin (6cLS) and five-coordinate high-spin (5cHS) in alkaline conditions.  This 
novel NEAT heme ligand set and recent sequence alignment studies by Honsa et al. (24) indicate 
a variety of heme binding motifs may exist among the NEAT family.  
S. pyogenes is a Gram-positive pathogen which cannot synthesize heme (7) and utilizes a 
heme uptake pathway containing NEAT domains to obtain heme from the environment (33-35).  
S. pyogenes is the cause of a variety of infections including toxic shock syndrome and 
necrotizing fasciitis and has shown increasing antibiotic resistance (19, 36, 37).  Inhibiting the 
ability of the pathogen to take heme from the environment by targeting the heme uptake pathway 
may lead to alternative therapies to combat this pathogen.   
The Sia heme uptake system of S. pyogenes is made of multiple proteins which bind and 
transfer heme to the intracellular environment.  The first protein in the pathway, Shr 
(streptococcal hemoprotein receptor), is a cellular surface heme binding protein which can obtain 
heme from methemoglobin (21).  The heme is transferred to a second cellular surface protein, 
Shp (streptococcal cell surface protein) (22, 38, 39) which gives the heme to SiaA (HtsA, the 
periplasmic binding protein) (40-42).  SiaA is part of an ABC (ATP-binding cassette) heme 
transporter including SiaB (the permease) and SiaC (the ATPase) which brings the heme into the 
cell (20, 43-46).    
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Shr contains two NEAT domains, Shr-NEAT1 (Shr-N1) and Shr-NEAT2 (Shr-N2).  
Previous work by our group showed Shr-N1 to utilize a bis-methionine axial ligation set to 
coordinate the heme iron.  Sequence alignment of Shr-N1 with Shr-N2 indicated Shr-N2 to also 
potentially employ a bis-methionine axial ligation using a M26 N-terminal ligand and a M136 C-
terminal ligand.  Heme transfer studies by Ouattara et al. showed Shr-N1 obtains heme from the 
extracellular space and is able to transfer to either Shr-N2 or to Shp, the next protein in the 
pathway.  Transfer of heme between Shr-N1 and Shr-N2 was shown to be reversible and may 
indicate Shr-N2 is used as a storage source of heme.  Shr-N2 is prone to autoreduction, unlike 
the sister domain Shr-N1, and could be utilized as a means of ensuring heme remains bound to 
the protein during storage.   
Herein we report the biophysical characterization of S. pyogenes Shr-N2, extending 
previous work from our laboratories.  We have shown Shr-N2 to have a bismethionine ligand set 
using UV-visible absorption, magnetic circular dichroism, and resonance Raman spectroscopies.  
These data, including determination of the reduction potential, are consistent with a 
bismethionine ligand pair.  In addition, we have probed the role of nearby lysine residues by the 
creation of alanine mutants (K29A and K57A) in the heme binding pocket in regards to 
autoreduction of Shr-N2. Protein unfolding studies via guanidinium hydrochloride and 
temperature of both ferric and ferrous Shr-N2 were also investigated to probe the stability of the 
domain in regards to heme transfer and release.  
8.2 Materials and Methods 
8.2.1 Homology modeling  
A homology model of Shr-N2 was built using I-TASSER, a secondary structure 
prediction program (47).  The program chooses ten similar programs to create the model.  Hbp2-
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N2 from Lysteria monocytogenes was the closest protein with an identity percentage of 18%.  
The model was visualized using PyMOL (48). 
8.2.2 Construction, expression, and purification of WT Shr-N2 and mutants 
The recombinant Shr-N2 protein was cloned as previously described (21).  Site-directed 
mutagenesis was used to construct recombinant Shr-N2 mutants with K29A and K57A amino 
acid substitutions.  100 ng of each primer containing the targeted base change and 75 ng of 
plasmid template were used in the mutagenesis reaction.  Methylated template DNA was 
removed via Dpn1 digestions and mutagenized DNA was recovered by transformation into 
BL21(DE3) competent cells.  Base changes were confirmed using sequence analysis.  Plasmid 
pASK-IBA-12 containing the cloned Strep-tag-neat2 gene was used for the site-directed 
mutagenesis.  The WT protein (E. coli XL1 blue strains) and mutants [BL21(DE3) cells] were 
grown in Luria-Bertani (LB) media containing 100 µg/mL ampicillin.  Inoculation was done 
with an overnight pre-culture and cells were grown at 30 °C.  When the OD600 of the culture 
reached 0.5 – 0.6, protein expression was induced by adding anhydrotetracycline (AHT) to a 
final concentration of 200 ng/mL.  The culture was incubated overnight at 27 °C.  Cells were 
harvested by centrifugation at 8000 g and 4 °C.  The cell pellet was resuspended in extract 
solution (20 mM Tris-HCl, 100 mM NaCl, Triton X-100 0.1%).  Protease inhibitor (Roche 
Complete Mini, EDTA-free) cocktail was added to the cell suspension (1 tablet per liter of 
culture).  The cells were lysed by French press (SIM AMINCO).  The cell lysate was centrifuged 
at 8000 g and 4 °C.   
All of the following purification steps were conducted at 4 °C using fast protein liquid 
chromatography and all buffer solutions were pH 8.0 unless specified otherwise.  The protein 
supernatant was loaded onto a Strep-Tactin Superflow column (5 mL, IBA BioTAGnology), 
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washed with 15 column volumes of buffer A (100 mM Tris-HCl, 150 mM NaCl, pH 8.0) and 
eluted with 10 column volumes of buffer B (100 mM Tris-HCl, 150 mM NaCl, 2.5 mM d-
desthiobiotin, pH 8.0) via a linear gradient.  Protein fractions were collected and analyzed for 
purity using sodium dodecyl sulfate polyacrylamide gel electrophoresis and matrix-assisted laser 
desorption (MALDI) mass spectrometry.  Minor differences in the optical spectra were observed 
as a function of the buffer type.  The Shr-N2 protein is purified as a mixture of ferric and ferrous 
states.  
8.2.3 Magnetic circular dichroism spectroscopy 
Magnetic circular dichroism (MCD) spectra were measured with a magnetic field 
strength of 1.41 T by using a JASCO J815 spectrophotometer.  This instrument was equipped 
with a JASCO MCD-1B electromagnet and interfaced with a Silicon Solutions PC through a 
JASCO IF-815-2 interface unit.  Data acquisition and manipulation using Cary or Jasco software 
has been previously described (49).  To ensure homogeneity of ferric oxidation for the various 
mutants, ferricyanide was used to fully oxidize the heme center, followed by desalting 
chromatography.  The resulting spectra were compared to data from other heme-containing 
proteins with known binding site structures and optical spectra.  All spectral measurements for 
all proteins were carried out with a 0.2 cm quartz cuvette at 4 °C in 50 mM phosphate buffer 
(either pH 6.5 or 10).   
8.2.4 Resonance Raman spectroscopy 
Resonance Raman (rR) spectra were collected using the 441.6-nm emission line from a 
HeCd laser or either 406.7 nm or 413.1 nm emission from a Kr+ laser.  The laser power was 
adjusted to 2 – 5 mW at the sample.  Spectra were recorded at ambient temperature using the 
135° backscattering geometry with the laser beam focused to a line on a spinning 5 mm NMR 
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tube.  Toluene, DMSO, and CH2Br2 were used as external standards for spectral calibration.  
UV-visible absorption spectra were recorded before and after rR experiments to verify that the 
samples were not altered by exposure to the laser beam.  The ferric spectra of the proteins were 
recorded following oxidation with ferricyanide and buffer exchange by centrifugal concentration 
and dilution to remove excess oxidant and glycerol.  The pH was adjusted by diluting a 
concentrated stock solution of protein into 20 mM MES, 20 mM TAPS, and 20 mM CAPS 
adjusted to the specified pH. 
Ferrous Shr-N2 samples (~40 μM) were prepared anaerobically in 5 mm NMR tubes.  
The protein samples were prepared in 0.1 M Tris-Cl pH 8.2 and equilibrated with water-
saturated, O2-scrubbed N2 that had been saturated with water.  After equilibration under the N2 
atmosphere, an 86-fold excess of aqueous sodium dithionite, buffered at the same pH, was added 
using a gas-tight 10 μL syringe.  Laser power for the ferrous samples ranged from 4 to 8 mW.  
Ferrous carbonyl adducts (40 to 75 μM) were prepared by reducing the proteins in 0.1 M Tris-Cl 
pH 8.8 with a 70- to 180-fold excess of buffered sodium dithionite, as described above, except 
that the reduction was carried out under an atmosphere of natural abundance CO or 13CO (99 
atom % 13C) instead of N2.  Laser power for the heme carbonyl samples was held between 2 and 
4.5 mW to minimize CO ligand photolysis. 
8.2.5 Guanidinium unfolding studies 
Protein unfolding experiments were performed using GdnHCl as the denaturant, 
according to the standard protocols (50).  The unfolding process was followed by UV-visible 
absorption spectroscopy in 50 mM Tris-HCl, pH 7.0 [Varian 50 Bio spectrophotometer, 1.5 mL 
quartz Supracil cuvettes (Spectracell) with 1 cm path lengths], following the changes at the 
Soret, using the single cell technique (51, 52).  The GdnHCl stock solution concentration was 
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8.32 M (50 mM Tris-HCl, pH 7.0) measured by refractive index (50).  Data were analyzed using 
the equation describing a two-state process (50):   
 
y = [(AbsF + mF[D]) + (AbsU + mU exp[m([D]-[D]1/2)/RT])]/1 + exp [m([D]-[D]1/2)/RT]  [1] 
 
where y is the absorbance at any point along the fitted denaturation curve, AbsF is the absorbance 
of the folded state, AbsU is the absorbance of the unfolded state, m is the slope at the midpoint, 
and also the dependence of the free energy of unfolding on the denaturant concentration, mF is 
the slope of the folded state, mU is the slope of the unfolded state, [D] is the concentration of 
GdnHCl, [D]1/2 is the concentration of GdnHCl at the midpoint of the unfolding curve, R is the 
gas constant, and T is the temperature (Kelvin).   
8.2.6 Thermal unfolding studies 
Thermal denaturation of Shr-N2 was carried out with a UV-visible absorption 
spectrophotometer (Cary 50 Bio) equipped with a temperature control (TC 125, Quantum 
Northwest).  Quartz Supracil cuvettes (Spectracell) with 1 cm path lengths were used.  The 
protein (~5 M) in sodium phosphate (50 mM, pH 7.5),  the spectrum (250 – 800 nm) was 
recorded every 2 °C from 20 °C to 60 °C after the sample was equilibrated for each temperature.  
The samples were cooled to room temperature and observed via UV-visible absorption 
spectroscopy for refolding.  In both the ferric and ferrous proteins, the protein was prone to 
precipitation above 60 °C.  The data were fit to a two-state unfolding model (53): 
 
Yabs = {(YF + mFT) + (YU + mUT) exp[ΔHm/R(1/Tm - 1/T)]}/{1 + exp(ΔHm/R(1/Tm - 1/T)]} 
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where the ΔHm is the enthalpy of unfolding, Tm is the temperature at which the protein is half 
unfolded and the remaining variables are as described above.  The extent of protein unfolding is 
presented as the fraction of folded protein.  
8.2.7 pH titration – autooxidation and autoreduction studies  
To analyze the autooxidation and autoreduction of Shr-N2, pH titrations were monitored 
via UV-visible absorption spectroscopy.  All samples were allowed to equilibrate for about 10 
min after each addition before a spectrum was obtained.  In the first experiment, Shr-N2 was 
reduced with dithionite followed by removal of the dithionite via ultrafiltration.  Aliquots of 1.0 
M NaOH were added to Fe(II) Shr-N2 in a buffer of 20 mM each CAPS, MES, and Tris-Cl until 
the pH was around 10.  The sample was then back titrated with 1.0 M HCl to the starting pH and 
the experiment was performed again using the same sample.  
In a second pH study, Shr-N2 in 20 mM each CAPS, MES, and Tris-Cl was treated with 
small aliquots of 1.0 M HCl or 1.0 M NaOH over a cumulative pH range of 6.5 - 10.5.  At each 
pH point, the solution was held until it reached equilibrium, e.g., until ASoret changed by less 
than 0.001 over 10 min.  UV-visible absorption spectroscopy was used to monitor the protein 
first in basic pH (10.4), then titrated to an acidic pH (6.6), and finally titrated back to basic pH 
(10.5).  The protein incubated for 24 h at each pH point.   
8.2.8 Electrochemistry 
Shr-N2was diluted to 10 μM with 50 mM Tris-HCl, pH 8 and 100 mM NaCl.  A 
mediator solution was prepared by dissolving phenazine methosulfate, 2,6-dimethyl 
benzoquinone, 2-methyl-1,4-benzoquinone, 1,2-napthoquinone-4-sulfonate, and quinhydrone in 
DMSO for a final concentration of 10 mM for each dye.  The final concentration of the mediator 
was 10 μM in the sample cuvette and covered the potential range of 80 – 280 mV.  The titrations 
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were carried out under a nitrogen atmosphere using 0.05 M dithionite as the reductant and 0.02 
M ferricyanide as the oxidant.  The Ag/AgCl reference 216 electrode was calibrated using 
buffered quinhydrone at pH 7 (Em = 292 mV vs. NHE) (54).  The UV-visible absorption 
absorbance spectra were recorded at each experimental potential after equilibrium had been 
established, as judged by the cell having reached a constant potential.  
The samples were initially treated with enough dithionite to completely reduce the heme.  
The solution was then titrated with ferricyanide to follow the heme oxidation spectroelectro-
chemically.  The reverse, reductive titration was then carried out by stepwise addition of 
dithionite.  The data were subsequently analyzed by global analysis and fit to a single potential 
model, as the mediator dyes contribute minimally to the overall absorbance changes observed. 
8.3 Results 
8.3.1 Sequence alignment and homology modeling 
Figure 8.1 shows the Clustal Omega sequence alignment of Shr-N2 with the following 
homologous proteins: B. anthracis IsdX1 and IsdX2-N5, L. monocytogenes Hbp2-N2, and S. 
aureus IsdA, IsdB-N2, IsdC, and IsdH-N3.  Previous work from our laboratory described the 
emerging diversity among NEAT proteins with regards to heme binding and secondary structural 
motifs (Chapter 7).  This diversity is also evident in the sequence alignment of Shr-N2.  As 
observed for Shr-N1, Shr-N2 does not contain the heme binding YXXXY motif as seen in the 
Isd and IsdX systems.  The second tyrosine is replaced with a leucine (YXXXL) in Shr-N2.  In 
addition, the conserved SXXXXY/SXXXXF 310 helix motif seen in Hbp2-N2 and the Isd and 
IsdX systems is also not conserved for Shr-N2.  The aromatic residue present at the end of the 
sequence is alanine in Shr-N2.  Furthermore, there is no tyrosine located on the β-7 strand in Shr-
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N2 in the position corresponding to the axial ligand in the Hbp2-N2 from L. monocytogenes.  
Together these observations are indicative of Shr-N2 having a unique set of heme axial ligands. 
 
Figure 8.1 Selected alignment of the amino acid sequence of S. pyogenes Shr-N2 with 
homologous proteins.  The proposed Shr-N2 ligand positions M26 and M136 are indicated by 
the red boxes.  The conserved Isd YXXXY heme binding motif is shown by the blue boxes. The 
conserved 310 helix SXXXXY/F motif is shown by the green box. 
 
Figure 8.2 shows the Clustal Omega sequence alignment of Shr-N2 with S. pyogenes Shr-
NEAT1 (Shr-N1) and S. pyogenes Shp.  Both Shr-N1 and Shp have been shown to utilize a 
bismethionine heme axial ligation (38) and (Chapter 7).  Alignment reveals the positions of the 
known heme ligand sets, Shr-N1 (M22 and M107) and Shp (M66 and M153), to be conserved 
with Shr-N2 M26 and M136.  
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Figure 8.2 Selected alignment of the amino acid sequence of S. pyogenes Shr-N2 with Shr-N1 
and Shp.  The conserved methionine residues are shown in the red box and are the previously 
determined heme axial ligands for Shp and Shr-N1 along with the proposed ligands of Shr-N2. 
 
The I-TASSER homology model of Shr-N2 (Figure 8.3) indicated the heme was in an 
exposed position on the surface of the protein.  Based on the sequence alignment and previous 
work on Shr-N1, it was probable that the heme axial ligands for Shr-N2 were M26 from the N-
terminal side and M136 from the C-terminal side of the protein.  The model was in agreement 
with this observation and showed M26 to be located on a small α-helix and the M136 ligand 
extending from an unstructured loop, opposite to M26.  
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Figure 8.3 I-TASSER homology model of Shr-N2.  Shown in magenta are the two proposed heme 
axial ligands, M26 and M136.  Shown in cyan are the predicted lysine residues involved in 
autoreduction (K29 and K57). 
8.3.2 Spectroscopy of Shr-N2 
Fe(III) Shr-N2.  Shr-N2 is isolated as a mixture of oxidized and reduced species (21, 39).  
The purified protein is easily oxidized with potassium ferricyanide and gives a UV-spectrum 
with (Figure 8.4) a Soret at 414 nm and α,β-bands at 507, 533, and 562 nm.  A weak band is also 
observed at 645 nm.   
K29 
K57 
M26 
M136 
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Figure 8.4 UV-visible absorption spectra of oxidized and reduced Shr-N2.  Both samples were 
recorded in 50 mM Tris-Cl, pH 7.0. 
 
MCD spectroscopy was utilized to assist in the determination of the Shr-N2 heme axial 
ligands.  The MCD spectra of Shr-N2 did not match standard axial ligand sets of His, His/His, 
His/Met, Tyr, or His/Tyr (55).  Figure 8 .5  compares Fe(III) Shr-N2 at pH 6.5 with both the 
five- and six- coordinate heme sites of H93G Mb bound with tetrahydrothiophene (THT); H93G 
Mb can bind to THT using either five-coordinate thioether or a six-coordinate bis-thioether axial 
ligation (56).  The UV and MCD spectra indicate ferric Shr-N2 majorly adopts a bismethionine 
ligation in the slightly acidic environment.  In the MCD, the 551 nm peak and the 575 nm 
trough are in a similar position to those observed in the H93G bis-THT spectrum; the same 
peak and trough are red-shifted for the mono-thioether model of H93G.  Although the peaks and 
troughs are in relatively the same position as in the H93G bis-THT spectrum, the intensity of the 
Shr-N2 575 nm trough is closer to the mono-THT spectrum and indicates there could be a 
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mixture in solution. Together, the UV and MCD data indicate ferric Shr-N2 is predominantly 
low-spin (LS) bismethionine at pH 6.5.  
 
Figure 8.5 The UV-visible absorption and MCD spectra comparison of Fe(III) Shr-N2 with 
Fe(III) H93G Mb mono-THT and Fe(III) H93G Mb bis-THT.  Samples were taken in 50 mM 
phosphate, pH 6.5.   
 
Ferric Shr-N2 at basic pH was also investigated (Figure 8.6) and gives a different 
spectrum compared to the acidic form of the protein.  Shr-N2 gives a band in the UV at 608 nm 
which is similar to the HS band marker at 604 nm in the H93G Mb mono-THT model.  In the 
MCD, the visible region peak and trough are located in similar positions to the mono-thioether 
model.  This indicates that basic pH conditions results in Shr-N2 losing an axial methionine and 
forming a five-coordinate high-spin (5cHS) heme ligation. 
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Figure 8.6 The UV-visible absorption and MCD spectra of Fe(III) Shr-N2 with Fe(III) H93G Mb 
bis-THT and Fe(III) H93G Mb mono-THT at pH 10.  Samples were taken in 50 mM phosphate, 
pH 10.   
 
Resonance Raman spectra of Shr-N2 at pH 8 indicated the protein is a mixture of 
oxidation states (as seen after purification) if the protein is not treated with an oxidizing agent 
(Figure 8.7).  The as-isolated protein is a mixture of both Fe(III) and Fe(II) 6cLS as indicated by 
the ν4 band at 1366 cm-1 and the ν3 band at 1502 cm-1.  Upon addition of potassium ferricyanide, 
predominantly Fe(III) 6cLS is detected (increase in ν3 band) along with a minor amount of 
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(FeIII) 5cHS seen at the 1490 cm-1 ν3 band.  These results correlate with the change in heme 
coordination number as a function of pH seen in the MCD.     
 
Figure 8.7 Resonance Raman spectral comparison of as-isolated Shr-N2 (black), Fe(III) Shr-N2 
(green), purified Shr-N1 (fraction 2, red), and purified Shr-N1 (fraction 3, blue).  Samples were 
prepared in 50 mM Tris-HCl, pH 8.0.   
 
Fe(II) Shr-N2.  Shr-N2 can be reduced with either dithiothreitol or sodium dithionite and 
the UV-spectrum gives a Soret at 429 nm and defined α,β-bands at 533 and 562 nm (Figure 8.4).    
The MCD spectrum was compared to Fe(II) bis-THT Mb H93G in Figure 8.8.  Fe(II) 
Shr-N2 does not give a pH dependence as seen in Fe(III) Shr-N2 (data not shown).  The MCD 
shows spectral agreement between Fe(II) Shr-N2 and the model bismethionine system.  
Therefore, Fe(II) Shr-N2 adopts a 6cLS bismethionine ligation at both pH 6.5 and 10. Similar 
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results were seen in the rR spectra of Shr-N2 at pH 8 (Figure 8.9).  Samples were reduced with 
excess dithionite and gave a ν3 band at 1493 cm-1, indicative of 6cLS heme.   
 
 
Figure 8.8 The UV-visible absorption and MCD spectra of Fe(II) Shr-N2 with Fe(II) H93G Mb 
bis-THT.  Samples were taken in 50 mM phosphate, pH 6.5.   
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Figure 8.9 Resonance Raman spectral comparison of Fe(II) Shr-N2 (red), Fe(II) Shr-N1 
(fraction 2, black), and Fe(II) Shr-N1 (fraction 3, blue).  Samples were prepared in 50 mM Tris-
HCl, pH 8.0 and reduced with 100-fold excess reducing equivalents of dithionite.   
 
Fe(II)-CO Shr-N2.  Reduction of Shr-N2 in the presence of carbon monoxide (CO) 
resulted in the formation of the Shr-N2 Fe(II)-CO complex.  Comparison of the UV-visible 
absorption and MCD spectra of the Shr-N2 CO adduct with that of Fe(II)-CO H93G Mb mono-
THT showed the spectra are very similar in both the UV and the MCD.  This indicates that upon 
the addition of CO, Shr-N2 loses an axial methionine and is replaced with a CO ligand.   
8.3.3 Electrochemistry 
Spectroelectrochemical titration of Shr-N2 is shown in Figure 8.10 covered the potential 
range from 50 – 300 mV through two oxidative and reductive cycles. The arrows on the 
absorbance spectra show the direction of absorbance change as the potential was decreased.  The 
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bottom panel shows the absorbance at the reduced Soret maximum as a function of potential for 
both cycles. The average oxidative potential is 256 ± 9 mV vs. SHE, and the average reductive 
potential is 275 ± 10 mV vs. SHE. These data sets agree within error and the potential appears to 
be irreversible with a difference of ~ 60 mV.  
 
Figure 8.10 Redox potential titration of Shr-N2. A mediator cocktail (10 μL of each dye) that 
covered the potential range from 50 – 300 mV was titrated to the sample through two oxidative 
and reductive cycles. This restricted range has the advantage of minimizing absorbance changes 
due to mediators. The oxidative and reductive titration data sets are shown in the top panel. The 
bottom panel shows the absorbance at the reduced Soret maximum (428 nm) as a function of 
potential for both cycles.  
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8.3.4 pH titration – autooxidation and autoreduction 
As-isolated Shr-N2 is a mixture of oxidized and reduced heme and is prone to apparent 
autoreduction, even in the presence of oxygen (21).  To probe this phenomenon, a series of pH 
titrations were performed.  In the first, the fully reduced sample in air was treated with small 
aliquots of 1 M NaOH (Figure 8.11A).  There was essentially no change in the visible spectrum 
as the pH was increased to 10.4.  The sample was then back-titrated to pH 6.2 with 1 M HCl 
(Figure 8.11B).  The protein converted from the reduced species, with a Soret at 428 nm, to the 
oxidized species, with a Soret at 411 nm.  The sample was approximately half oxidized and half 
reduced.  To see if further changes occurred over time, the sample was held at this pH for 
approximately an hour, and continued to oxidize until it was primarily in the ferric form.  The 
apparent pKa of the autooxidation was 6.5 – 7.5 as judged by single-wavelength and global 
fitting (data not shown).  During the titration, there was increasing absorbance in the 375 nm 
region, presumably indicating some protein denaturation and heme loss.   
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Figure 8.11 pH titrations of Shr-N2. A) NaOH titration of Fe(II) Shr-N2. (B) The second NaOH 
titration titration. 
 
Another pH titration was performed on Shr-N2 with longer incubation times between 
changes in pH (Figure 8.12).  Shr-N2 at pH 10.4 was approximately 65% in the reduced form at 
the beginning of the experiment and did not change over 17 h.  The pH was adjusted to 6.6, the 
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reduced Soret began to decrease, and the sample was completely oxidized after 24 h.  Figure 
8.12B shows that this conversion was not isosbestic.  When the pH of this sample was increased 
to 10.5, only a small amount of protein re-reduced.  Overall, the tendency of the protein to 
autoreduce and autoxidize was variable; experiments to evaluate the effects of EDTA as a metal 
chelator or glycerol and amine-containing buffers as electron sources gave inconsistent results.   
 
Figure 8.12 pH titration of Shr-N2 in 20 mM each CAPS, MES, and Tris-HCl at 4 oC monitored 
by UV-visible absorption spectroscopy. (A) After equilibration in each step. (B) Equilibration 
between step 1 and step 2 in panel A at 1 h intervals. 
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8.3.5 Guanidinium and thermal unfolding studies 
To assess the ease of unfolding of Shr-N2, the protein was treated with increasing 
concentrations of GdnCl.  The data were fit with a standard two state transition model (Figure 
8.13).  The midpoint of the transition was at 2.2 ± 0.1 M GdnCl for the ferric protein and 
approximately 2.6 ± 0.5 M GdnCl for the ferrous protein.   
 
Figure 8.13 GdnCl unfolding of oxidized (black diamonds) and reduced (red squares) Shr-N2 in 
50 mM Tris-Cl, pH 7.0. 
 
Thermal unfolding of ferric and ferrous Shr-N2 was also performed to compare the 
overall protein stability between heme oxidation states (Figure 8.14).  Both proteins were 
unfolded and the data were fit to a two-state transition model.  Ferric Shr-N2 gave a Tm of 68.7 ± 
0.2 °C compared to a Tm of ≈ 75 °C for ferrous Shr-N2.  Ferrous Shr-N2 tends to precipitate out 
of solution above 80 °C. 
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Figure 8.14 Thermal unfolding of oxidized (black squares) and reduced (red diamonds) Shr-N2 
in 50 mM potassium phosphate, pH 7.0. 
 
8.4 Discussion 
8.4.1 Bismethionine axial ligation 
Sequence alignment and homology modeling indicated M26 and M136 to be the potential 
heme binding residues of Shr-N2.  The domain of Shr, Shr-N1, also utilizes a Met/Met heme 
ligation as previously reported by our group (Chapter 7).  Additionally, the observed reduction 
potential of Shr-N2 ~ +260 mV indicated tyrosine was not an axial ligand.  Reduction potentials 
measured for heme proteins with tyrosine as an axial ligand are very low (57).  For example, S. 
marcescens HasA, with a histidine/tyrosine ligand set, has a redox potential of −550 mV (58).  
Additionally, MCD spectra of Tyr and Met/Tyr models did not match the spectra for Shr-N2 in 
either the ferric, ferrous, or ferrous-CO states.  
The most probable ligand pair candidates were either Met/Met or Lys/Met.  Both of these 
ligand pairs would be consistent with the observed reduction potential of about ~ +260 mV, 
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leaving reduction potential alone unable to identify the heme ligand pair.  Ethylbenzene 
dehydrogenase from Aromatoleum aromaticum, with a Lys/Met axial ligand set, has a reduction 
potential of +254 mV (59), while the reduction potential of dimethylsulfide dehydrogenase, also 
thought to have a Lys/Met axial ligand set (59, 60), has a reduction potential of approximately 
+320 mV (61) (60).   
Although K29 and K57 in Shr-N2 are near the heme pocket (and adjacent to the proposed 
Met axial ligands) according to homology modeling (Figure 8.3), it is possible that these residues 
are playing a role in stabilization of the bound heme through interactions, such as salt bridges, 
with the heme propionates.  Cationic side chains have showed to play such a role in other heme 
proteins (62).  Lysine could also be present in order to facilitate autoreduction (discussed below). 
Site-directed mutagenesis ruled out the possibility of a Met/Lys or Lys/Lys heme ligation system 
in Shr-N2.  
UV-visible absorption spectral data comparing Shr-N1 and Shr-N2 showed similarities 
between ferric species and are almost identical in the ferrous oxidation state.  Ferric Shr-N1 
gives a Soret at 409 with α,β-bands at 506, 540, 585, and 645 nm, similar to ferric Shr-N2 (414, 
507, 533, 570, and 645 nm).  Although there are slight differences in optical spectra maxima, 
there are little known examples of other bismethionine heme systems in which to compare.  
From the comparisons which can be made, optical data for these proteins and models systems 
show a wide variety of optical spectra.  In addition, sequence alignment indicated a 
bismethionine pair for Shr-N2 based on known heme ligation for S. pyogenes Shr-N1 and Shp 
which also utilize two methionines for axial ligation.  Therefore, the experimental data for Shr-
N2 can be interpreted to indicate the protein utilizes a bismethionine axial ligation.    
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8.4.2 Autoreduction 
Shr (21, 63) and the Shr-N2 domain (21) are isolated as a mixture of oxidized and 
reduced species.  The extent of as-isolated Shr-N2 autoreduction ranged from 20% to 80%.  In 
the presence of 1% EDTA during protein purification, Shr-N2 was also isolated as a mixture of 
oxidation states.  Such findings could indicate metal ions in solution are not serving as the 
primary source of electrons for the autoreduction phenomenon.  No effort was made to exclude 
oxygen during purification, indicating that autoreduction still occurs in the presence of oxygen. 
Changes in pH show Shr-N2 to either readily autoreduce or autooxidize.  Upon acid and 
base titration, the protein goes initially to a mixture of the Fe(II) and Fe(III) forms that are 
dependent on pH.  Attainment of equilibrium at a new pH (as shown by no further changes in the 
optical spectrum) takes approximately two hours.  The apparent pKa of this process is 6.5 – 7.5.  
The residue responsible for this pKa is presumably not the heme propionic acids, as it would be 
expected that deprotonation to give a propionate would stabilize the ferric form of the protein, 
and Shr-N2 autoreduces as the pH of the solution increases.   
The autoreduction/autooxidation process occurs smoothly through one cycle of pH 
increase and decrease, and to some extent in a second cycle (Figure YC4.21).  The process seems 
to occur in an amine-containing buffer (e.g., Tris-HCl), but not in phosphate buffer.  For the 
titration in the latter buffer, addition of Tris-HCl two hours after the start of the experiment does 
not result in autoreduction.   
Autoreduction of other heme proteins has been reported.  Some of the most studied 
proteins (64) are the cytochromes cH and cL from Methylobacterium extorquens [originally called 
Pseudomonas AM1 or Methylobacterium AM1 (65)].  Cytochrome cL acts as an electron 
acceptor for methanol dehydrogenase, and transfer electrons to cytochrome cH (66).  Cytochrome 
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cH then donates electrons to oxidase.  Cytochrome cL is a protein of 21 kDa with a low isoelectric 
point (pI) of 4.2 and a reduction potential of +256 mV (64).  It has a six-coordinated cysteine-
covalently-bonded heme c with a histidine as the fifth ligand (67).  The sixth ligand is Met109 in 
solution (68) and His112 in the crystal (67), indicating the relatively flexible nature of the heme 
binding site.  Cytochrome cH is a protein of 11 kDa with a high pI of 8.8 and a reduction 
potential of +294 mV (64).  The heme at the binding site is covalently bonded to a cysteine and 
six-coordinate with Met and His (69).  For these cytochromes, the autoreduction is first-order in 
30% glycerol, with a rate constant that increases by approximately a factor of five as the pH of 
the solution is raised from 9 to 11 (64).   
In other studies, cytochrome c552 from the Gram-negative bacterium Pseudomonas 
alcaliphila AL15-21T is isolated in an almost fully reduced state when grown at pH 10 (70).  
This cytochrome can be reoxidized by potassium ferricyanide, absence the presence of glycerol, 
and autoreduces at basic pH, but not at neutral pH.  The redox potential of the heme in this 
protein is also sensitive to pH, increasing from +228 mV to +276 mV (Em values) as the pH is 
raised from 7.0 to 8.3.   
Cytochrome c6 from Monoraphidium braunii, with a pI of 3.6, is also purified 
predominantly in the reduced state and autoreduces after being oxidized with ferricyanide above 
pH 8 (71).  The reduction potential of this cytochrome is about +358 mV at pH 5.5 – 7, and pH 
dependent between pH 7 and 9 (decreasing to about +300 mV at pH 9).  Cytochrome ƒ, a 
Japanese radish protein, undergoes a slow autoreduction with a midpoint potential of +350 mV 
(72).  Overall, the higher the reduction potential of the heme, the more likely it is to reduce, as 
expected.  Although most reports of autoreduction have not involved formal studies of the 
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process, it does seem that Shr-N2, with a reduction potential of +260 mV, is at the low end of the 
proteins that easily autoreduce. 
The source of reducing equivalents in the Shr-N2 autoreduction process is not clear.  
Adventitious metal ions are known to contribute to the autoreduction of cytochrome c (73).  
Neutral tyrosine radicals might be able to contribute to autoreduction of yeast cytochrome c (74).  
The observation that the protein is isolated as a mixture of oxidized and reduced protein even in 
the presence of EDTA argues that metal ions are not the primary source of electrons in the case 
of Shr-N2. 
Shr-N2 has 19 lysines and a pI of 9.74.  It is possible that deprotonation of a lysine near 
the heme allows autoreduction to take place.  Such a mechanism was proposed for the 
cytochrome cL system (75) in which it was hypothesized that increasing the pH resulted in 
deprotonation of a nearby group, which was then able to transfer an electron to the iron center.  
In model systems, amines readily reduce iron porphyrins in solution (76-87).  It could be that 
case that K29, K57, or both are contributing to the autoreduction of Shr-N2. 
In conjunction with the observation of facile autoreduction of Shr-N2, it is worth noting 
that the two genes in the sia operon after siaC, siaD and siaE, a proposed exporter with 
significant homology to ABC transporters, in particular, the CydDC exporter system from E. 
coli.  CydDC exports cysteine in an ATP-dependent process; it also exports glutathione (88-90).  
The cydC and cydD genes are part of an operon containing cydAB, which encodes for terminal 
bd-type respiratory oxidases and are required for the assembly of the oxidases.  Experimental 
studies have shown that CydDC controls the redox milieu outside the cell membrane, potentially 
influencing the formation or reduction of disulfide bonds of the Dsb protein disulfide folding 
pathway (90).  In a study of the E. coli system, the periplasm became more oxidizing as Dsb 
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proteins were removed, indicating that these proteins are part of the redox balance in the 
periplasmic space (91).  Removing DsbC alone increased the reduction potential by about 10 
mV. 
It could be the case that SiaD and SiaE form a similar exporter system as CysDC in 
which the reduction potential is controlled by the export of glutathione and cysteine.  The redox 
potential of a cell is approximately -200 to -250 mV (92).  The effective redox potential of the 
environment of Shr-N2, anchored in the cell wall, is unclear.  In E. coli, the redox potential of 
the periplasm is about -165 mV (91), significantly higher than that of the cytoplasm.  Presumably 
the cell wall milieu has an even higher redox potential and may be influencing the autoreduction 
of Shr-N2.  
8.4.3 Unfolding studies and oxidation state 
Both chemical and thermal unfolding titrations were performed on ferric and ferrous Shr-
N2.  In both studies, ferrous Shr-N2 was more resistant to unfolding than ferric Shr-N2.  Given 
the reduction potential of free heme is about −60 mV (93) and the experimental reduction 
potential for Shr-N2 of approximately +260 mV, the ferrous state will bind heme approximately 
five orders of magnitude more tightly than the ferric state.  Overall, as the reduction potential of 
the bound heme increases, the ferric protein loses heme more readily than the ferrous protein.  
This can be due to a variety of effects:  destabilization of the ferric heme only, stabilization of 
the ferrous heme only, or differential stabilization of the two states such that the binding in the 
ferric form is disfavored with respect to binding in the ferrous form. 
8.4.4 The mechanism of heme uptake 
In visualizing the mechanism of heme uptake, it seems most likely that heme enters the 
pathway in the ferric form.  This is consistent with the rapid autooxidation of hemoglobin once it 
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is released from the cell (94), making ferric hemoglobin (methemoglobin) the most probable 
source of heme.  It is also consistent with experimental studies in which methemoglobin is a 
source of heme for Shr-N1 and Shr-N2 (21).  It was also shown that the full Shr construct 
accepts heme from methemoglobin (95).   
 Recent heme transfer studies of either Shr-N1 or Shr-N2 to apo-Shp show Shr-N1 
to be the heme donor to Shp in a two-phase process with second-order rates of 2.5 s-1μM-1 and 
0.017 s-1μM-1 (22).  In addition, studies of heme transfer between the two domains were also 
performed using stopped-flow spectrophotometry.  Results showed Shr-N1 rapidly and 
reversibly transfers heme to Shr-N2.  Heme transferred from oxidized Shr-N1 to apo-Shr-N2 
showed to be a mixture of oxidized and reduced heme. This indicates the very facile 
autoreduction of Shr-N2.  Shr-N2 autoreduces as the pH is raised and reoxidizes as the pH is 
lowered.   In the absence of added oxidants and reductants, the process takes about two hours.  It 
is possible that both the reduced and oxidized forms of Shr-N2 are important in the heme transfer 
process.  In particular, the next protein in the pathway, Shp, has an active site in which the heme 
is bound by two methionines (38, 39, 96) and has been shown to be able to bind ferrous heme.  
Methionine ligands are known to bind ferrous heme more tightly than ferric heme (97-99).  This 
was also observed in the guanidinium and thermal unfolding studies of the protein with the 
ferrous species being more resistant to unfolding in both cases.  
  As discussed above, the redox potential of the heme bound in Shr-N2 is 
about +260 mV, which translates to a binding of the ferrous heme that is about six orders of 
magnitude tighter than the ferric form.  The tighter binding of the ferrous form would seem 
inconsistent with the proposal that the ferrous form is transferred to Shp.  However, the strength 
of binding of the heme and its transfer rate are not necessarily correlated.  For example, transfer 
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of heme from Shp to SiaA has been described as formation of a protein complex followed by 
heme transfer within the complex (42).  Both the equilibria for binding and the rate constants for 
transfer within the complex are very similar for the ferric and ferrous oxidation states, with 
values of approximately 100 µM for formation of the complex and 30 – 50 for heme/hemin 
transfer within the complex.  For SiaA, the reduction potential determined via spectro-
electrochemistry is about +75 mV (average of oxidative and reductive processes) (20).  Taking 
the SiaA binding constant for hemin as > 1012 M-1 and the reduction potential for free heme as -
75 mV gives a binding constant for ferrous SiaA of 1013 M-1.   
Outtara et al. proposed that in a plentiful heme environment the heme transferred to Shr-
N1 can either transfer directly to Shp or give to Shr-N2 as a means of heme storage.  If levels of 
heme become low, the cell can then transport the stored heme from Shr-N2, to Shr-N1 which 
delivers the heme to Shp.  This idea was based on the kinetic studies discussed above in which 
Shr-N2 transfers heme to Shp slowly. Shr-N2 autoreduction may be a means in which to store 
heme for Shr until needed by the cell as reduction of the heme results in a more stable protein as 
indicated by unfolding studies.  The proposed SiaDE exporter may work to control the reduction 
of Shr-N2 and ultimately assist in the regulation of this pathway.  
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9 GENERAL CONCLUSIONS 
This dissertation investigated the biophysical and biochemical characteristics of heme-
binding proteins in heme uptake pathways found in Corynebacterium diphtheriae and 
Streptococcus pyogenes.  These studies contribute to the growing field of heme protein 
structure/function determination.  Many pathogenic bacteria which utilize the human as a host, 
including antibiotic resistant pathogens, require iron to survive and commonly obtain the needed 
iron in the form of heme (1, 2).  Studies have shown the deletion of bacterial heme uptake 
pathways can diminish the survival of these pathogens.  It is of increasing interest to understand 
these proteins in more detail in order to potentially design therapeutic agents as an alternative to 
antibiotics.  
Many reviews have highlighted studies of b-type heme transfer proteins from Gram-
positive, Gram-negative, and other types of bacteria (1-11).  These studies utilize a combination 
of site-directed mutagenesis, UV-visible absorption, fluorescence, circular dichroism (CD), 
magnetic circular dichroism (MCD), resonance Raman (rR) and electron paramagnetic resonance 
spectroscopies, along with mass spectrometry (MS) and X-ray crystallography to shed light on 
the mechanism of heme binding and transfer.  These proteins have shown to utilize a variety of 
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heme binding motifs, commonly ligating the heme iron in a six-coordinate fashion with a 
combination of His, Tyr, or Met with the His/Tyr coordination being the most rare.  Five-
coordinate Tyr-ligated proteins have also been observed (12).  Based on the emerging themes of 
heme ligation, it was of importance to investigate other proteins which could lead to new insights 
into bacterial heme uptake.  
Chapters 2 – 4 provided a detailed look into the important amino acid residues involved 
in heme binding of the substrate binding protein HmuT from C. diphtheriae.  This protein was 
studied using various spectroscopic techniques such as UV-visible absorption, CD, MCD, and rR 
spectroscopies.   Other techniques including site-directed mutagenesis, electrospray ionization 
mass spectrometry (ESI-MS), chemical and thermal unfolding, pH titrations, and heme 
reconstitution were also performed.  Initial sequence alignment and homology modeling of 
HmuT indicated the protein to utilize a His/Tyr motif which is not a common binding system for 
heme proteins; only four others have been studied to our knowledge (13).  In addition, HmuT 
utilizes a histidine from the N-terminal region of the protein and a tyrosine from the C-terminal 
end of the protein which is opposite to what other His/Tyr heme proteins use.  In light of these 
findings, HmuT was studied in detail to add to the growing types of heme transfer protein 
studies.  
Chapter 2 was a detailed spectroscopic look at the heme axial ligation of HmuT (13).  A 
combination of site-directed mutagenesis, UV-visible absorption, MCD, and rR spectroscopies 
showed the heme to be ligated by H136 and Y235.  HmuT was studied in both the ferric and 
ferrous oxidation states, as well as the ferrous-carbonyl (Fe-CO) state.  Reduction of WT HmuT 
was only possible in the presence of CO and dithionite indicating a very negative reduction 
potential; another characteristic of tyrosine-ligated heme proteins.  It was also shown through 
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hemoglobin-iron utilization studies that Y235 is essential for HmuT heme uptake.  Additionally, 
WT HmuT was not affected by changes in pH, while the axial ligand mutant Y235A was altered 
by pH and gave a pKa of 6.3 ± 0.1.  MCD of this mutant indicated a water bound in place of the 
tyrosine and was the lowest known pKa for b-type heme proteins with a water bound trans to a 
histidine. 
The studies performed in Chapter 2 shed light on other amino acids which although are 
not directly binding to the heme, may be of importance to the protein and were therefore 
investigated in Chapter 3.  HmuT and mutants (axial ligands and other residues) were studied 
with site-directed mutagenesis, UV-visible absorption spectroscopy, rR spectroscopy, thermal 
unfolding, and collision-induced heme dissociation experiments via mass spectrometry.  The pH 
studies performed in Chapter 2 indicated the possibility of a hydrogen-bonding amino acid 
residue to the axial tyrosine.  Based on conservation, R237, Y272, and M292 were mutated to 
alanine and studied.  In addition, a conserved tyrosine, Y349, was also studied although not 
predicted to be near the heme pocket.  Thermal unfolding showed Y235A (axial ligand mutant), 
R237A (predicted hydrogen-bonding partner), and Y349A (predicted to be involved in protein 
folding) were most affected by temperature with reduced melting temperature differences of ~10, 
13, and 17 degrees, respectively, compared to the WT. 
Collision-induced heme dissociation with ESI-MS complemented the thermal unfolding 
results showing R237A to lose heme in a similar fashion compared to one of the axial ligand 
mutants, H136A.  Heme-bound Y235A was not detected by the MS, indicating the importance of 
this residue as a heme axial ligand.  This study also showed the removal of M292 effected heme 
binding.  This is the first example of a collision-induced heme dissociation study on a heme 
transfer protein.  A similar study has been performed on myoglobin and cytochrome b5 (14).  
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This collision mass spectrometry experiment could potentially be an easier method to estimate 
the relative contribution of amino acids in heme protein binding pockets.    
A recent crystal structure of holo-HmuT from C. glutamicum has been resolved and 
confirmed the His/Tyr heme axial ligation determined by our spectroscopic studies in C. 
diphtheriae (15).  The structure also indicated that an arginine residue is most likely the 
hydrogen-bonding partner to the axial tyrosine.  Two different heme orientations were also 
detected for the structure.  Contrary to the crystal structures of the sister proteins Pseudomonas 
aeruginosa PhuT (16) and Shigella dysenteriae ShuT (16), the heme propionates of C. 
glutamicum HmuT do not appear to form any hydrogen bonds with other residues in the pocket 
which may be allowing the multiple orientations of the heme in the pocket.  Overall, these 
findings were in line with the spectroscopic evidence presented in our work on C. diphtheriae 
HmuT.      
Proteins from the streptococcal iron acquisition (sia) heme uptake pathway in S. pygoenes 
were also investigated.  Chapters 5 and 6 examined the SiaA heme protein which is similar to 
HmuT in that both are substrate binding proteins to the respective ABC transporters. SiaA differs 
from HmuT in heme axial ligation by using a His/Met binding motif rather than a His/Tyr (17).  
The SiaA protein has been shown to take a very long time to unfold, as indicated by chemical 
time-scale unfolding studies (18).  These same studies showed that SiaA unfolds in two phases, 
rather than one.  The two unfolding phases are indicative of the heme bound to the protein in two 
different orientations.  Differences in heme orientation have been seen in other heme proteins 
such as horse heart myoglobin (19) and cytochrome b5 (20).  The half-lives of the fast and slow 
phases for the WT SiaA and non-axial ligand mutants ranged from 1 – 3 h and 8 – 50 h, 
respectively, indicating the importance of other amino acids in respect to the heme binding of 
286 
these proteins.  This slow process of unfolding may assist in the heme transfer process which 
allows a change of conformation sufficient to release the heme without the risk of the protein 
proceeding along an unfolding pathway that could leave it dysfunctional. 
Chapters 7 and 8 discussed the first and second NEAT domains from the Shr 
(streptococcal hemoprotein receptor) protein in S. pyogenes.  Shr delivers heme to the protein 
Shp which in turn transfers heme to SiaA.  NEAT (near iron transporter) domains are conserved 
groups of 150 amino acids which share similar secondary structure (21, 22).  These domains are 
mainly β-stranded and include a 310 α-helix in which a serine residue extends and hydrogen-
bonds with a heme propionate.  Characterized NEAT proteins studied to date show the domains 
utilize a conserved YxxxY heme binding motif in which the first tyrosine binds to the heme and 
the second tyrosine hydrogen-bonds to the first (21).  A detailed bioinformatics study in 2014 by 
Honsa et al. indicated other NEAT heme-binding motifs are likely to be discovered and therefore 
it was of interest to characterize the NEAT domains of S. pyogenes.   
Our work on Shr-NEAT1 (Shr-N1) and Shr-NEAT2 (Shr-N2) showed the first example 
of NEAT domain proteins which utilize a bismethionine axial ligation, rather than a five-
coordinate tyrosine in a YxxxY motif.  A combination of site-directed mutagenesis, UV-visible 
absorption, MCD, and rR spectroscopies, along with spectroelectrochemical and pH titrations 
were used to determine this novel ligand set.  Both proteins were isolated as a mixture of ferric 
and ferrous forms with the coordination number of the heme sensitive to pH e.g. Shr-N1 is six-
coordinate methionine in acidic pH and five-coordinate methionine in alkaline conditions.   
Shr-N2 exhibited a rare phenomenon of heme autoreduction in which the protein converts 
bound ferric heme to ferrous heme, even in the presence of oxygen.  Downstream of the sia 
operon, in which Shr is encoded, are the genes which encode for a cysteine and glutathione 
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exporter which, proposed in a similar system in E. coli, acts as a redox regulator (23).  It could 
be the case that the facile reduction of Shr-N2 may be controlled by this exporter in vivo.  
Ouattara et al. have proposed through kinetic studies that the role of Shr-N2 is to store heme for 
use by the pathogen in low heme environments.  It is known that methionine ligands bind tighter 
to ferrous iron rather than ferric (24).  A control of the Shr-N2 reduction by the exporter could be 
linked to the need to either store or release heme in this protein based on the environmental 
availability of heme to the pathogen. 
The work on both HmuT and SiaA has shown that heme binding is not only dictated by 
the amino acids which bind directly to the heme, but is also influenced by other nearby residues.  
In addition to spectroscopy and unfolding studies, the collision energy voltage mass 
spectrometry experiment performed on HmuT and mutants provided a novel method to estimate 
the relative contribution of amino acids to heme binding in heme transfer proteins.  The 
unfolding studies of SiaA added to the examples of heme proteins which can bind heme in 
different orientations and showed that heme protein unfolding can be very slow.            
This dissertation has exemplified the variety of heme binding motifs heme transfer 
proteins are able to employ.  Although SiaA utilizes a commonly known His/Met ligand system, 
HmuT uses a rarer His/Tyr ligand set, yet the proteins are similar in function.  In the case of the 
NEAT proteins from S. pyogenes, a look into the literature would lead to the assumption that the 
heme is most likely coordinated with a tyrosine.  In contrast, our work has shown that these 
proteins use a novel bismethionine coordination, rather than the canonical YxxxY motif.  
Although common heme binding ligands for heme transfer proteins include His, Tyr, and Met, it 
could be the case that other amino acids such as Cys or Lys may be discovered in the future as 
axial ligands for heme transfer proteins. 
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